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This project focused on the recent global reforms in TB diagnostic policy and the 
implementation of Xpert MTB/RIF (GeneXpert) diagnostic technology into the health 
system, as a case to assess the extent to which software issues - particularly the human 
qualities of the system – mediates policy implementation. It centres the experiences of 
frontline workers in local implementation contexts as imperative because of frontline 
workers’ have discretionary power and influence in their practice. The premise of this mini-
dissertation is that researchers and policy makers should centre the lived experiences of 
service delivery level health workers when implementing policy or programmatic reforms. 
This may deepen people-centred approaches which is essential for health systems 
strengthening. This mini-dissertation is structured into three parts:  
Part A: This is the research protocol that was submitted for ethical review and approval to 
the Faculty of Health Science Ethical Review Committee (FHSERC). The protocol frames 
the study objectives and the initial intentions of the research study. The justifications for the 
research question, theoretical framework, the research design, methods for data collection 
and analysis and timelines are clearly presented and discussed. 
Part B: Using GeneXpert policy reform implementation as a pathfinder, this section presents 
an undertaking of a structured narrative review of the existing literature addressing the major 
barriers and enablers for health systems implementation reform. This review assesses the 
extent to which people issues and people-centred practices are considered in policy 
implementation research of GeneXpert. The aim of this section of the dissertation is to 
identify and map-out literature considering the human experiences and relationships of 
frontline health workers and how these may intersect with hardware, contextual and social 
systemic factors, that may potentially mediate the implementation of GeneXpert TB 
diagnostic policy. 
Part C: This section presents the background, methodology, findings and interpretations 
from the research, as a journal-ready manuscript. This paper seeks to contribute to the policy 
implementation literature in the field of HPSR from the perspective of centering nurses' lived 
experience – especially nurses who are overburdened and undervalued – as imperative in the 
field of inquiry. The main findings reflect that nurses are burdened by the pressure to meet 
policy targets, the encumbrance to enforce administrative and bureaucratic procedure, and the 
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minimal platforms or pathways to input on challenges and innovations back to higher level 
management and decision makers. Within the context of top-down, target-driven and highly 
structured and standardized operational processes for diagnosing TB, nurses navigate 
multiple overlapping and contradictory modes of being in their interactions with patients as a 
response to these pressures. This paper seeks to offer voice to nurses’ experiences of 
implementing TB diagnostic policy in PHC settings in SA considering its relationship with 
broader systemic and contextual influences. It also raises particular issues about tensions 
between efforts to achieve efficiency and effectiveness through enforcing the system, and 
facilitating people-centered and responsive practices in implementation. 
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ACRONYMS,	  ABBREVIATIONS	  &	  DEFINITIONS	  
AIDS       Acquired Immunodeficiency Syndrome  
 
HIV       Human Immunodeficiency Virus  
 
NDoH      National Department of Health  
 
PHC       Primary Healthcare  
 
WHO       World Health Organisation  
 
HPSR      Health Policy and Systems Research  
 
TB       Tuberculosis  
 
MDR TB      Multi-drug Resistant Tuberculosis  
 
XDR TB      Extreme-drug Resistant Tuberculosis 
 
GeneXpert MTB/RIF® Xpert Diagnostic Technology (Test) 
 
Contact Any person who has been exposed to someone 
who is TB positive  
Health Policy and Systems Research  A field that seeks to understand and improve 
how societies organize themselves in achieving 
collective health goals, and how different actors 
interact in the policy and implementation 
processes to contribute to policy outcomes. By 
nature, it is interdisciplinary, a blend of 
economics, sociology, anthropology, political 
science, public health and epidemiology that 
together draw a comprehensive picture of how 
health systems respond and adapt to health 
policies, and how health policies can shape − 
and be shaped by − health systems and the 
broader determinants of health (Alliance for 
Health Policy and Systems Research, 2011) 
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Software Factors Health system software encompasses the 
institutions (norms, traditions, values, roles and 
procedures) embedded within the system. 
Hardware Factors  Health system hardware includes the particular 
organizational, policy, legal and financing 
frameworks that structure any health system, as 
well as its clinical and service delivery 
requirements 
Health System(s) Health system(s) consists of all organizations, 
people and actions whose primary intent is to 
promote, restore or maintain health. This 
includes efforts to influence determinants of 
health as well as more direct health-improving 
activities. A health system is therefore more 
than the pyramid of publicly owned facilities 
that deliver personal health services. It includes, 
for example, a mother caring for a sick child at 
home; private providers; behaviour change 
programmes; vector-control campaigns; health 
insurance organizations; occupational health and 
safety legislation. It includes inter-sectoral 
action by health staff, for example, encouraging 
the ministry of education to promote female 
education, a well known determinant of better 
health. 
People-centred Health Systems  People-centred health systems is an approach to 
health systems thinking that consciously adopts 
the perspectives of individuals, families and 
communities, and sees them as participants as 
well as beneficiaries of trusted health systems 
that respond to their needs and preferences in 
humane and holistic ways. People-centred care 
requires that people (both patients and 
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providers) have the education and support they 
need to make decisions and participate in health 
systems and healthcare. It is organized around 
the health needs and expectations of people 
rather than diseases. 
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STUDY	  PROTOCOL	  
Premise  
Implementation of policy is a universal challenge across the health system. This is 
primarily because the health system is a complex adaptive system (Gilson, 2012). Health 
systems strengthening through embracing complexity have thus increasingly become the 
focus to combat gaps in policy implementation (Gilson, 2012). Strengthening the health 
system demands a greater need to understand the complexity of the system at all levels and 
how different factors influence the components, processes and relationships that make-up the 
health system for different policy issues and contexts. This study will use TB control and its 
associated policy and implementation issues to uncover deeper meanings of factors that 
mediate the implementation of GeneXpert TB diagnostics. 
Tuberculosis (TB) is one of the leading global health challenges (Raviglione & Pio, 
2002). For many years new international policies have been implemented within different 
countries in a global attempt to combat this infectious disease (Raviglione & Pio, 2002). 
However, TB control strategies and implementation have not been without challenges. 
Efforts to combat TB are continuously changed and developed, resulting in the perpetual 
introduction of new and revised policies and technologies (Palamountain et al., 2012). The 
continuous reform in TB control strategies has made it difficult to assess the effectiveness of 
previous and existing efforts (Palamountain et al., 2012). Some reports assert that TB 
programmes have had limited success for the outcomes of TB outcomes (Dye & Williams, 
2010; Storla, Yimer & Bjune, 2008).  
Early case detection, treatment initiation, treatment follow up, continuity of care, 
adherence and multidrug resistant management are some of the areas that are important in TB 
control, yet many gaps exist in these domains in countries most burdened by the disease 
(Lönnroth et al., 2009; Piatek et al, 2013; Raviglione & Pio, 2002). Many report that health 
system and related challenges in the implementation of TB control policies are significant 
contributors to these shortfalls (Loveday, Smith & Day, 2013; Storla, Yime r& Bjune, 2008).  
Subsequently, it is important to focus to the implementation of TB control policies. It 
is essential to understand implementation from a health systems perspective (Gilson, 2012). 
More importantly, health care workers and their experience of the health system are 
important for effective implementation of TB control strategies (Gilson, 2012). It is thus 
becoming more significant to hone in on how health workers’ experiences and their ‘doing’ 
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of policy influences actual implementation processes (Buse, Mays & Walt, 2005), especially 
for a dynamic policy arena such as TB control.  
 
Background 
i. Global impact of TB  
Tuberculosis (TB) is a communicable bacterial disease that is caused by 
Mycobacterium tuberculosis. It most commonly affects the lungs but the infection can spread 
to other parts of body (Knechel, 2009). Although TB can be treated with a six-month regimen 
of antibiotics it is one of the major contributors to disease and death worldwide (Knechel, 
2009). Even with slow declining TB rates internationally it is reported that approximately 9 
million new TB cases were detected in 2013 of which 13% of these were HIV infected 
individuals (Churchyard et al., 2014). Furthermore, 1.3 million TB-related deaths were 
estimated during this time. It is further predicted that approximately 45% of all TB cases 
globally are undetected (Churchyard et al., 2014).The WHO has characterised 22 high TB 
burdened countries (Churchyard et al., 2014). These countries are predominantly low to 
middle income countries (LMIC) and account for about 82% of all approximated incidences 
of TB cases internationally. With the rise of HIV infection in many low to middle income 
countries, TB/HIV co-infection has resulted in increasing mortality and morbidity 
(Churchyard et al., 2014). WHO (2015) reports that 2.1 million people globally became HIV 
incident cases in 2013 where most of incident cases were found in sub-Saharan Africa. In 
addition, co-infection has contributed to the increase in more complicated forms of TB that 
are difficult to manage and treat such as multi-drug resistant (MDR-TB) and extreme 
multidrug resistant TB (XDR-TB) (Churchyard et al., 2014). It is thus evident that countries 
affected by TB are also burdened by high rates of HIV incidence and prevalence. 
ii. TB/HIV co-infection  
Human immunodeficiency virus (HIV) infection is the leading risk factor for the TB 
incidence and contributor to the development of the disease from latent infection to active TB 
disease (Kochi, 2001). 2008 reports show that there were 1.4 million TB incident cases 
among HIV-infected individuals, therefore accounting for about 26% of AIDS-associated 
mortalities worldwide (Churchyard et al., 2014). 30% of the 33.2 million people are currently 
living with HIV are anticipated to be TB-positive (Churchyard et al., 2014). A strong 
association thus exist with the progression of TB and HIV infection as TB infection worsens 
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immunosuppression in HIV-infected individuals. Furthermore, TB/HIV co-infection has 
complicated the diagnosis and treatment of TB in HIV positive individuals (Loveday, Smith 
& Day, 2013). Key reasons for the gaps in TB control in high TB/HIV burdened countries are 
related to the complexities and inadequacies to diagnose individuals with TB (Palamountain 
et al., 2012; Perkins & Cunningham, 2007). South Africa is a country that is particularly 
burdened by high prevalence and incidence rates of people who are co-infected.  
iii. TB disease burden in South Africa 
South Africa’s TB burden is propelled by the HIV epidemic of the country. When 
adjusting for population size, SA has the highest incidence and prevalence of TB globally 
(Churchyard et al., 2014). It also has the largest number of HIV/TB co-infection cases and 
the second largest amount of diagnosed MDR-TB cases worldwide (India being the largest) 
(Churchyard et al., 2014). In 1994, the post-apartheid government established the National 
Tuberculosis Programme (NTP) in attempt to address TB control. This programmed faced 
challenges related to integrating TB services into inadequate primary health care settings in 
the context of an emerging HIV epidemic (Churchyard, 2014). Subsequently, TB incidence 
cases grew substantially post 1994. A further burden was added with the rise in MDR-TB and 
the emergence of extensively drug-resistant (XDR) TB in 2006 that overstretched health 
services (Churchyard, 2014). In order to respond to the dual epidemics of HIV and TB 
rationally, SA formulated the integrated National Strategic Plan (NSP) for HIV, STIs and TB 
(2012 - 2016). The targets set in the NSP for TB were to reduce TB incidence and mortality 
by 50% in 2016 and reduce incidence of TB cases by 100%. Although SA has made notable 
progress in reducing TB prevalence, mortality rates and improving treatment outcomes for 
new smear-positive TB cases, the burden of TB remains substantially high. This has 
primarily been attributed to the limitations in and barriers to effective detection and diagnosis 
of TB. In addition to implementing the fundamentals of TB diagnostics and treatment, 
strengthening TB control calls for novel approaches including the adoption of new 
technologies including drugs, diagnostics and technologies. It is foreseen that the scaling up 
the use of Xpert MTB/RIF as a replacement for sputum smear microscopy has potential to 
further accelerate progress towards TB control in South Africa and other high burden 
countries.  
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Because of its infectious quality, the diagnosis and detection of TB plays an important 
role in controlling the spread of the disease (Knechel, 2009). TB diagnostics further play a 
key role in TB control because undetected TB cases and late diagnosis of TB may result in 
infected persons being left untreated. Not detecting and diagnosing cases at earlier stages 
may result in the burdening of the health system with aggravated cases of TB that may be 
difficult to treat and manage (Storla, Yimer & Bjune, 2008).  However, current clinical and 
organization efforts in the health system to facilitate early detection and diagnosis of TB are 
not successful in mitigating the spread of infection (Wilson et al., 2011). Limitations in 
diagnosing TB have been of the main contributing factors to the negative impacts of the 
disease in high burdened countries (Storla, Yimer, & Bjune, 2008). There are certain 
diagnostics tools for a number of years but there is a need for improved or novel approaches. 
It is hoped that GeneXpert can address some of the limitations in conventional diagnostic 
technology.  
  a. Conventional diagnostic methods   
Until recently, there has been a high dependence on using sputum smear microscopy 
and chest X-rays as primary diagnostic tools for TB (Evans, 2011). These methods have their 
own limitations in addressing contemporary issues associated with the complexities of 
HIV/TB co-infection and drug resistant strains of TB that are difficult to detect 
(Palamountain et al, 2012). For example, standard TB diagnostic technologies have reduced 
sensitivity in co-infected persons (Evans, 2011; Perkins & Cunningham 2007). Co-infected 
persons are likely to have a false negative result when utilizing a sputum smear test 
diagnostic tool, resulting in significant numbers of active TB incident cases remaining 
undetected and undiagnosed. In addition, the cost of X-rays as a TB diagnostic tool makes it 
less feasible for under resourced settings. Overall, diagnosing TB using conventional 
methods has become increasingly intricate, arduous and expensive for applying to complex 
TB cases such a MDR/XDR TB and co-infection (Evans, 2011). It is thus argued that efforts 
to combat TB should focus on strengthening mechanisms for detecting TB cases through 
innovative diagnostic and screening technologies (Evans, 2011). The MTB/RIF Xpert 
diagnostic test has been introduced as an innovation that can possibly address the gaps in the 
current diagnostic efforts in TB control (Chang et al., 2010; Dorman, 2010; Piatek et al., 
2013).  
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b. MTB/RIFXpert diagnostic technology  
The Xpert MTB/RIF diagnostic test is a single test that detects TB faster and is 
sensitive to resistant strains of TB (Chang et al., 2010). It is thus effective in identifying cases 
of multi-drug resistant1 (MDR) TB or extreme resistant2 TB (XDR TB) and is sensitive to co-
infection (Chang et al., 2010). After the World Health Organization (WHO) endorsed the 
Xpert MTB/RIF assay in early 2011, over 20 countries accepted and implemented policy 
reform for TB diagnostics to include the use of this innovative technology in health care 
settings (Churchyard et al., 2014). These are all high TB burdened low to middle income 
(LMIC) countries. National governments and policy makers have been at the frontline of 
decision making about adopting, implementation and scaling up the technology (Weyer et al., 
2013). Apart from increased sensitivity in detecting co-infection and resistant forms of TB, 
there number of other benefits that support the implementation of GeneXpert.  
GeneXpert is argued to be favourable as it is foreseen to contribute effectively to 
diagnosing TB despite the health system context or circumstance for a given country or 
facility. The Xpert MTB/RIF diagnostic test is programmed, thus special skilled staff or 
sophisticated facilities are not required to run the test (Chang et al, 2010). The turnaround 
time for Xpert MTB/RIF result is two hours post commencing the test and does not require 
intensive operational time, administration and management (Chang et al., 2010). In addition 
to its efficiency, the test has potent TB killing properties, thus eradicating biosafety concerns 
to a greater degree (Banada, 2010). The main requirements for the Xpert MTB/RIF 
technology are a steady and stable electrical power source, temperature regulation, and an 
annual refurbishment of the cartridge components (WHO Rapid Implementation, 2011). This 
technology is unlike conventional methods in that it provides a more practical solution to low 
resource health systems as it may facilitate effective and efficient TB diagnosis and treatment 
in high burden diseases. This is especially at primary care level that serves high burdened 
communities with limited resources and other health systems constrains (Palamountain et al., 
2012).  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
1Multidrug-­‐resistant	  TB	   (MDR	  TB)	   is	   caused	  by	  an	  organism	  that	   is	   resistant	   to	  at	   least	   isoniazid	  and	   rifampin,	   the	   two	  most	  potent	  TB	  
drugs.	  These	  drugs	  are	  used	  to	  treat	  all	  persons	  with	  TB	  disease	  (Chang	  et	  al,	  2010).	  
 
2 Extensively drug resistant TB (XDR TB) is a rare type of MDR TB that is resistant to isoniazid and rifampin, plus any 
fluoroquinolone and at least one of three injectable second-line drugs (i.e., amikacin, kanamycin, or capreomycin) (Chang et al, 
2010). 
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Being directed at low-resource settings and point of care facilities to simplify 
patients’ access to early and accurate diagnosis, MTB/RIF test is anticipated to play a central 
role in reducing mortality and morbidity associated with diagnostic delay and misdiagnosis 
(Palamountain et al., 2012).  This technology thus offers approaches to improve diagnostic 
capacities of point-of-care services to easily and efficiently identify affected patients to 
enable and accelerate the initiation of appropriate TB treatment (Palamountain et al., 2012). 
Although there are a number of crucial benefits, the actual effectiveness has yet to be 
determined. However, there is a need to ascertain the effectiveness of GeneXpert in 
addressing the challenges in TB diagnosis and control and whether its implementation is 
meeting its intended expectations.  
 Existing literature on the effectiveness of diagnostic test in experimental conditions 
report that MTB/RIF Xpert test has proven to be effective in early and accurate detection of 
TB, thus reducing aversive outcomes of TB linked with delays in diagnosis (Helb et al., 
2009). The test is reported to have high sensitivity compared to other diagnostic methods for 
TB (Palamountain et al, 2012). Studies found that Xpert MTB/RIF is more sensitive and 
specific when detecting TB in both HIV negative and positive patients compared to smear 
microscopy (Palamountain et al, 2012).In addition, a meta-analysis done on the overall 
accuracy of Xpert MTB/RIF assay for diagnosing TB and RIF-resistance found that the 
accuracy in diagnosis for MTB/RIF test is higher in smear-positive specimens (Chang et al., 
2012). Nevertheless, although diagnostic technologies are found to be effective in 
preliminary studies where they are trialled and tested in smaller and usually close- to-ideal 
conditions, their robustness and effectiveness often lessen when implemented in ‘real-world’ 
settings (Lawn & Nicol, 2011). 
Literature available on the implementation of point of care MTB/RIF Xpert provide 
differing perspectives. For example, Lawn et al. (2013) argue that Xpert MTB/RIF has 
advanced sensitivity and specificity in experimental settings but this is similar to that of 
microscopy when implemented in clinical settings. In addition, other scholars report that the 
actual turnaround time for GeneXpert for most patients are not significantly reduced when 
implemented in a primary health care facility in SA compared to conventional methods 
(Clouse et al., 2012). This is contradictory to the known benefits of GeneXpert which 
includes a 2 hour turnaround time. It is thus necessary to question the relevance of this new 
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technology if its sensitivity and specificity for detecting TB is akin to traditional techniques 
and if other the benefits such as reduced turnaround time does not occur when Xpert is 
implemented in clinical and point of care facilities. Nevertheless, other scholars report more 
positive outcomes and that GeneXpert has improved effectiveness (Fielding et al., 2014). 
Literature reports that GeneXpert has provided a solution to many of the bottlenecks 
and challenges in the health system (Boehme, 2012). Much of the literature evaluating the 
effectiveness of Xpert MTB/RIF test against traditional methods in detecting TB in clinical 
settings has repeatedly shown high efficacy and performance, especially when used under 
testing conditions and target environments advised by the WHO (Lawn et al., 2011; Lawn et 
al., 2013; Weyer, 2013). Some authors found that GeneXpert has more practical benefits for 
faster diagnosis and detecting complex TB cases compared to traditional microscopy and X-
ray TB screening and diagnostic techniques (Boehme, 2012; Lawn et al., 2013). These results 
are consistent with outcomes from initial trial studies on GeneXpert that supported its 
adoption and implementation. Other authors also state that the implementation of GeneXpert 
has improved patient access and accuracy in diagnoses when implemented (Lawn et al., 
2013; Piatek et al, 2013).  
Despite these reports, there is still much work that needs to be done to uncover the 
outcomes, performance, effectiveness and efficiency of TB policies and technologies in ‘real-
world’ settings (Lawn & Nicol, 2011; Lawn et al., 2013; Van Rie et al., 2010). This is the 
same for XpertMTB/RIF. This is especially for primary care settings with lower level health 
workers that are often neglected in complex health systems (Van Rie et al., 2010). 
Furthermore, the impact and effectiveness of TB programmes like GeneXpert technology 
further depends on how it is implemented within the particular settings it is designed to 
operate in (Piatek et al., 2013). SA was of the first countries to roll out GeneXpert where it 
was decided based on cost considerations to implement instruments in national laboratories 
and microscopy centres (Clouse et al., 2012).  
 
v. GeneXpert in South Africa  
South Africa adopted a phased approach to implement GeneXpert technology in 
health facilities across high TB burden districts in all nine provinces (Fielding, 2004). 
Initially, Gene Xpert has been tested in facilities in the Western Cape, Kwazulu-Natal and the 
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Gauteng where approximately 30 machines have been bought by the state. Exactly two years 
after the launch, 203 instruments have been put in place. 1,180,669 tests have been carried 
out across all nine provinces. Public officials support reports from piloting phases that argue 
for an urgent need to have the Gene Xpert in all clinics in South Africa. With plans for rapid 
implementation and prospective scaling up proposals, the national strategy for the roll out of 
GeneXpert is to be implemented in 2-3 years.  
The national policy for the implementation of GeneXpert is based on the compelling 
WHO recommendation that the technology be used as the initial diagnostic tool in suspected 
MDR-TB, XDR-TB and HIV/TB co-infected cases. The National policy does not yet include 
the exclusive use of Xpert MTB/RIF for diagnosing EPTB (Pulmonary TB), largely for 
reasons of data insufficiency that proves that GeneXpert can effectively diagnose pulmonary 
TB compared to conventional methods of TB diagnosis. This demonstrates the complexity of 
TB diagnosis for different form of TB and how implementation of GeneXpert requires 
careful consideration to meet positive outcomes.    
Despite the need to consider the complexities of TB in the implementation of 
GeneXpert, earlier findings from process evaluations suggests that case detection for 
individuals suspected of having active TB has increased to an average of 14% and detection 
of drug resistant stands of TB is averaged at 7%. However, more impact evaluation reports 
are needed to ascertain the extent of effectiveness of the implementation to GeneXpert in SA. 
While the GeneXpert machine itself is relatively easy to operate, as demonstrated by 
the Minister in 2011, implementing and integrating the machines into the health system is 
proving to be less simple (Fielding et al., 2014). 
vi. Implementation of GeneXpert 
 
Health systems challenges make it difficult for national policy makers to decide to 
adopt novel programmes and technologies. Experience has showed us that merely 
introducing technology is not sufficient to undertake and solve multifaceted public health 
issues (Lonnroth et al. 2009; Raviglione & Pio 2002). The complexity of the health system 
presents specific challenges for the implementation of reform. This is especially for TB 
initiatives because TB policies constantly undergo reform or revision. As countries start 
implementing Xpert MTB/RIF, the reform introduces particular technical and organizational 
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challenges (Dorman, 2010; Schneider, Gilson, Ogden, Lush, & Walt, 2006). There therefore 
are a number of factors that contribute to implementation.  
A wide range of interacting factors mediates the actual implementation of any 
programme in a particular setting. Factors that mediate the implementation transcends 
beyond the programme guidelines or the mechanics of the programme itself (Scott et al., 
2014; Lawn, & Nicol, 2011). These influences operate at the point at which the particular 
programme and the health system intersect (Gilson, 2012). These influences can be grouped 
into hardware and software issues.  
Hardware elements are defined as the structural components that shape the 
functioning of the system (Gilson, 2012). An example of hardware factors that influence 
implementation is limitations in the health system and resource constraints (Gilson, 2012). 
How a specific country adapts new policy (such as prioritizing target populations for 
screening and testing) may be determined by the extent of available resources. Despite good 
policies for delivering suitable innovative technologies and adapted by national policy 
makers, health system constraints are key influences in contributing to the ineffectiveness of 
some of TB control policies in LMIC countries (Zumla & Cobelens 2012). Other examples of 
hardware factors that may influence the implementation include challenges pertaining to 
financing, monitoring and evaluation, facility preparedness, human resources and capacity 
issues, and so forth (Lawn, & Nicol, 2011; Schneider, Gilson, Ogden, Lush, & Walt, 2006). 
In contrast, software elements are defined as the social, intangible or indirect factors 
that may also influence implementation (Gilson, 2012). Software elements that may 
potentially influence implementation include organizational culture, issues of power, decision 
making, health worker motivation, diffusion and integration of the programme, 
actor/stakeholder buy-in, health workers’ experiences of working in TB care and their 
experiences of the ‘actual’ implementation of a reform (Kirwan, Cárdenas & Gilman, 2012; 
Gilson, 2012; Schneider, Gilson, Ogden, Lush, & Walt, 2006). Furthermore, different actors’ 
experiences and the relationships between these actors are central to programme or policy 
implementation (Gilson, 2012). In isolation or in combination, these issues interact with one 
another and influences implementation at various degrees and at different levels of the 
system. Thus in order to advance health systems strengthening, scholars must consider, 
identify and implement changes in structural, social and behavioural components that are 
most likely to guarantee intended policy effects (Gilson, 2012).    
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In much scientific literature, there still remains a great need to understand how human 
qualities of the health system influence implementation (Alanen, Välimäki & Kaila, 2009; 
Boehme et al., 2011). There has been a reasonable focus in the implementation literature on 
the hardware factors (Buse, Mays, & Walt, 2005). However, the knowledge base of how a 
wider range of software issues influence implementation still needs advancement (Schneider 
et al., 2006). This is especially for the implementation of TB policy, programmes and 
technology into the health system (Boehme et al., 2011; Clouse et al., 2012; Van Rie et al., 
2010). Specifically, there is a greater need to understand how software issues of the health 
system influence guideline implementation, particular at lower levels of the health system 
(Gilson, 2012; Schneider et al., 2006). Although there are conceptual and theoretical models 
for the role that complex ‘software’ issues exist in the general implementation literature, 
there is opportunity for application of these tools in empirical investigations (Gilson, 2012). 
In addition, very few of these frameworks are applied to assessing how actors’ experiences 
and human aspects mediate implementation processes, especially for TB programmes.  
Despite the impact that software factors have on policy implementation (Gilson, 
2012), there is limited empirical evidence accounting for such factors. More specifically, 
there is paucity in the GeneXpert literature on how actors’ perceptions, interpretations and 
experiences of policy, novel technology, implementation guidelines and other issues facilitate 
or hinder actual implementation. For example, Boehme et al. (2011), Clouse et al. (2012) and 
Van Rie et al. (2010) investigated the implementation of GeneXpert in point-of-care and 
other clinical settings but there is no account of how health workers may influence 
implementation. The focus of these studies was rather to understand operational elements in 
implementation such as the specific requirements for the implementation of GeneXpert that 
are specific to financial, operational and logistical support. Health workers in primary 
settings thus play an important role in how policy is implemented and they hold strong 
discretionary power that may influence the effectiveness of policy implementation for a given 
facility and this need to be more accounted for in the literature (Buse, Mays, & Walt, 2005; 
Rice, 2013).  
Health workers expected to implement policies are people, and people are complex 
beings. Thus, how they ‘do’ policy may be influenced by their experiences, which in turn are 
shaped by their perceptions, understandings and relationships (Buse, Mays, & Walt, 2005; 
Gilson, 2012). Health workers in SA and in TB policy contribute extensively to 
implementation processes and the outcomes thereof. Much of the TB reforms in SA have 
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focused on point of care services in community clinics or primary care facilities. Moreover, 
many primary care facilities in SA and other LMIC countries are nurse-led and each facility 
has their own values and principles that shape their functions, operations and the overall 
quality of their services. How policy directives from national government adopt, translate and 
diffuse policy is greatly influenced by the existing organizational culture, operations and 
relationships between actors (Buse, Mays, & Walt, 2005; Rice, 2013). In addition, how 
exiting relational issues and organizational space operate in combination with the 
introduction of novel policy and guidelines shapes how health workers will understand, 
interpret and experience the implementation of that policy. These experiences may further 
mediate their actions and thus the overall effectiveness of the implementation processes 
involved in introducing a new policy (Gilson, 2012, Rice, 2013).    
 
Study Rationale  
The specific objective of this study was to investigate PHC nurses’ experiences of 
diagnosing TB following the implementation of GeneXpert policy in their practice. This was 
done to understand the barriers that limit implementation of TB diagnostic policy in nurses’ 
practice. An investigation into nurses’ experiences through an analysis of discourse and 
practice offer important lessons for people-centered health systems in TB diagnostic policy 
implementation. 
Nurses’ experiences will be the primary focus of this investigation. This will be 
coupled with and analysed in relation to ‘policy on paper’, their interpretations, interactions 
and actions within the implementation context. Understanding the relationship between their 
narratives and their practice will be central to this study. Consequently, to better understand 
this relationship further within implementation contexts, it is crucial to generate better 
insights into how policies on promising novel technologies from international and national 
levels are adapted and transferred into health policy implementation by health workers at 
local levels (Gilson, 2012; McLaughlin, 1987; Rice, 2013). There is a further need for deeper 
insights into the implementation of GeneXpert policies overall (Piatek, 2013) and how 
people, being at the centre of policy implementation, are important in contributing to the 
effectiveness or ineffectiveness of policy implementation (Bergen & While, 2005; Rice, 
2013). However, people operate within broader contexts and it is important to consider the 
broader contexts that govern and shape their practices.  
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There is a dearth in the GeneXpert and broader TB literature engages with the 
particular issues this paper seeks explore and grapple with. Little is known about point-of-
care experiences of GeneXpert at primary health care level (Clouse et al., 2012). This is a 
broad and particularly complex issue, yet undergoing this investigation can yield many 
underlying layers of meaning. It is the intention that the findings generated may contribute to 
a deeper understanding of the nuanced issues in the implementation process ‘on the ground’, 
which have potential to generate relevant and constructive ideas for health systems 
strengthening. Person-centered research approaches are necessary to understand the 
subjective experiences of lower level actors who practice implementation of policy. This 
study aims to provide information that may strengthen policy guideline formulation and 
implementation at cross-cutting levels of the health system. Furthermore, interpretations of 
information generated in this study will aim to understand the levels at which these factors 
operate and gain insight into broader systems that shape health workers’ experiences of 
implementation. In essence, this study will attempt to address questions related to the ‘how’ 
in Xpert MTB/RIF implementation and scaling up through gathering appropriate ‘real world’ 
data and design methods that can contribute to strengthening the assessment and evaluation 




The research question for this study is thus as follows:  
How do the experiences of local level health workers in primary health care settings in 
the Western Cape mediate the implementation of the MTB/RIF Xpert diagnostic 
technology introduced by higher level governance in South Africa?  
• How do health workers’ experiences influence their practices in the 
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Methods 
i. Theoretical Framework  
 
Figure 1: Micro-Institutionalist Theory of Policy Implementation (Rice, 2013)  
 
The Micro-Institutionalist Theory of Policy Implementation (MITPI) (Rice, 2013) 
framework (Figure 1) will be used to assist in developing insights into micro-level analyses 
of programme implementation. In this study the MITPI framework will be used to describe, 
analyse and interpret health workers’ individual experiences and actions in relation to the 
GeneXpert policy and its implementation, the facility specific facility selected in which the 
policy is implemented, and the overall context and broader systems and processes. This 
conceptual framework provides a rationale and lens for analysing low level health workers as 
the basic unit of analysis within the health system as an institution (Rice, 2013). There has 
not been sufficient focus on micro-level perspectives recognizing the roles and experiences of 
low level health system actors in implementation overall (Scott, Schaay, Olckers, Nqana, 
Lehmann, & Gilson, 2014).This study seeks to direct the focus on primary care health 
Figure 1:	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workers as fundamental in the implementation of policy. For the purposes of this research, 
the institution refers to the overall health system and the organization to the primary care 
facility.  
Micro-Institutionalist theory draws on the street-level bureaucracy (SLB) theory 
developed by Lipsky but provides a comprehensive set of ideas for taking into account 
complex factors in the shaping of micro-level actors’ experiences, perceptions and relational 
issues between different levels at policy implementation operate (Rice, 2013). SLB theory 
posits that the behaviour of health workers is influenced by two key elements: 1) the 
organizational context and 2) intrinsic individual cognitive and emotional functions 
interacting with the organizational context (Lipsky, 2010; Rice, 2013). Organizational 
context determines with conditions for bureaucratic action and the individual factors 
interacting with the organizational context determines the way in which health workers adapt 
or undermine policy implementation (Lipsky, 2010; Rice, 2013) (See Figure 1). 
In addition to Lipsky’s ideas, micro institutionalist theory incorporates components of 
sociological institutional theory (Giddens, 1981; Powell & DiMaggio, 1991, as cited in Rice, 
2013).  This means that the theory is based on an understanding of social reality as governed 
by individual human experience in combination with behaviour (Giddens, 1981 as cited in 
Rice, 2013). Institutions exist and interact with larger political, economic, and contextual 
processes and once established, structure, regulate and limit human action to what is 
acceptable, relevant, and appropriate to particular circumstances and contexts. The 
fundamentals for individual action are thus consistently modified by adaptations and reform 
in the tenets of institutions as prompted by systemic changes (Rice, 2013). The full picture of 
micro institutionalist framework provides us with an understanding of interactions between 
institution and individual action, context and institution, and context and individual action are 
thus intricate and operate as a complex interconnected feedback looping system.    
The micro institutionalist framework of policy implementation presents a conceptual 
tool for understanding how individual health workers’ experiences and actions are entrenched 
in and governed by an interconnected web of economic, political, cultural, and social 
structures (Rice, 2013). This model will be used to assist in offering directives for building 
conceptual bridges between the different levels at which the implementation of policy 
operates, i.e. micro-level health worker experiences, interactions and actions, meso-level 
organizational context and macro-level broader socio-political systems and structures (Rice, 
2013). This model further requires that the South African health system and the context in 
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which TB control functions to be considered in understanding how health worker’s 
experience policy implementation and how these experiences mediate low level 
implementation.     
 
ii. Setting and context  
South Africa has the highest TB burden in the world and with the largest HIV/TB co-
infection rates, the country has faced major challenges associated with an increased 
prevalence in multidrug resistant TB (MDR-TB) and extreme resistant TB (XDR-TB) 
(Wood, Lawn, Johnstone-Robertson, Bekker, 2011).  The South African public system across 
all provinces largely deals with the diagnosis and treatment of TB at primary care level and 
more complex presentations of TB are managed in secondary level specialized facilities 
(Wood et al., 2011). The TB sphere has undergone a number of changes and developments 
and a lot of these reforms have been implemented in different levels of the public health 
system (Wood et al., 2011). To address the TB issue, country level policy makers were the 
first to adopt the molecular TB diagnostic test after recommendations were made by WHO 
(2008; 2011; 2012), thus resulting in the introduction of the GeneXpert diagnostic tool 
(Schnippel, Meyer-­‐Rath, Long, MacLeod, Sanne, Stevens, & Rosen, 2012). Similar to the 
adaptation and implementation of all health policy in South Africa, the National Department 
of Health formulated and establish the policy and different provincial level governments were 
assigned to implement the policy at different levels of the provincial health system (Gous, 
Cunningham, Kana, Stevens, & Scott, 2013).  
The Western Cape Province has been reported to have the highest rate of all types of 
TB in South Africa (Claassens et al., 2013). This study will be based in the Western Cape 
Province because of the reported TB burden in this particular province. Over the years, the 
Western Cape Province has taken active strategies to address the issue of TB (Claassens et 
al., 2013) and changes in approaches in policy will give us richer and more ‘realistic’ insights 
into how these complexities shape and mediate implementation. With regards to the 
anticipated appropriateness of the diagnostic technology for point of care, this study will 
select a case facility that is located in the City of Cape Town. The justification for this is that 
the anticipated case facility should be situated in a setting where there are high rates of 
incidence and prevalence of TB to ensure that implementation of GeneXpert test is aligned 
with the need for effective diagnostic testing procedures. The case facility will operate at 
primary care level where GeneXpert reform has been introduced and is in at least in its three 
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year period of implementation and operation.  The facility should also be approximately 10 
years in operation, to frame perspectives around historical versus contemporary circumstance 
and the changes the facility had undergone with TB policy and implementation.    
iii. Research design  
The overarching design strategy of this investigation is flexible in nature. A case 
study approach will be utilized in this study. The case study approach to research can be 
defined as an in-depth empirical inquiry of particular events, systema, persons, relationships, 
policies, institutions, or other issues that may draw on a combination of research methods 
(Yin, 2013). A combination of issues or a single issue is studied scrupulously where a 
number of different of tools and methods are used to collect and analyse information 
(Hancock & Algozzine, 2006). A particular case is central to a research investigation and is 
regarded as a main case, as it offers a unit or units for analyses and provides a ‘snapshot’ for 
understanding the issue under investigation at particular period in time (Gilson, 2012; Yin, 
2009). Other cases can be embedded in the primary case and they are called embedded cases 
in case study research (Yin, 2013). The case study research approach is most appropriate for 
this study because of the nature of the research question and the overall purpose of the study. 
The case study approach is said to be relevant to research projects with both explorative and 
explanatory features (Yin, 2009; Yin, 2013) thus enabling the study of both the ‘how’ and 
‘why’ of phenomena. Many scholars in the field of health policy and systems research 
(HPSR) who have undertaken explorative investigations have successfully generated valuable 
findings and analytical generalizable claims through the effective use of case study 
approaches (see Gilson, 2012 for examples). Subsequently, analytical generalizable claims 
produced from insights regarding processes and strategies observed in a particular setting via 
the case study approach can be applied to other circumstances, contexts and settings (Gilson, 
2012). This approach is further most fitting for this investigation, as the researcher will have 
little control over the processes and events under study. In addition, the focus of this research 
is based on a contemporary phenomenon within a real-life context (Gilson, 2012; Hancock & 
Algozzine, 2006; Yin, 2009). Furthermore, case study research allows for detailed 
descriptions and interpretations of particular experiences.  
Two types of case study research approaches are presented in the literature (Yin, 
2009; Yin, 2013). Single case studies and embedded case study approach. Single case studies 
involve a focus on a specific case or a combination of cases of the nature. The embedded case 
study research encompass one particular case is situated within a broader case. This study 
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will be based on the latter approach to case study research where individual health worker 
experiences in different PHC facilities are embedded in a particular case sub district where 
GeneXpert has been implemented. The particular sub district under investigation will thus be 
the overarching case. Health workers from different facilities within the case sub district and 
their experiences are the primary unit of analysis. In addition, implementation experience of 
the facility, its contextual factors and broader systems and structures will also form part of 
the focus of the scientific inquiry (Gilson et al. 2011). This study is a therefore a multiple 
embedded case study as it seeks to interview approximately ten health workers from different 
PHC TB facilities in a specific sub district in the Western Cape.  
Within the overarching case study approach, qualitative data collection and analysis 
will be employed. By utilizing qualitative investigation approaches, this study aims to gain 
in-depth understandings of participants’ experiences with regards to particular events, 
interactions, interpretations, actions, relationships and circumstances. Qualitative research 
methods offer tools to observe actions and interactions, allowing researchers to interpret and 
explain constructed experiences in relation to observed reality (Miles & Huberman, 1994; 
Willig, 2001). Qualitative work allows for flexible open-ended strategies, thus making it 
suitability for the purposes of this research project. The researcher is able to immerse him or 
herself within the data generated and iterative strategies are encouraged in this research 
design approach (Langdridge & Hagger-Johnson, 2009). Like case study approaches, 
qualitative research methods does not aim to generalize findings for the purposes of 
projecting it onto the population group under study such as with fixed approaches (Hancock 
& Algozzine, 2006; Gilson, 2012; Yin, 2009). For this inquiry, using qualitative methods 
allows researchers to adapt to findings that may provide authentic and unanticipated 
meanings (Langdridge & Hagger-Johnson, 2009).  
iv. Case selection and sampling 
Because there are three interrelated streams for collecting data in this study, a three-
component sampling approach will be employed to sample documents and cases for this 
investigation. All three components of sampling for data collection will draw on the 
purposive sampling approach.    
a. Policy documents  
For the first level of sampling, national policy and implementation documents on 
GeneXpert will be sampled. This level of sampling will be to gather different policy and 
program documents, implementation guidelines and protocols. Facility records related to the 
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formulation and implementation of the MTB/RIF Xpert diagnostic will be sought for. These 
include meeting minutes and communication trails related to the GeneXpert policy and its 
implementation (emails, posters, policy briefs and so forth). A purposive sampling method 
will be employed to sample policy and implementation documents papers to be included for 
review. Purposive sampling is a kind of non-probability sampling where the researcher 
selects samples for study on the basis of intentions of their subjective judgment and not to 
sample to with for the purposes of statistical generalizability (Marshall, 1996). It is best used 
in studies where the aim is to sample specific characteristics of a population of interest and in 
relation to the issue being addressed and the questions raised (Burger & Silima, 2006; Kuzel, 
1992; Marshall, 1996). Furthermore, this sampling method will be most useful because of the 
exploratory nature of the investigation, its relevance toward the particular paradigm that this 
study is situated in, and the kinds of insights this inquiry aims to generate (Marshall, 1996).  
   b. Case facilities  
The second sampling frame will be to sample the sub district, situated in the Western 
Cape Province in South Africa where the GeneXpert TB diagnostic technology has been 
implemented for a period of at least two years in different PHC facilities. The population to 
sample embedded cases from are health workers in TB care who are working in dynamic 
primary care facilities where the MTB/RIF Xpert diagnostic technology has been 
implemented. This sub district will be the main case of this research investigation.   
The sub district will also be selected using a purposive sampling strategy because of 
the complexities associated with TB diagnostic policies and the implementation of these 
policies, particularly at primary care level. Purposive sampling of cases is also best suited 
because the case associated with the phenomena of interest is difficult to sample and the case 
is most practically accessible for the purposes of research (Burger & Silima, 2006; Kuzel, 
1992; Marshall, 1996). Selection of the sub district will be based on the researchers 
judgements of the suitability of the sub district and case facilities to the research aims, 
research question, and the methods for data collection. The implementation period of 
GeneXpert in the sub district must be at least two years collectively for the facilities where 
the health workers are working in. This is a good length of time to assess health workers’ 
experiences of the implementation and how actual implementation is mediated by their 
experiences across the sub district. Given that GeneXpert was incrementally introduced in 
South Africa, it is foreseen that there will be a limited number of primary care facilities 
within a particular sub district that has implemented GeneXpert for more than 2 years. In 
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relation to the characteristics sought for the case facility in this investigation and the broader 
South African historical and contemporary socio-political realities, the facilities in the sub 
district where health workers’ will be selected must have a reasonably high TB case load. 
The subdistrict should also have a high incidence and prevalence of TB. These characteristics 
of the subdistrict and its PHC facilities are anticipated to offer unique contextual perspectives 
that may generate deeper insights into the implementation of GeneXpert technology. In 
making interpretations, the geographical location attributes (e.g. rural/urban, size of the 
community the facility must serve, etc.) and socio-economic and political issues will also be 
taken into account. Furthermore, the selection of the prospective sub district will be 
potentially based on existing literature and theoretical arguments about the subdistrict, if 
available.  
  c. Health worker case narratives  
The third level of sampling will be to sample the embedded cases – frontline health 
workers (including facility managers) from the PHC facilities in the sub district and who 
have been directly or indirectly involved in the implementation of GeneXpert. To establish an 
in-depth understanding of the experiences of health workers with the implementation of 
GeneXpert, an approximate of 10-12 low level health workers will be selected from the 
particular case sub district to generate 10-12 health worker case narratives. These health 
workers must have an understanding of the operational and administrative aspects of the 
technology from the time the technology was introduced (or when they have started working 
at the facility) in their primary care facility up until to how it is currently operated. They may 
mainly include lab staff and nurses. Health managers and workers will also be sampled using 
a purposive sampling approach. Purposive case selection allows researchers to examine 
unusual cases and to take into account the contextual factors that are unique to a particular 
case and how it differentiates from other cases (Hancock & Algozzine, 2006; Yin, 2009). 
This sampling method will be used to ensure that health workers have the necessary 
involvement, experience and knowledge about the policy and the implementation of the 
policy and the facility to validate their narratives. This study will also focus on particular 
roles that different health workers play in the implementation processes and the sample seeks 
to include health workers with varied involvement and contributions that they offer to the 
GeneXpert policy and implementation in the facility. An important inclusion criterion for 
health workers to be interviewed is that they should have a sound degree of involvement in 
the implementation of GeneXpert. This may be at any level or area of implementation 
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including whether they were involved in orientation, operating the technology, referral for 
testing or any other activity required in the implementation of GeneXpert.  
The sub district manager will be asked to serve as a key informant to provide 
information about the characteristics and issues of interest. They will be further asked to 
recommend facilities and health workers who are most suitable as sample participants. The 
sub district manager and the facility managers will also be asked to assist in recruiting 
participants in that the researcher will request from the facility managers 10 minutes of the 
weekly meeting time to present the background, purpose and aims of the research study to the 
health workers of the facility. Health workers who express interest to participate in the study 
will be asked to meet with the researcher after the meeting where they will be provided with 
information sheets and will be able to ask questions about the research and the nature of their 
participation.   
vi. Data collection 
A useful attribute about the case study approach is that it allows for the gathering of 
multiple sources of evidence using diverse methodological tools (Gilson, 2012). This study 
will thus draw on different forms of qualitative research methodologies that will be vital for 
enhancing the trust worthiness of our findings through the process of triangulation (Gilson, 
2012). Qualitative research methodology is most useful for this study because it offers scope 
and tools to obtain comprehensive accounts and perspectives of experience (Parker, 2005). It 
further allows researchers to be able to describe, unfold, interpret and develop meanings and 
understandings of these experiences. Qualitative research methods have proven to be relevant 
tools in health systems and implementation research because it accommodates for 
investigating issues of complexity (Gilson, 2012). Drawing on multiple methods of 
qualitative inquiry will allow the researcher to converge findings and interpretations across 
data collected through different methods (Gilson, 2012). The data collection procedures will 
occur in three interrelated streams in the health facility. These streams will not occur in 
isolation and there is a lot of overlap in the time that these streams of data collection will take 
place. It is expected that these streams are likely to occur concurrently.   
a. Document review of policy and implementation guidelines 
The first stream will be to analyse international, national and provincial policy 
reviews and implementation guidelines, facility documents, meeting minutes, information 
gathered from modes of communication (e.g. email threads relates to policy under study). 
During this stream, the researcher will collect data to construct a document review with the 
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aim of understanding policy directives, anticipated implementation procedures from higher 
level governance and overall policy and implementation plans of GeneXpert in the facility. 
This data from the document review will primarily serve as a pathfinder to assess the 
experiences, interpretations and actions of health workers against a clear set of expectations, 
procedures and guidelines.  
  b. Formal in-depth face-to-face interviews   
The second stream of data collection will comprise of conducting formal open-ended 
semi-structured face to face interviews where health workers from the sub district facilities 
will be asked to uncover their experiences and interpretations of the implementation of the 
GeneXpert diagnostic test in their specific facility. The aim of this study is to gather and 
grapple with in-depth copious accounts of health worker experience with the implementation 
of GeneXpert. To facilitate the direction for an open, intensive and non-intrusive 
interviewing process, principles of narrative interviewing will be utilized. In the interviews, 
participants will be asked open-ended semi-structured questions (see Appendix E for 
interview schedule). The open ended semi-structured approach to interviewing facilitates the 
exploration of new ideas and thoughts to be expressed that is not limited to the researcher’s 
existing knowledge and allows for probing of information that sparks interest (Connelly & 
Clandinin, 1990; Corbin, 2003). Semi-structured interviews enable the researcher and the 
participant to have key roles in the interview process, where both are co-constructors of 
meaning (Corbin, 2003). 
The narrative accounts constructed by health workers about their implementation of 
experience will allow the researcher to gain access to their experiences through language. By 
drawing on the narrative research it is recognized that language only offers a window through 
which experience can be described and interpreted (Emerson & Frosh, 2004).  Furthermore, 
experience through language is socially constructed and are situated within broader social 
systems that shape the experiences and how they are depicted through language (Emerson & 
Frosh, 2004).  Utilizing narrative research in data collection and analysis processes is 
therefore aligned the broader aims of this research investigation.   Micro, meso and macro 
level systems, issues and contexts that govern the health workers’ narratives about their 
experiences will be considered. By offering narratives of experience, participants will be able 
to construct stories based on their own subjectivities in a way that provides them with the 
agency to give their own explanations and interpretations of their experiences (Langdridge & 
Hagger-Johnson, 2009; Emerson & Frosh, 2004).  Narrative research also considers how 
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actors’ identities, roles, responsibilities, interactions, and so forth are constructed in the 
stories they tell (Riessman, 2008). This may provide us with insights into how they define 
their role and position as health workers in relation to the policy and actual implementation of 
GeneXpert. Finally this approach will allow the researcher to explore a combination of 
hardware and software issues that they understand to influence their experiences of policy 
implementation. 
c. Direct observations in case facility    
The third stream of data collection will constitute direct observations where the 
researcher will ask to observe and engage with some of the health workers in their day-to-day 
operations and activities associated GeneXpert in their facilities. Here the focus will be on 
unstructured direct and indirect observations. Engaging with the health workers directly and 
observing their actions, interactions and relationships will provide the researcher a better 
perspective into their lived reality as an external observer. The researcher is able to interpret 
their behaviour, attitudes, perceptions, and discourses through the participant observation 
approach. Direct observation will further include gathering information through informal 
conversations with health facility managers and health workers, notes of meetings, 
conversations (face to face and telephonic conversations), interactions between health facility 
managers and higher levels of governance. In relation to the policy document review stream 
of data collection, policy and implementation material and other files or documents specific 
to the facility that may give insights into the implementation will also be reviewed on 
availability. Substantive field notes will be documented using a fieldwork journal.  
In combination with information from the document review and the direct 
observation, health workers’ narratives will be used to understand on organizational 
arrangements, barriers to implementation, administrative and financial functions, governance, 
power and actor relationships, institutional culture and how these issues operate at the micro 
level, where micro level experiences are influenced by higher level contexts. Furthermore, a 
focus on the experiences of lower level health managers is justified by the key role that they 
play and the discretionary power they have in policy implementation. Through allowing them 
a platform to share their insights and be actively part of policy and implementation 
strengthening is a form of empowerment where they may interpret themselves as active 
players in health systems strengthening through improved low level policy implementation 
(Gilson, 2012). This is in line with the ‘people-centred’ approaches (Gilson, 2012) that are 
pertinent in health systems strengthening discourse.    
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vii. Data analysis 
Analysis of the data across the three integrated streams will be iterative. The story 
units constructed within the open ended semi-structured interviews will be analysed using the 
Riessman’s (2008) thematic narrative approach. Thematic narrative analysis offers 
researchers the opportunity to develop rich accounts of interpretation and experience, to 
gather comprehensive descriptions of action, and to draw out patterns of meaning in the form 
of themes (Babbie & Mouton, 2007; Riessman, 2008). This method of analysis explores both 
the content and structure of the participants’ told stories (Riessman, 2002).  
An initial step in the analysis process will be to identify and code themes from the 
content of health workers’ stories of their experiences of the implementation of GeneXpert 
(Braun & Clarke, 2006; Riessman, 2008). Narrative components will be categorized into 
overarching themes and subthemes. Themes developing from narratives are layers of 
meaning embedded in the content of the stories with the function of directing and informing 
conclusions (Riessman, 2002). In addition to extracting themes, assumptions of narrative 
structure, implications, and contexts will also be considered (Riessman, 2002). The 
researcher will analyse these textual elements of the narratives of health managers. The 
analysis of both narrative content and structure elevates the analytical process and contributes 
to the significance of the inferences drawn from the interview data (Riessman, 2008, 2012). It 
permits for the analysis of how identities are constructed in participants’ stories. This method 
of analysis also allows researchers to take into account the micro and macro contexts and 
broader societal systems that shape health managers’ stories and discourses embedded in 
them of their experiences of their relationship with provincial health managers. Thus, the 
combination of the content-driven and structural analytical methods embedded in the 
thematic narrative approach will be most appropriates for the analysis of participant 
narratives this study (Riessman, 2008, 2012).  
Moreover, the sampled policy documents and substantive hand written notes from 
short-term ethnographic data will be analysed by utilizing the principles of content and 
thematic analysis. These frameworks to guide analysis of policy documents and data 
collected from direct observations will permit for themes and patterns of meaning to be 
extracted. Health workers’ narratives will be analysed in combination with policy review and 
direct observation data to triangulate and identify patterns of data across these data sources.  
viii. Ethical considerations 
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Ethics is an important aspect of research as it directs appropriate methods that limit 
harm to the participants and the researcher (Willig, 2007). In order for this study to have been 
conducted, ethical issues need to be considered and thought through before entering into the 
research field for investigation. 
a. Informed consent.  
Before initiating the research process and engaging with participants with research 
related protocol, participants will be explicitly informed about the nature and purpose of the 
research (Willig, 2001).  Informed consent suggests that the research participants provide an 
explicit statement of agreement and understanding of the nature of the research investigation 
and their involvement (Willig, 2001). This will be presented in the form of an informed 
consent document (attached as Appendix A, B, C and D). The researcher will provide the 
participants with all the information related to the aims and methods that the research seek to 
address before undertaking in the study for participants to make an enlightened decision to 
partake in the study. Outlined in this form are the aims, benefits, risks, costs, role of the 
researcher, duration of interviews and so forth. Participants will be informed that they have 
the right to withdraw from the study at any time and that they can decide to end the interview. 
They will further be informed that the interview would be recorded with an audio recording 
device and that they can terminate recording at any time of the interview. The researcher will 
give verbal explanations of the information on the consent forms and signatures of 
participants will be requested to authorize their consent for involvement in the study. Copies 
of signed consent forms for the facility and for individual participants will be requested from 
the participants or necessary parties before the research will take place where it will be kept 
in a safe place.     
b. Harm to subjects.  
It is the researcher’s responsibility to make sure that the study does not inflict 
physical, emotional or psychological harm on the participant (Willig, 2001). Participants will 
be interviewed and observed in confines of the facility where they work and no additional 
harm is anticipated that may place the participants at risk of physical or emotional harm. It is 
anticipated that some information that participants may potentially provide in the interviews 
may have negative consequences for the health workers, the facility and the case sub district. 
Strict measures will be put in place in the management and reporting of information to 
maintain the anonymity of the participants, the facility and the case sub district. This is 
further discussed under the privacy and confidentiality section of this paper.  
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  c. Harm to researcher 
The researcher visiting the particular facilities in the sub district will do the data 
collection. The researcher is aware of the risk of contracting TB in health facilities. The risk 
is particularly higher in facilities situated in high TB risk communities such as the 
prospective case facility for this study. The researcher will thus ensure to wear TB masks 
when conducting participant observations in the case facilities. Interviews with health 
workers will be conducted in high-ventilated spaces or outside of facility where the risk of 
contracting TB is reduced. The low level of interaction with patients further reduces the risk 
for the researcher. In the event that conducting interviews will create an additional burden to 
the workload of health workers, they will be requested to do the interviews at their own time 
and in spaces that they prefer (for example, in their home).   
d. Privacy and confidentiality 
Participants’ personal identities and the name and specific details that may make the 
facility easily identifiable will not be disclosed in the reporting and publishing of the 
prospective findings of the study. Only the researcher, transcribers and supervisors will be 
able to obtain access to the recordings of the interviews and interview transcripts. Participants 
and the facility will thus remain anonymous in the research report and their privacy and 
confidentiality will be strictly maintained. Pseudonyms will be used to maintain the facility 
and participants’ anonymity. All this information will be included in the informed consent 
form and a verbal confirmation will be given to the participants before the study commences. 
Limitations to confidentiality will also be mentioned and stated regarding the research being 
written up in the form of a master’s research project and that it may be published in an 
academic journal.  
 
xi. Anticipated timeline (revised)  
1st October 2015 – 1st February 2016: Narrative Literature Review and preparation for the 
field  
1st Feb 2016– 21st Feb 2017: Data Collection and Field Work  
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This chapter begins by framing an argument for focusing on software issues in health systems 
and policy research - particularly the human attributes of health systems and the experiences 
of health system actors - and its role in and implications for the implementation of policy 
reform. Using GeneXpert policy reform implementation as a pathfinder, this paper continues 
with the objective of undertaking a structured narrative review of the existing literature, to 
understand the major barriers and enablers for health systems implementation reform. More 
importantly, this review intends to assess the nature and extent to which people issues and 
people-centred practices are considered in the policy implementation research of GeneXpert 
and  novel TB diagnostic teachnologies broadly. The aim of this section of the dissertation is 
to identify literature considering the human experiences and relationships of frontline health 
workers and how these may intersect with hardware, contextual and social systemic factors, 
that may potentially mediate the implementation of GeneXpert TB diagnostic policy. 
Background	  
The urgent need for improving the health system is entrenched in public and academic 
discourse, particularly for Low-and Middle-Income Country (LMIC) settings (Bennett, Mills 
& Russell, 2011; Berman & Bossert, 2000). Multiple reforms have been implemented in 
various levels of health systems over time, with intentions to strengthen and improve its 
performance, efficiency and effectiveness. Despite decade’s worth of reform efforts, there 
still are major gaps in discussing challenges that limit health systems strengthening (Bennett, 
Mills & Russell, 2011; Berman & Bossert, 2000; Cassels, 1995). Health Policy and Systems 
Researchers (HPSR) argue that this is because policy makers and researchers of health sector 
reforms still perceive the implementation process of reform as primarily rational, linear and 
mechanical (Bennett, Mills & Russell, 2011; Berman & Bossert, 2000).  
For many years, implementation scholars and policy makers have understood structural 
elements as being of most significance in their implementation (Bennett, Mills & Russell, 
2011; Berman & Bossert, 2000; Cassels, 1995; Gilson et al., 2011; Gilson & Mills, 1995; 
Sabatier, 1986). From this perspective, changes in the health system structures and functions 
will direct standardized procedures and processes that will automatically result in measurable 
predicted outcomes (Blaauw, Gilson, Penn-Kekana & Schneider, 2003; Gilson & Mills, 
1995; Sabatier, 1986). These structural elements with their distinct functions are known as 
the hardware in health systems and policy implementation (Gilson et al., 2011; Gilson, 2012). 
They make up the essential building blocks of the health system, described by the World 
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Health Organization (WHO) as leadership and governance, health information systems, 
health financing, human resources for health, essential medical products and technologies, 
and service delivery (Gilson, 2012; World Health Organization, 2000). In contrast, software 
aspects of the health system are the intangible features and manifestations that drive and 
influence processes, functions and relationships across different components (Blaauw, 
Gilson, Penn-Kekana & Schneider, 2003; Freedman, 2005; Gilson, 2012). They include 
ideas, values, attitudes, power, culture and norms. Software factors interact with hardware 
elements to influence the processes and outcomes of health policy implementation 
(Freedman, 2005; Gilson, 2012). People functioning at various levels of the health system - 
and not only higher-level policy makers - have agency and experiences that are important 
software factors influencing the system (Blaauw, Gilson, Penn-Kekana & Schneider, 2003; 
Freedman, 2005; Gilson, 2012; Sheikh, George & Gilson, 2014).  
Health systems and policy scholars are increasingly acknowledging the notion that health 
systems are primarily social institutions through the complex realities of actors and the 
interactions between them (Freedman, 2005; Gilson, 2012; Sheikh, George & Gilson, 2014). 
There is growing empirical evidence that recognizes and considers the broader contextual 
issues and the social, political and economic circumstances and how they intersect, to 
influence health policy and systems implementations (Sheikh et al., 2011; Freedman, 2005, 
Gilson, 2012; Mash et al., 2013). These advances are important but for health systems and 
policy research to contribute to health systems strengthening, people-centric practice needs to 
emerge in scholarship and policy making (Sheikh, George & Gilson, 2014). This means that 
scholars and policy makers must appreciate the intersections between hardware components, 
social systemic and contextual influences, and the strong influence of actors as people with 
complex lived realities and human factors. Health systems and policy implementation 
scholars make the compelling argument that the limited gains and failures from past and 
present health sector reforms is a consequence of ignoring the extent to which software - and 
particularly human factors - may influence health sector implementation (Sheikh, George & 
Gilson, 2014). In the past few decades, there has been an unrelenting focus on the hardware 
in the implementation of health systems reform and limited emphasis on software issues that 
equally affect implementation (Atkinson, 2002, Bennett, Mills & Russell, 2011; Berman & 
Bossert, 2000; Cassels, 1995; Gilson & Mills, 1995).  
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Recent global reforms in TB diagnostic policy offers an interesting case to assess the extent 
to which software issues - particularly the human qualities of the system - are considered in 
scholarship. This critical health systems and policy research perspective on understanding the 
recent TB diagnostic policy reforms may offer insights into how relationships, social 
networks, personal attributes of front-line workers and them exercising discretion in their 
practice influence the process of ‘real life’ policy implementation. This is also because TB 
policies and implementation systems are dynamic, complex and constantly changing. 
Understanding the experiences of frontline staff in dynamic and unpredictable local 
implementation contexts is imperative, because of their discretionary power and how they 
exercise discretion in their practice (Blaauw, Gilson, Penn-Kekana & Schneider, 2003; 
Freedman, 2005; Gilson, 2012).  
Tuberculosis (TB) is a communicable bacterial disease that is caused by Mycobacterium 
tuberculosis. It most commonly affects the lungs but the infection can spread to other parts of 
the body (Knechel, 2009). TB is one of the leading global health challenges (Raviglione & 
Pio, 2002). Although TB can be treated with a six-month regimen of antibiotics, it is one of 
the major contributors to disease and death worldwide (Knechel, 2009).  It is estimated that 
nine million new TB cases were detected in 2013 of which thirteen per cent of these were 
HIV infected individuals (Churchyard et al., 2014). The WHO has characterised 22 high TB 
burdened countries (Churchyard et al., 2014). These countries are Low-and Middle-Income 
Countries (LMIC) and account for about 82 per cent of all approximate incidences of TB 
cases internationally. With the rise of HIV infection in many low to middle income countries, 
TB/HIV coinfection has resulted in increasing mortality and morbidity (Churchyard et al., 
2014). WHO (2015) reports that 2.1 million people globally became HIV incident cases in 
2013, where most of the incident cases were found in sub-Saharan Africa. In addition, 
coinfection has contributed to the increase in more complicated forms of TB that are difficult 
to manage and treat, such as multi-drug resistant tuberculosis (MDR-TB) and extensively 
drug resistant tuberculosis (XDR-TB) (Churchyard et al., 2014). It is thus clear that countries 
affected by TB are also burdened by high rates of HIV incidence and prevalence. 
For many years, new international policies have been implemented within high burdened 
countries in a global attempt to combat this infectious disease (Raviglione & Pio, 2002). 
However, global TB control and diagnostic reform strategies and their implementation have 
not been widely successful. Efforts to combat TB are continuously being changed and 
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developed, which means that new and revised policies and technologies are constantly being 
introduced (Palamountain et al., 2012). Early case detection, treatment initiation, treatment 
follow up, continuity of care, adherence and multi-drug resistant management are some of the 
areas that are important in TB control, yet many gaps exist in these domains in countries most 
burdened by the disease (Lönnroth et al., 2009; Piatek et al., 2013; Raviglione & Pio, 2002). 
Many report that health system and related challenges in the implementation of TB control 
policies are significant contributors to these shortfalls (Loveday, Smith & Day, 2013; Storla, 
Yimer & Bjune, 2008). 
The Xpert MTB/RIF diagnostic test (GeneXpert) has been introduced as an innovation that 
could address the some of the important gaps in global TB control (Chang et al., 2010; 
Colvin et al., 2015; Dorman, 2010; Piatek et al., 2013). This technological innovation was 
endorsed by the WHO in 2010. The fully automated test rapidly detects TB in less than two 
hours and is more effective in identifying cases of multi-drug resistant TB (MDR-TB) or 
extensively resistant TB (XDR-TB), than conventional methods such as traditional 
microscopy and X-ray TB screening (Chang et al., 2010). Unlike conventional methods, 
GeneXpert gives a more workable solution to many of the bottlenecks in low resource health 
systems, as it may facilitate effective and efficient TB diagnosis and treatment in high burden 
diseases. It promises to improve diagnostic capacities for point-of-care services to find 
affected patients easily and efficiently, and to enable and accelerate the initiation of TB 
treatment (Palamountain et al., 2012). 
As more cross-country and cross-contextual operational research evidence is emerging, there 
is greater understanding of implementation in diverse contexts and settings and the factors 
that hinder or help effective implementation. Contexts and actors’ experiences of different 
health systems may generate meaningful insights consider in addressing gaps in 
implementation and research. This is especially prevalent at primary care level that serves 
high burdened communities with limited resources and other health systems constraints 
(Palamountain et al., 2012). Nevertheless, both hardware and software elements interact to 
shape the outcome of GeneXpert implementation in the health system. It may therefore be 
important to consider how structural hardware components and relational or human software 
qualities of the health system impact implementation policy-making and research. Moreover, 
it may be argued that health workers’ human experiences and relationships are central in 
research inquiry to understand how it may enable or constraint GeneXpert implementation. 
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Objectives of Literature Review 
Using GeneXpert policy reform implementation as a pathfinder, this paper sought to 
undertake a structured narrative review of the existing literature, to understand the major 
barriers and enablers for health systems implementation reform. More importantly, this 
review intends to assess the extent to which people issues and people-centred practices are 
considered in its policy implementation research.  The aim of this section of the dissertation 
is to identify and map-out literature considering the human experiences and relationships of 
frontline health workers and how these may intersect with hardware, contextual and social 
systemic factors, that may potentially mediate the implementation of GeneXpert TB 
diagnostic policy. 
Literature Search Strategy 
This review focuses on the emergent international policy implementation literature of the 
recently implemented GeneXpert TB diagnostic technology, to examine the extent to which 
human elements that make up the health system are accounted for in the GeneXpert policy 
implementation literature. The review started with the reading of policy documents, 
implementation guidelines and protocols for GeneXpert TB diagnostics. Government policy 
documents and papers from global agencies such as the WHO, Foundation for Innovative 
New Diagnostics (FIND) and Stop TB Partnership were surveyed. This was done to gain a 
deeper understanding of the policy and implementation process of GeneXpert. A more 
structured review approach began after the reading of policy and implementation documents, 
unpublished and published papers, books, articles and scholarly papers. 
The search strategy was designed to identify studies that addressed issues related to health 
workers in the health system in ways that illuminate their experiences, agency and 
relationships. Searches were conducted across four databases: Academic Search Premier, 
PsycINFO on EBSCOhost, PubMed, and Scopus. The following set of keywords were used 
to frame the literature search:  
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Searches were narrowed to include only peer reviewed journal articles published between 1 
January, 2010 (the year that GeneXpert was endorsed by WHO) and 30 April, 2017. The 
literature search was not explicitly framed according to a country or context but low to 
middle income country (LMIC) settings were prioritisd in reviewing abstracts. Only studies 
from high income countries were considered if their research aims and findings were strongly 
alligned to issues that this review sought to investigate.  The decision not to exclude country 
settings in the search strategy was also based on the idea that GeneXpert is a recent 
innovation and experiences from different country contexts and settings are important. 
Furthermore, GeneXpert promises to be an effective point-of-care test in local contexts. 
Hence, the reviewer was intentional about including papers that reported on Point-Of-Care 
(POC) diagnostic implementation experiences that were not limited to GeneXpert or TB 
diagnostic implementation. Only articles published in English were considered. Relevant 
literature was also searched through, snowballing from relevant articles selected for review 
that best address the issues explored in this review. Dominant themes were identified 
inductively from using the review objectives as a lens. The following set of factors were 
considered in reviewing abstracts:  
• Studies that specifically sought to understand implementation in real world settings 
and existing health systems contexts. Studies from clinical control trials and 
laboratory settings were excluded from this review.  
 
“GeneXpert OR Xpert MTB/RIF AND policy AND implementation AND Health worker*”;  
 
“nurses* AND experience AND GeneXpert OR Xpert MTB/RIF”; 
 
‘primary health care AND nurses AND TB AND diagnosis*’; 
 
“GeneXpert AND health systems AND people-centred micro AND practice* AND TB 
diagnosis* AND software”;  
 
“Point of Care OR POC test* AND TB diagnosis* AND implementation.” 
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• Studies specifically focusing on primary care, primary health care, or point of care. A 
focus on other settings were not strictly excluded but depended on whether “software” 
issues were explored.  
• Studies that centred or included frontline or health workers experiences in clinical 
settings – especially POC or primary care settings.  
• Studies conudcted in low to middle income country (LMIC) settings were prioritised 
in the reviewing of abstracts.  
 
Summary of Literature  
Most papers included for review were empirical in nature. Two papers (Theron et al, 
2014; Cox et al, 2014) that conducted pragmatic randomized control trials and one paper 
(Churchyard et al, 2015) that conducted a cluster randomized control trial were found from 
the search strategy that sought to investigate the feasibility, accuracy, and clinical effect or 
impact of point-of-care Xpert MTB/RIF testing for tuberculosis in primary-care settings. 
Much of the research acknowledges that more research is needed about the process and 
impact of GeneXpert on implementation practices at frontline levels. A total of 5 studies were 
found that explicitly sought to explore the social and relational aspects of the implementation 
of point of care diagnostic TB technologies. Only three studies (Colvin et al, 2015; Engel, 
2012; Engel et al, 2015) were found that accounted for the experiences and agency of front 
line workers and how their experiences of implementation may influence the implementation 
of point of care diagnostic technologies. One review paper (Albert et al, 2016) was found that 
mapped out key lessons for the implementation for new TB diagnostics that may be 
considered at all levels of the health system but is very useful for considering implementation 
practice for frontline workers. Many of the papers and research from the search strategy were 
from low to middle income country (LMIC) settings and many papers from South Africa and 
other African contexts were found. No study sought to account of front line narratives and 
focusing on giving voice to front line workers in the implementation of TB novel diagnostic 
implementation. This shows that there are explicit gaps in the literature for health workers 
being recognized as both people with lived realities and experts with discretionary power and 
agency. However, this literature review is by no way exhaustive and the search strategy does 
not represent the rigor of a systematic literature review.	   
 
	   	   	   	   9	  |	  P a g e 	  
	   	  
Interpretation of Literature 
Innovation in TB diagnostic technology and POC testing holds a lot of promise, but 
understanding the integration of technologies and programmes into complex health systems, 
and identifying major barriers to successful implementation is important (Pai et al., 2012). 
Literature investigating factors that mediate the implementation of TB diagnostic technology 
and associated policy and programmatic reform, is emerging. Findings from this review offer 
some important insights into the barriers and facilitators for the effective implementation of 
GeneXpert Diagnostic Policy. It further underscores some of the gaps in the current 
evidence-base in diagnostic policy implementation and offers some recommendations for 
future research and policy-making.  
Although GeneXpert seemed to be a simple solution to addressing the limitations of 
conventional diagnostic procedures in low resource settings and highly burdened health 
systems, there is strong recognition that programmatic and operational aspects are more 
important for implementation than the promise of technological solutions (Colvin et al., 
2015; Palamountain et al., 2012; Salje et al., 2014). Having innovative diagnostic 
technologies is not enough for reform implementation because they alone do not define TB 
diagnostic testing (Piatek et al., 2013). It is the integration and use of these tests into 
diagnostic programmes that will decide how effective the technology addresses diagnostic 
and treatment gaps (Pai et al., 2012; Engel et al., 2015). The broader POC literature for 
diagnostic testing, particularly, suggests that POC diagnostic testing technologies will be 
futile if their implementation into practice does not lead to successful use and uptake.  
More importantly, scholars acknowledge that ensuring prompt same-day diagnosis and 
treatment initiation are all determined by the programmatic implementation environment and 
process (Cowen et al., 2015; Pai et al., 2012; Piatek et al., 2013, Salje et al., 2014). 
GeneXpert can begin to address TB diagnostic and treatment challenges only if it is 
implemented within capable health systems and where existing health systems constraints are 
thoroughly considered (Piatek et al., 2013). Colvin et al. (2015) cautions against techno-
optimism and dependence on technological innovations to address complex health systems 
challenges, without a deepened consideration of the process and programmatic issues 
throughout implementation.  
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Some of the recent literature that assessed the implementation of recent TB diagnostic 
technologies in POC settings in Low-and Middle-Income Countries (LMIC) argues that a 
health systems approach that supports a comprehensive technical implementation within and 
across various organizational settings is lacking (Albert et al., 2016; Clouse et al., 2012; 
Colvin et al., 2015; Cowan et al., 2015; McNerney et al., 2012; Zumla et al., 2012). This 
means that all aspects of implementation - from programme and policy planning and 
formulation, to policy transfer and implementation practice, to monitoring and evaluation and 
back to planning and formulation – needs to be considered.  
For example, empirical papers studying the implementation of GeneXpert technology in POC 
settings in both India and South Africa, found that management and frontline staff described 
several avoidable delays, inconsistencies and inefficiencies in the implementation of these 
tests in practice (Albert et al., 2016; Clouse et al., 2012; Colvin et al., 2015; Engel et al., 
2015). Similarly, there are other reports that reflect gaps in the links between policy 
development and demonstration studies (Albert et al., 2016; Colvin et al., 2015; Kampen et 
al., 2015; Pai et al., 2012; Rendell et al., 2017; Weyer et al., 2013; Zachariah et al., 2012). 
Consequently, some authors raise issues of policy makers not adopting health systems, in the 
implementation of GeneXpert (Albert et al., 2016; Colvin et al., 2015; Pai et al., 2012; Engel 
et al., 2015). Adopting and maintaining health systems thinking and considering the context 
of health systems may facilitate policy implementation.  
Research shows that organizational health systems contexts are major barriers to the 
implementation of GeneXpert and POC diagnostic policies (Albert et al., 2016; Pai et al., 
2012; Rendell et al., 2017; Clouse et al., 2012). Organizations are faced with operational and 
logistical challenges because of changes in laboratory and staff arrangements, added 
workload because of institutionalizing reform practices, diagnosing algorithms, and resource 
demands (Albert et al., 2016; Kampen et al., 2015; Pai et al., 2012; Rendell et al., 2017; 
Weyer et al., 2013; Zachariah et al., 2012).  
The financial and resource costs of implementing GeneXpert into the health system have 
been substantial. Implementing one GeneXpert test in one POC facility is more expensive 
than running the tests from reference laboratories (Albert et al., 2016; Menzies et. al., 2012). 
These costs are elevated in organizational settings that are under-resourced, severely 
burdened, fragmented and highly privatised. Not only is the equipment and consumables of 
the technology more expensive than conventional technologies, but implementation needs 
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added programmatic costs for infrastructure development, health worker capacity, an increase 
in both first-line and second-line TB treatment demands, an increase in HIV testing and 
treatment demands for co-infected individuals, and other indirect costs (Menzies et. al., 2012; 
Meyer-Rath et al., 2012). Operational, implementation and economic evaluation literature 
underscores financial resources, presenting barriers for implementing GeneXpert effectively 
in health systems in low level primary care settings (Dowdy et. al., 2011; Menzies et. al., 
2012; Meyer-Rath et al., 2012). A key challenge reported in the literature is the integration of 
GeneXpert calling upon existing human resources and infrastructure, to support its 
implementation in incapacitated and constrained organizational settings. 
The resource demands associated with modifications to physical and organizational clinical 
and laboratory infrastructure to guarantee successful uptake and implementation of the 
diagnostic technology, is a major barrier for GeneXpert diagnostic reform (Albert et al., 
2016; Menzies et. al., 2012; Rendell et al., 2017). The literature reports that inadequate and 
unmaintained infrastructure resulted in poor uptake. Operational challenges where GeneXpert 
machines were placed in district or sub-district level POC facilities limited implementation in 
these settings (Rendell et al., 2017). Environmental issues such as humidity and dust resulted 
in equipment failure in some settings and there were challenges in sustaining suitable local 
power supply systems in others (Albert et al., 2016; Colvin et al., 2015; Cowan et al., 2015). 
Limitations in supply and demand management, namely the maintenance, repair or 
replacement of equipment – limited implementation (Albert et al., 2016; Colvin et al., 2015; 
Rendell et al., 2017). Although infrastructural capacity is a critical issue to consider in 
preparing organizations, effective implementation needs organizations to meet human 
resource requirements – another critical issue that stood out in the literature.  
Inadequate staffing arrangements and limited staff capacity is a barrier to effective 
implementation of reform; especially in high burden settings and with diseases such as TB 
(Rendell et al., 2017; Kampen et al., 2015). Despite GeneXpert low staff capacity and 
technical ability requirements, already limited resource capacities in many low resource 
settings was a major barrier to implementation. High-level policy makers took for granted the 
considerable human resource requirements for policy reform implementation (Clouse et al., 
2012; Palamountain et al., 2012; Rendell et al., 2017; Salje et al., 2014).  
Operational managers and frontline staff report that the implementation of GeneXpert 
resulted in increased workload, with no added human resource capacity (Colvin et al., 2015; 
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Cowan et al., 2015). This is compounded by the added procedures and standardized practices 
for example, changes in the diagnostic algorithm – which added pressure to an already heavy 
administrative load and other already existing organizational challenges that management did 
not discuss before implementation.  
In addition, training and readily available technical support was lacking, especially in settings 
that were not targeted for demonstration studies in the first phases of implementation (Albert 
et al., 2016; Menzies et. al., 2012; Rendell et al., 2017; Colvin et al., 2015; Cowan et al., 
2015). Clinical staff had to depend on unplanned and irregular training opportunities, with no 
consideration from management to discuss the stockpile in workload (Albert et al., 2016; 
Menzies et. al., 2012; Rendell et al., 2017; Colvin et al., 2015; Cowan et al., 2015). This 
results in nurses not wanting to attend training sessions. Consequently, nurses are not 
informed and knowledgeable about programme guidelines – another barrier in 
implementation (Rendell et al., 2017). It is recommended that standardised training can 
address this issue (Rendell et al., 2017).  
Limited staff capacity, poor training, and overburdened work load, compounds technical 
shortfalls and bottlenecks within organizational settings, and between centralised or reference 
laboratory systems and local clinical settings (Albert et al., 2016; Menzies et. al., 2012; 
Rendell et al., 2017; Colvin et al., 2015; Cowan et al., 2015). 
Communication and coordination is a major barrier for the implementation of GeneXpert in 
local organizational contexts. Lack of communication and coordination between clinical staff 
and the laboratory results in the following issues:  
1)  lack of understanding of error messages from the laboratories;  
2)  continued collection of inferior quality and quantity samples;  
3)  lack of follow up on scanty results;  
4)  conflicting information between clinical staff and the laboratory about the type of 
specimen needed for GeneXpert testing and clear indications when a GeneXpert 
must be done with all the required information; and  
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5)  misunderstanding of the laboratory request forms and procedures (Albert et al., 
2016; Menzies et. al., 2012; Rendell et al., 2017; Colvin et al., 2015; Cowan et al., 
2015; Pai et al., 2012; Palamountain et al., 2012).  
In some instances, implementation has been eased by adequate transportation systems for 
specimen collections and administration paperwork. However, paper based systems for 
tracking and communication, lack of information and computer training (ICT) impedes the 
implementation of GeneXpert (Albert et al., 2016; Menzies et. al., 2012; Rendell et al., 2017; 
Colvin et al., 2015; Cowan et al., 2015; Pai et al., 2012; Palamountain et al., 2012). In some 
studies, it was found that nurses do not prefer electronic databases for record keeping, 
coordination and communication (Albert et al., 2016; Rendell et al., 2017; Cowan et al., 
2015). This is despite the challenges with communication and record keeping systems – 
which include paper-based communication (for example lab request forms, lab result 
printouts), which is dependent on the accuracy of written information, and the added work of 
manually capturing information from paperwork into electronic databases. Literature reports 
that low uptake of electronic databases and systems is due to low availability of online 
systems and existing systems not coordinating with each other. This results in repeated 
capturing of information, creating more work rather than alleviating the workload (Albert et 
al., 2016; Cowan et al., 2015; Colvin et al., 2015; Rendell et al., 2017).  
Nevertheless, communication and coordination within and between organizations is not only 
contingent on the mechanisms that are put in place. The success of policy implementation 
within the health system transcended beyond the adequacies of the health systems building 
blocks. Social relationships, human agency, values, norms, attitudes and experiences and how 
they interact with health systems hardware, drives effective implementation in organizational 
settings.  
Although lacking there is some acknowledgement in the broader POC diagnostic literature 
about the contribution of deepened social science research to understanding barriers to 
implementing diagnostic policy reform. Some studies have relied on interview, focus group 
and some limited direct observational data to understand actors’ perceptions of POC 
diagnostic implementation (Albert et al., 2016; Rendell et al., 2017; Colvin et al., 2015; 
Cowan et al., 2015; Pai et al., 2012; Palamountain et al., 2012; Kampen et. al., 2015). These 
studies focused on making interpretations from health workers and managers responses about 
barriers, related to resource constraints and barriers associated with organizational hardware, 
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that is, financing, human resource constraints, infrastructural challenges, and communication 
and coordination mechanisms.  
Although these interpretations are important to understanding operational aspects of policy 
implementation, there still is a gap in the literature contributing to the understanding of how 
diagnostic practices are shaped by the social and human elements of the health system and 
how they interact with hardware components to shape implementation outcomes. There are a 
few scholars in the broader POC diagnostic literature and GeneXpert literature that account 
for health worker-patient relationships in relation to the social realities associated with the 
patients’ diagnosis (Chandler et al., 2011; Colvin et al., 2015; Engel et. al., 2012; Engel et 
al., 2015; Angotti, 2010). For example, Engel et al., (2015) explored relationships among 
providers and between patients and providers, and found that they may form a major barrier 
for POC diagnostic implementation. One of Engel et al.’s (2015) main findings are that 
relationships and coordination between providers, labs and patients is important for succesful 
POC testing and that POC and follow up testing is more likely to take place if there is 
relationship and coordination between providers and patients. For example, they report that 
how in India’s private sector coordination between doctors and labs means that testing is 
often accomplished within the same day. A patient is seen in a clinic in the morning, goes to 
a nearby or in-house lab for tests and usually returns to the doctor with the results in the 
afternoon or evening. Labs and doctors have adjusted opening hours and try to cater to 
patients’ schedules. Private facilities usually have the required human resources and 
infrastructure to do this and coordination between providers results in efficient service 
delivery, which in turn facilitates a relationship and coordination with patients. In contrast, 
they found that in the public sector a lack of coordination among clinic providers, influenced 
by human resources shortages, fosters a culture of blame and mistrust among staff. High 
workload, staff shortages, coupled providers being over-burdened, over-worked, 
insufficiently supported, and lack of accountability had implications for whether providers 
had the time or was willing to carry out POC testing effectively. ‘The different actors blame 
each other for poor quality of sample collection or laboratory work, and for inadequate 
numbers of investigations ordered to reach targets of disease control programs’ (Engel et al., 
2015, p. 9). This study offers pertinent insights into how POC diagnostic technology, 
procedures, demands and infrastructure has the potential to constrain and to facilitate 
relationships and coordination, but also how coordination and relationships may support 
clients to follow through with diagnostic cycles (Engel et al., 2015). 
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Then, Chandler et al., (2011) and Angotti (2010) also found that the socio-cultural context 
and organizational norms in which diagnostic practices work is linked to health worker-
patient relations and shape the outcome POC diagnostic implementation (Engel et al., 2015). 
While recognizing that organizational norms are influenced by broader structural contextual 
factors, Chandler et al., (2011) found that social distance at public health clinics is 
charatcerised by a set of norms in the space of the clinic and the nature of health worker–
patient relationships. Their participants told stories of their experiences of blatant power 
assymmatries between providers and patients. ‘Front-line workers treated them rudely, even 
shouting at them, and did not have time or inclination to care for each patient’ (Chandler et 
al., 2011, p. 939). This serves as a barrier to accessing POC testing services and for patients 
to return for follow up testing which has implications for case detection and treatment 
(Chandler et al., 2011).  
In contrast, another constraining factor that may limit POC testing is the extent to which 
providers have room to manipulate standard procedure to accommodate patients’ needs. 
Engel et al., (2012) explored the tension between recognizing health workers agency for 
innovation and the need to control the diagnostic process, through standardized practices and 
procedures that may implicate programmatic outcomes. Engel et al., (2012) argues ‘that a 
balance is needed between the extremes of controlling the diagnostic process through 
standardization, in such a way that it becomes exclusive for particular local settings or ability, 
and innovating a diagnostic test without standardizing operational processes; which is not 
programmatically possible’.  Similarly other studies have shown how issues of power and 
asymmetrical relationships between global, national and local policy may hinder or help 
front-line implementation in that these broader structural relations and dynamics impact on 
provider and patient-provider relationships within local settings (Albert et al., 2016; Colvin et 
al., 2015; Kampen et al., 2015). These implications may impact on access, uptake and 
delivery of POC diagnostic tests.  
 
Issues illuminated in these studies are often taken for granted in policy implementation and 
may form part of the reasons for the lack in improvements in policy reform implementation. 
These studies contribute immensely to policy implementation reform for health systems 
strengthening them holistically.  
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Gaps or Needs for Further Research 
A review of the literature about barriers and enablers of diagnostic implementation reforms 
yields important insights about the gaps and opportunities for future research and policy 
considerations for GeneXpert policy implementation, as well as for scaling-up TB diagnostic 
reform. Although this was not a comprehensive review of existing literature, it is clear that 
emerging findings are increasingly proving the need for holistic health system perspectives as 
important for policy making and research inquiry. This means considering the ways in which 
health systems contextual issues – structural, functional and social elements govern 
implementation. This also means that centering low level health workers in GeneXpert policy 
implementation, is important to understand their challenges, values, agency and contributions 
diagnostic reform. In considering their experiences, agency, voice and values, it may be 
valuable to locate these issues within broader institutional structures and consider power 
relations and its implications for social and working relationships at various levels of the 
health system as demonstrated by Colvin et al., 2015 and Engel et al., (2012). Both these 
studies deomstarte the importance of focusing on the voice of frontline workers, as both 
people with lived realities and experts with discretionary power and agency. Although the 
literature reviewed here argue for major gaps in accounting for health workers as people with 
lived realities, and who must respond to patients with complex needs, these studies are 
limited. They only represent a small percentage of the broader TB diagnostic and GeneXpert 
literature that considers software elements of the health system as important for pragmatic 
implementation. These papers also demonstrates that there is a gap in the literature for 
focusing on the voice and agency of nurses and frontline workers in diagnostic 
implementation. For scholarship and policy-making to contribute to advancing people centred 
health systems, in the implementation of policy reform; there is a need for:  
1)  an intentional focus on social and human elements, as on hardware factors in 
operational organizations for implementation;  
2)  operational research needs to centralise the voice of frontline workers, as both 
people with lived realities and experts with discretionary power and agency; and  
3)  a deeper consideration for relationships and power in implementation across 
different layers and actors within health systems. 
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‘Doing things right but not doing the right thing’: Centering Primary Health Care 
(PHC) Nurses' Experiences of their Practice in Health Policy Implementation - TB 
Diagnostic Policy Reform in the Western Cape, South Africa 
 
Lance Louskieter1, Chris Colvin2, Helen MacDonald3 
 
Abstract  
Health systems are socially constructed through the complex realities of actors and 
the interactions between them. People-centered scholarship, policies and systems have been 
argued by some health policy and systems researchers to contribute meaningfully to health 
systems strengthening. This means that scholars and policy makers must appreciate the 
intersections between hardware components, social systemic and contextual influences, and 
the strong influence of actors as people with complex lived realities and human agency. 
Recent global reforms in tuberculosis (TB) diagnostic policy and the implementation of 
Xpert MTB/RIF (GeneXpert) diagnostic technology into the health system offer an 
interesting case to assess how software issues - particularly the human qualities of the system 
- are considered in scholarship. Understanding the experiences of frontline staff in local 
implementation contexts is imperative because of their discretionary power in their practice. 
Yet, there is little written about point-of-care diagnostic experiences of nurses who are the 
principle actors of TB diagnostic policies and technologies at primary health care (PHC) 
levels. This paper seeks to contribute to the policy implementation literature in the field of 
Health Policy and Systems Research (HPSR) through an exploration of nurses' lived 
experience – especially from the perspective of those nurses. A total of 10 nurses were 
interviewed from three PHC facilities in a Western Cape sub-district, South Africa. Direct 
observations were conducted to support the interview data. Findings reflect that within the 
context of top-down, target-driven and highly structured and standardized operational 
processes for diagnosing TB, nurses navigate multiple overlapping and contradictory modes 
of being in their relationships with patients. These contentions in their roles, actions and 
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responses, as well as apparent contradictions between discourse and practice, are mediated by 
broader organizational and systemic ideologies and processes that are entrenched in health 
systems. These include pressures to meet policy targets, the encumbrance to enforce 
administrative and bureaucratic procedure, and the minimal platforms or pathways to provide 
management and decision-makers with their own input on challenges and innovations. 
Nurses struggle to navigate these pressures and challenges, especially in relation to having to 
deal with and respond to the complex realities of patients. Based on their discourse, it seems 
that nurses make sense of implementation as being driven by service delivery through 
dignified and people-centred care. However, the system limits this in practice. The findings 
of this study offers voice to nurses’ experiences of implementing TB diagnostic policy in 
PHC settings in South Africa considering that nurses’ experiences are situated within broader 
systemic and organizational contexts. This study also highlights tensions between efforts to 
achieve efficiency and effectiveness through enforcing the system, and facilitating people-
centered and responsive practices in implementation. Researcher and policy makers should 
consider these tensions for low level health workers when implementing reforms that seek to 
strengthen health systems. 
 
Keywords: Implementation; Nurses; Experience; People-centred; Health Systems and 
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Background 
Policy implementation, defined by practices or actions in the 'real world’ following 
policy formulation, is a universal challenge across health systems. This is mainly because 
health systems are complex adaptive systems (Gilson, 2012; Plsek, 2001). A complex 
adaptive system in health systems thinking is a complex and dynamic web of interrelated 
sub-systems and processes including the interactions and relationships of different 
components simultaneously affecting and being shaped by the system (Gilson, 2012). These 
components include health system actors and they can often behave in ways that are 
unpredictable and, thus, may influence changes in context as well as the actions of other 
actors (Plsek & Greenhalgh, 2001). These complexities have been and continue to be taken 
for granted. Scholars in the field of health policy and systems research (HPSR) argue for the 
consideration of complexity in policy implementation as imperative for strengthening health 
systems (Gilson, 2012; Plsek & Greenhalgh, 2001; Sweeney & Griffiths, 2002).  Embracing 
complexity requires a deepened understanding of different components, processes and 
relationships that operate at different levels of health systems. In particular, special focus 
needs to be drawn to the interaction between the structural or bureaucratic and human 
elements that make up the system (Gilson, 2012; Plsek, 2001). Implementation scholars need 
to acknowledge that strengthening the health system requires going beyond addressing issues 
KEY	  MESSAGES:	  
• There	  is	  a	  need	  for	   intentional	  and	  deliberate	  consideration	  for	  the	  human	  qualities	  of	  
the	   health	   system	   in	   policy	   implementation.	   A	   focus	   on	   the	   human	   and	   relational	  
elements	  is	  essential	  for	  advancing	  responsiveness	  and	  people-­‐centeredness.	  	  
• TB	   targets,	  highly	  bureaucratized,	   routinized	   and	  heavy	   administration,	  and	  autocratic	  
approaches	  to	  communication	  and	  engagement	  with	  nurses	  undermine	  their	  capacities	  
to	  be	  responsive	  to	  the	  needs	  and	  complex	  realities	  of	  individual	  patients.	  
• It	   is	   important	   for	  policy	  makers	   and	   researchers	   to	   be	  critical	  of	   the	  extent	   to	  which	  
targets,	  bureaucracy	  and	  administration	  are	  prioritized	  over	  dignity,	  responsiveness	  and	  
humanity	  in	  the	  process	  of	  diagnostics	  care	  in	  TB	  policy	  implementation.	  
• There	   is	  a	  need	   for	  public	  health	  officials	  and	  different	   levels	  of	  management	   to	  offer	  
opportunities	  and	  platforms	  for	  nurses	  to	  share	  their	  voices,	   input	  and	  prowess	   in	  the	  
policy	  process.	  Research	  and	  policy	  efforts	  must	  seek	  to	  actualize	   the	  contributions	  of	  
nurses.	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pertaining to physical health. Rather, there is a need to consider the social, political and 
economic realities of people in society and the promotion of respect and dignity in the 
delivery of services to persons (Gilson, 2003; World Health Organization, 2000; 2007).  
This paper seeks to contribute to the policy implementation literature in the field of 
health policy and systems research (HPSR) by exploring the lived experiences and voices of 
low-level frontline workers - especially nurses who are overburdened and undervalued. By 
drawing on people-centred scientific approaches (Sheikh, George, & Gilson, 2014), this 
paper argues that foregrounding the humanity of nurses in their organizational and social 
systemic policy contexts can strengthen health systems implementation.     
 
The gaps in health policy implementation research focusing on health workers' experiences 
as an important factor in implementation  
From this perspective, effective implementation of international policy requires global 
policy makers and researchers to reflect on the plurality within the global health system. They 
should also have a strong regard for local realities, spaces and voices (Hyder et al., 2007; 
Martin, 2008; Gostin & Mok, 2009). Policy implementation mainly relies on front-line 
workers in low level organizations. At this level, local complex realities and challenges make 
it difficult for novel global and national policies and technologies to be adopted (Colvin et al, 
2015). Experience has shown us that merely introducing new technologies and policies is not 
sufficient to undertake and solve multifaceted public health issues (Walt & Gilson, 1994; 
Campillo-Artero, 2012; Dussault & Dubois, 2003; Lonnroth et al., 2009; Raviglione & Pio, 
2002). A wide range of interacting factors mediate the implementation of policy in a 'real-
world' setting. Factors that mediate the implementation transcend beyond the programme 
guidelines or the mechanics of the programme itself and are described as ‘software’ factors 
(Gilson, 2012).  
Software elements are defined as the social, intangible and nuanced factors (such as 
attitudes, beliefs, values, norms, roles, procedures, and relationships within the health system) 
that may also influence implementation (Gilson, 2012). Actors’ experiences and their 
relationships are central to policy implementation (Gilson, 2012). In isolation or in 
combination, these issues interact with one another to various degrees and at different levels 
of the system and may present various challenges for the implementation of policy (de 
Savigny & Adam 2009; Gilson, 2013; Sheikh et al. 2011).  
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In advancing people centredness for health systems strengthening, scholars and 
policy-makers must acknowledge that, similarly to patients, health workers are people with 
complex lived realities and this adds to the complexity of the health system (Eade, 1997; 
Namakula & Witter, 2014; Sheikh, George & Gilson, 2014). Their lived experiences are 
shaped by the complex issues, interactions and relationships that drive their practice. Based 
on the implementation science literature, there appears to be a great need to understand how 
health policy implementation practices are mediated by health workers' experiences, 
interactions and relationships (Buse, Mays, & Walt, 2005; Gilson et al, 2011; Rice, 2013; 
Walker & Gilson, 2004). This paper discusses the findings from an inquiry into frontline 
primary health care (PHC) nurses’ experiences of the implementation of recent tuberculosis 
(TB) diagnostic policy reforms in their practice.   
 
Novel TB diagnostic policy implementation offers a unique lens for understanding low level 
health workers' experiences of policy implementation 
Global advances and innovations in TB diagnostic technology have called for new 
policies and programmes to be integrated into local settings (Colvin et al, 2015). The 
MTB/RIF Xpert diagnostic test has been introduced as an innovation that could possibly 
address the gaps in current TB diagnostic efforts (Chang et al., 2010; Colvin et al, 2015; 
Dorman, 2010; Piatek et al., 2013). The Xpert MTB/RIF diagnostic test (GeneXpert) is a 
single test that detects TB rapidly, and is sensitive to resistant strains of TB (Chang et al., 
2010). Compared to previous conventional methods, this test is reported to be more effective 
in identifying cases of multi-drug resistant1  (MDR) TB or extremely resistant  TB2 (XDR-
TB) and is more sensitive to co-infection  (Chang et al., 2010). This novel diagnostic 
technology has the potential to improve diagnostic capacities of point-of-care services. In 
particular, this test can easily and efficiently identify affected patients which will, therefore, 
accelerate the initiation of appropriate TB treatment (Palamountain et al., 2012). Unlike 
conventional methods, GeneXpert provides a more practical diagnostic approach for primary 
care in low resource health systems which often serve communities with a high disease 
burden (Palamountain et al., 2012). However as discussed earlier, the implementation of 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
1
Multidrug-­‐resistant	  TB	   (MDR	  TB)	   is	  caused	  by	  an	  organism	  that	   is	   resistant	   to	  at	   least	   isoniazid	  and	  rifampin,	   the	   two	  most	  potent	  TB	  
drugs.	  These	  drugs	  are	  used	  to	  treat	  all	  persons	  with	  TB	  disease	  (Chang	  et	  al,	  2010).	  
 
2 Extensively drug resistant TB (XDR TB) is a rare type of MDR TB that is resistant to isoniazid and rifampin, plus any 
fluoroquinolone and at least one of three injectable second-line drugs (i.e., amikacin, kanamycin, or capreomycin) (Chang et al, 
2010). 
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promising diagnostic technologies and associated policies does not automatically translate 
into clinical impact.  
In addition to the limitations of research studies investigating the influence of 
software factors in policy implementation, there also appears to be limited empirical evidence 
accounting for these factors in the TB diagnostic literature and in the GeneXpert policy 
implementation literature (Clouse et al, 2012; Colvin et al, 2015; Engel et al, 2015; Pai et al, 
2012; Piatek et al, 2013; Rendell et al, 2017). More specifically, there seems to be a dearth 
of TB diagnostic literature of that explores front-line workers’ perceptions, interpretations 
and experiences of new technologies and how their relationships may facilitate or hinder 
actual implementation of TB diagnostic policies. Although Boehme et al. (2011),  Clouse et 
al. (2012) and Van Rie et al. (2010) investigated the implementation of GeneXpert in point-
of-care and other clinical settings, there is limited information available concerning nurses' 
experiences and how these experiences impact their implementation practices. This is 
surprising considering that these low level health workers are central to the implementation 
of policy. Front-line health workers are described as Street Level Bureaucrats (SLBs) as they 
operate at the level where policies are transferred into action (Rice, 2013). SLBs are people, 
and people are complex beings that consistently position and reposition themselves in 
proximity to different policy issues, processes and activities in health systems (Buse, Mays, 
& Walt, 2005; Gilson, 2012; Rice, 2013). They may adapt their practices to cope with health 
systems challenges, which may cause further diagnostic delays for patients (Engel et al, 
2015). In this way they hold agency and discretionary power that may influence the 
effectiveness of policy implementation, and this needs to be more accounted for in the 
literature (Buse, Mays, & Walt, 2005; Rice, 2013).  
 
Nurses are at the forefront of implementation South African Health Systems and their voices 
are important  
The majority of the primary health care facilities in SA and other LMIC countries are 
nurse-led. Nurses are at the frontline of the TB epidemic in SA. Most of the recent TB 
diagnostic policy innovations in SA have focused on point-of-care services in community 
clinics or primary care facilities. This is the level at which the role and practice of nurses 
influence all layers of policy implementation in its entirety. TB is a challenging disease to 
work with since it is airborne, highly stigmatized, possibly drug-resistant, and often life-
threatening. Nurses must face these threats whilst still delivering patient care which involves 
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providing health education to patients, families and the broader community; treatment 
management and observation; sputum collection, management and coordination; and contact 
tracing and screening. Nurses put their own lives at risk in their practice and during the 
implementation of TB policies. Yet, there is little written about point-of-care TB diagnostics 
that focuses on nurses’ experiences and voice as key to their practice of the implementation 
of TB policies and technologies at primary health care levels (Clouse et al., 2012). This calls 
for a need for deeper insights into how nurses as people are important in contributing to 
effective TB policy implementation (Bergen & While, 2005; Rice, 2013). Previously, there   
has not been sufficient focus on the complex experiences that may deter practices of TB 
diagnostic testing and diagnosing at point-of-care (Scott et al., 2014).  
 
The first objective of this study was to investigate PHC nurses’ experiences of 
diagnosing TB following the implementation of GeneXpert policy in their practice. This was 
done to understand how nurses’ experiences mediate the implementation of TB diagnostic 
policy in nurses’ practice. An investigation into nurses’ experiences through an analysis of 
discourse and practice offer important lessons for people-centered health systems in TB 
diagnostic policy implementation. A second objective of this study was thus to explore 
whether and how GeneXpert policy implementation may or may not be contributing to 
fostering people-centeredness in health systems.  
 
Methods 
Research design  
The design of this investigation was explorative in nature. A case study approach was 
used.. This approach was appropriate because of the explorative features of this study (Yin, 
2009; 2011; 2013). This approach enabled us to explore how nurses’ subjectivities are deeply 
situated within contexts. This approach was further relevant for this investigation as the 
researcher had little control over the processes and events under study because it was based 
on a contemporary phenomenon within a real-life context (Gilson, 2012; Hancock & 
Algozzine, 2006; Yin, 2009). Within the overarching case study approach, qualitative data 
collection and analysis tools were employed. Qualitative research methods offer tools to 
obtain narratives about nurses' experiences and to observe actions and interactions in their 
organizational contexts. This allows researchers to interpret and explain constructed 
experiences in relation to observed reality (Miles & Huberman, 1994; Willig, 2001). 
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Qualitative research methods have proven to be relevant tools in health systems and 




The Micro-Institutionalist Theory of Policy Implementation (MITPI) framework 
developed/detailed by Rice (2013) was used to guide the analysis of nurses’ narratives and 
their implementation practices of TB diagnostic policies (Figure 1). The MITPI framework 
draws on the street-level bureaucracy (SLB) theory developed by Lipsky but provides a 
comprehensive set of ideas for taking into account complex factors in the shaping of health 
workers’ experiences and practices at the different levels of policy implementation (Rice, 
2013). The theory posits that the social realities of health workers are influenced by four 
interacting domains: 1) intrinsic individual cognitive and emotional processes, 2) the 
organizational context, 3) institutions characterized as norms or procedures that shape 
practices, and 4) the social systemic context (Lipsky, 2010; Rice, 2013). Individual human 
experience governs behaviour, and organizational and systemic contexts determine the 
conditions for bureaucratic action. These four contexts interact to influence the way in which 
health workers facilitate or constrain implementation (Lipsky, 2010; Rice, 2013). This 
framework was meaningful in the design of this research study as a thinking tool to 
understand complex interactions between different policy contexts operating at different 
levels of the health system.  
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Figure 1: Micro-Institutionalist theoretical framework for policy implementation (Rice, 
2013)  
 
Setting and context  
TB is major contributor to mortality in South Africa. SA has high HIV-TB co-infection rates 
and has a high incidence of drug resistant TB cases.  In order to rationally respond to the dual 
epidemics of HIV and TB, SA formulated the integrated National Strategic Plan (NSP) for 
HIV, STIs and TB (2012 - 2016) (South African National AIDS Council, 2012). The targets 
set in the NSP for TB were to reduce TB incidence and mortality by 50% in 2016 and to 
reduce incidence of TB cases by 100% (South African National AIDS Council, 2012). 
Although SA has made notable progress in reducing TB prevalence and mortality rates, and 
has improved treatment outcomes for new smear-positive TB cases, the burden of TB 
remains substantially high. This has primarily been attributed to the limitations in and 
barriers to effective detection and diagnosis of TB. TB is managed largely within the public 
healthcare system in which TB diagnosis and treatment occur at the primary health care 
(PHC) level. This means that SA provided an ideal setting for the implementation of the 
global GeneXpert diagnostic policy framework in 2011. The decision to adopt this policy was 
made by the National Department of Health (NDoH) who are responsible for the national 
roll-out of health policies. They adopted a phased approach to implement GeneXpert 
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technology in health facilities across high TB burden districts in all nine provinces (Fielding 
et al., 2014). 
The Western Cape Province has been reported to have the highest rate of all types of 
TB in South Africa (Claassens et al., 2013). This study was based in a sub-district in the 
Western Cape Province. The province and the sub-district have high incidence and 
prevalence of TB. Three PHC clinic facilities were selected in the sub-district and formed the 
three cases for the research inquiry.  
 
Sampling and recruitment of cases  
Three PHC case facilities were selected within a specific sub-district in the City of 
Cape Town Metropole Region. PHC day clinics managed by the City of Cape Town 
Metropole mainly diagnose, manage and treat TB cases. TB patients diagnosed at hospitals 
and community health centres are referred to clinics for management and treatment. The 
strategy adopted for sampling and selecting the clinic case facilities for this study was based 
on the accessibility of the case facilities and the feasibility of carrying out the data collection 
methods. Caseloads and performance outputs were considered to select facility cases with 
differing expectations, challenges and successes and this allowed for richer cross-contextual 
case analysis. The organization of the three TB rooms which exist in the three district clinic 
facilities is characterized by different actors, contexts and attributes. Each case facility has its 
unique facility manager, TB room coordinator, facility staff composition, TB room staff 
composition, caseloads and suspect loads, and is situated in different communities with 
distinct characteristics. Nonetheless, all three case facilities are governed by the same sub-
district management team, and they are mostly similar in terms of resources availability, 
infrastructure, coordination mechanisms, and accountability structures.  
 
Data collection methods 
Data collection started with a document review of the TB policy documents. The following 
policy documents were purposively sampled to inform the researchers of the broader TB 
policy framework at global, national and local levels. The documents included global and 
national policy frameworks and guidelines, diagnostic algorithms, Clinical Practice 
Guidelines, Standard Operational Procedures, meeting minutes available in the facilities and 
documents made available by the different facility managers and the sub-district TB 
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coordinator. The document review data was triangulated with interview and direct 
observational data. 
 
Face-to-face interviews were conducted with ten nurses across the three case facilities. These 
nurses included the three facility managers, three Clinical Practice Nurses coordinating the 
TB rooms, and four staff and assistant nurses. The researcher spent five months in the three 
PHC facilities to conduct direct observations. To facilitate an open, intensive and non-
intrusive interviewing process, principles of narrative interviewing was utilized. In the 
interviews, participants were asked open ended questions. The narrative thematic analysis 
approach by Riessman (2002, 2008) was used. This was most useful because nurses’ 
experience was obtained through language. Narrative inquiry recognizes that language is 
socially constructed and is situated within broader social and contextual systems that shape 
lived experiences (Emerson & Frosh, 2004). Utilizing narrative research in data collection 
and analysis processes was, therefore, aligned to the broader aims of this research 
investigation.  
 
In addition, direct non-participant observations were conducted in the three case facilities 
over a period of six months. The researcher was mostly based in the TB room of these clinics 
and interacted with nurses working in the TB room, administrative staff in the facility and the 
facility managers. The researcher also sat in on a series of clinic staff meetings and TB policy 
meetings in each facility. Direct observations also allowed for data from informal continuous 
conversations with nurses, facility managers, and the sub-district TB coordinator. Field notes 
were taken and the researcher mainly observed activities and interactions in the TB rooms of 
the case facilities.  
 
Drawing on different forms of qualitative research methodologies was important for 
enhancing the trustworthiness of the findings of this paper through the process of 
triangulation (Gilson, 2012). 
 
Data Analysis 
Audio files and notes were transcribed and cross-checked. Interview transcripts were coded 
and analysed using Riesmann’s (2008) thematic narrative analysis approaches. Observational 
and document review data were analysed using a thematic analysis approach. A code book 
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was created with relevant codes that addressed the research question. Codes were further 
grouped into categories of emerging themes in an iterative manner using thematic analysis. 
Different sources of data were triangulated to analyse for similarities and contradictions. Data 
was also analysed to account for patterns and linkages between emerging themes and codes 
across different clinic cases.  
 
Ethics 
This study was approved by the Faculty of Health Science Research Ethics Committee 
(HREC REF 821/2015) at the University of Cape Town, South Africa. Written and verbal 
informed consent was provided by the nurses and facility managers for the in depth face-to-
face interviews and direct observations. All signed informed consent forms were collected 
prior to participation. Notices were placed in facilities to notify clients that a researcher 
would be gathering observational data. In the event of personal and private consultations 
between nurses and patients, the researcher would leave the TB room or the nurses would 
move the consultation to a private room if available. The nature of personal and private 
consultaitons were assessed according to the nurses’ interpretive judgements and patients’ 
requests. All patients were told by the nurses about the role and purpose of the researcher in 
the TB room and patients were asked for verbal consent by the nurses for the researcher to be 
present in general consultations. Professional roles were used to mask nurses' identities. 
Approval to conduct interviews and observations at public healthcare facilities was sought 
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Findings and Discussion 
From the plethora of factors that affect implementation, nurses’ experiences of their practice 
of implementation are important to consider when assessing the barriers and facilitators for 
successful implementation. Their experiences offer access to understanding the realities of 
implementation needs, gaps and failures that are not always accounted for by policy makers, 
implementation guidelines and the perspectives of higher level management. They also 
provide an understanding how historical and present contexts and personal attributes shape 
implementation processes. This study found three broad health systems issues most 
prominent in nurses’ discourse and practices that impact TB diagnostic policy 
implementation. These are: 1) the strong culture of target driven approaches, 2) highly 
bureaucratized systems and administrative pressures, 3) Gaps in the engagement between sub 
district management and nurses. These issues limit the ability to foster people-centeredness in 
health systems because of contradictions, demands and pressures that result in feelings of 
anxiety, confusion and voicelessness.   
1) ‘Management will rather ask us: What did you do to keep the patient in the system? You 
know how numbers tell our story’. Nursing for targets rather than nursing patients with 
complex lives. 
 TB programmes in South Africa are highly target-driven (National Strategic Plan 
[NSP] for HIV and AIDS, TB and STIs 2012 – 2016). Although numerical targets set 
direction and can help drive systems behaviour, they have unintended consequences for 
nursing practice (Meadows, 2008). The impact of a target-driven culture on nurse-patient 
interactions was central in nurses' narratives. Nurses talked about management valuing 
achieving and maintaining programmatic target rates (such as case finding rates, smear 
conversion rates, treatment outcome rates and defaulter rates – see National Tuberculosis 
Management Guidelines 2014) more than focusing efforts on delivering the best possible care 
and curing patients. All nurses in this study reported that the quality of care for their patients 
is negatively impacted by target-driven approaches in TB policy implementation.  
Many nurses constructed narratives about the support from sub-district management 
which tends to be limited to nurses ‘doing things right but not whether we are doing the right 
thing’ (Facility Manager, Facility 2). It was apparent from the narratives that management at 
the sub-district level does not acknowledge how nurses interpret quality-of-care, nor their 
effort in offering their patients the best service and care. Rather, these nurses indicated that 
	   	   	   	   15	  |	  P a g e 	  
	   	  
management seems to emphasise targets, numbers and statistics more than the values of the 
nursing profession – which they explained to be defined by principles of compassion, treating 
clients with dignity, and the quality of care for the patients. This perspective from health 
workers is evident in contemporary health systems contexts where the successful 
implementation of programmes is mainly based on quantified outcomes (Baillie & Gallagher, 
2010).  
The following quote explains how nurses talk about how this emphasis on numerical 
targets may be a potential barrier for the effective implementation of TB programmes in their 
nursing practice: 
 
‘The city is target driven and all our outcomes are target driven… and that actually 
puts a lot of strain on the facility. It’s all about the rates and stats…This is the biggest 
challenge for implementation for us’ (Facility Manager, Facility 2)  
 
Furthermore, this target-centred approach has been shown to make nurses feel undervalued 
and adds additional pressure to an already demanding working environment (Allan, Traynor, 
Kelly & Smith, 2016; Anderson, 2016; Sawbridge & Hewison, 2011). These issues were 
evident in the current study, as illustrated in the quote below:  
 
‘Sometimes it feels like the people (management) do not care or worry about us. They 
will just preach stats, or they will just see the negatives and not see the positives. They 
will not see that we try and they hammer us a lot – especially in TB.’ (CPN, Facility 
3)  
 
The strong emphasis on targets was also observed in practice. In one observed 
scenario, a facility manager expressed her disappointment in the TB nurses after the sub-
district TB coordinator1 informed her that the TB nurses were failing to reach their targets. 
This scenario provides evidence to suggest that the success of implementation is determined 
only by numerical goal achievement and performance targets, and does not include aspects of 
care encapsulated in nurse’s relational work with patients (Bender et al., 2011).   
Nevertheless, similar to Harper’s (2010) findings, nurses in this study understood that 
achieving programmatic targets is dependent on patients' compliance and that patient 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
1 Sub-district TB coordinators are responsible for the provision of TB services within the local health sub-district. They are 
responsible for planning, organizing, implementing, and evaluating activities of a district TB control programme.	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compliance can only be facilitated through being responsive to patients’ lived realities. In 
their discourse, nurses emphasized that the behaviour of their patients has direct implications 
for achieving performance targets in nursing practice.  
 
“Patients defaulting and not complying is a big thing for us. We struggle with our 
patients because they do not listen to us. They can make our jobs very difficult, you 
know… and when [management] come back to us, they ask: What did we do to keep 
the patient in the system? The patient can make or break us... but it's like 
[management] don’t see our struggles with patient in the stats’ (CPN, Facility 3)  
 
In addition to poor patient compliance, another issue that emerged from the narratives 
was that some patients expressed distress concerning the challenges of coming to the clinic 
for follow up visits which are important for relaying diagnostic results and initiating 
treatment. Reasons for this distress are often related to transportation costs, the possibility of 
being too physically weak to travel, or having to take care of dependents. This is congruent 
with findings reported by Gebremariam, Bjune and Frich (2010), and Needham, Foster, 
Tomlinson and Godfrey-­‐Faussett (2001). Some patients had challenges producing sputum 
samples because they were too weak or found it painful to cough. In addition, similarly to 
Møller and Erstad (2007)’s findings, other patients refused to provide personal information 
about where they lived because of the stigma associated with TB and the fear of rejection by 
friends, family and colleagues. Issues of patient compliance, loss to follow up and the spread 
of infection are strongly associated with issues of psychosocial issues of communities 
(Murray et al, 2012). Substance abuse, lack of formal education, unemployment, mental 
health and poor living conditions all influence policy implementation (Gebremariam, Bjune 
& Frich; Murray et al, 2012; Needham, Foster, Tomlinson & Godfrey-­‐Faussett, 2001).  
 
Care-giving, responsiveness and relational work is a crucial part of nursing practice 
(Baillie & Gallagher, 2010; Benner, Tanner & Chesla, 2009; Escott & Walley, 2005). 
However, it was clear from the narratives that nurses felt a definite tension between wanting 
to be responsive to the needs of patients with complex realities and having to achieve 
performance targets which sometimes requires them to ‘turn a blind eye to patients’ needs’ 
(Facility Manager, Facility 2). Observational and narrative data reflects how nurses deal with 
these tensions. Overall, nurses in this study responded to the conflict associated with the 
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pressures of targets and the demands of responding to the complex realities of patients by 
navigating contradictory modes of being in their practice.     
For example, it was observed that some nurses from all three clinics would shout at 
patients, refuse to listen to pleas, and enforce the rules of diagnostic policy over the realities 
of patients. Some would act ambivalently when requested to make exceptions for patients’ 
personal circumstances and would focus on strictly following the prescriptive regimens set 
out by higher management. In other cases, nurses would insist that, following diagnosis, 
patients should present to the clinic daily after for treatment even though some patients 
pleaded that daily presentation would be challenging. In one instance, a patient refused to 
provide information about where he lived and the contact details of his landlord for the fear 
that his landlord and people in the community would find out that he had TB. The nurse grew 
increasingly frustrated because, according to the policy, all people who have been in close 
contact with someone with TB must be screened. The nurse remained resolute despite the 
patient expressing his concerns about being evicted if his landlord finds out.  
Yet, in other instances the same nurses would act or allow patients to behave outside 
the diagnostic policy instruction. For example, some nurses allowed clients who were 
struggling to produce sputum due to weakness or it hurting when coughing to take the sputum 
jars home. The understanding was that the patient could produce sputum at home without 
supervision and return the sputum jars to the clinic the following day. This action may result 
in patients producing scanty or poor quality specimens, and is also risky because a patient 
might not return to the facility. Despite these risks, the nurses acknowledged patient struggles 
and used their discretion based on their value judgements.  
 
“We should not shout and scream at patients for not presenting proper sputums or 
not coming to the clinic after we phone them to tell them to come because they have 
TB... [rather] we must show them that we are disappointed but remain supportive and 
understanding. It is difficult and that is why you will see me shout. Our role should 
not be to police or hold guns to their heads. We must help them to take control of their 
TB but we have so much pressure that we need to control them. There is no time to 
listen to their problems, they must just do what we need them to do at the end of the 
day”. (Staff Nurse, Facility 1) 
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This quote from nurses’ narratives reflects how nurses make sense of the conflict between 
having to achieve targets whilst also responding to the needs and realities of patients. It also 
illustrates the contestation in discourse and practice. Nurses make sense of these 
contradictions by discursively recognizing patients’ agency in the diagnostic and treatment 
process and talk about themselves as facilitators for patient well-being rather than regulators 
of the health outcomes of patients.  
At face value it may seem that practices which contradict policy may compromise 
effective diagnostic practice procedure. This may be interpreted from nurses’ making 
concessions for patients and behaving outside of standard policy directives. However, 
responding to patients’ complex realities is more important to them as reflected in their 
decisions to behave outside policy, trusting that this will facilitate the process of diagnosing 
an individual patient (Pires, 2011). This reflects how human agency of both nurses and 
patients in their relationship, and its interaction with broader societal structures, shape TB 
diagnostic implementation in health systems (Engels et al, 2015; Gilson, Schneider & Orgill, 
2014). However, the pressure of performance targets limits this agency and forces them to act 
as regulators instead of nurses facilitating care through being responsive to complex realities 
of patients (Pires, 2011).  
These pressures and how they affect nurses’ practice of policy implementation has 
unintended consequences. For example, a number of researchers have pointed out that 
pressures to achieve targets may result in already vulnerable patients not feeling considered, 
trusted or supported which could cause alienation and disenfranchisement (Escott & Walley, 
2005; Gebremariam, Bjune, & Frich, 2010; Stack, 2003). Furthermore, top down, target 
driven approaches place strain on health facilities and heightens pressure on nursing staff 
which may result in feelings of anxiety and being overwhelmed, and possible burnout (Stack, 
2003). In this study, nurses’ narratives about the implementation of diagnostic policy in their 
practice relates to challenges reported in the literature for nurses in strengthening and 
promoting dignity conserving care (Baillie & Gallagher, 2010). An over emphasis on targets 
in practice presents challenges for advancing people-centeredness for health systems 
strengthening (Sheikh, George, & Gilson, 2014). This is exacerbated by the heavy 
administrative demands as a result of enforcing structured, standardized and routinized 
practices in TB implementation practices.  
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2) 'I do not like nursing paperwork- I came to be a nurse to work with patients and care for 
them'. Dealing with heavy administrative demands in nursing practice of TB diagnostic 
implementation 
Although nurses recognize the importance of the administrative processes in their 
practice of policy implementation, many of them report the frustration of navigating between 
what they consider effective patient care and ‘nursing books’. All nurses in this study felt that 
their administrative demands hinder their quality of care. The following narratives provide 
some evidence for how nurses view administrative demands and how these impact their 
practice of TB policy: 
 
'Here in the TB room, we have to do so much admin. It is a challenge for us because 
there will be times when we do not have someone to help us with the admin and then 
we have to do the admin stuff ourselves because the person they will give us will be 
new and know nothing and we will be stuck. Now you can imagine seeing all the 
patients and then also all the admin.' (CPN PHC nurse 2, Facility 1) 
 
'The bosses will not see that they can’t expect us to have such a big admin load and 
then also expect us to be there for our patients. Something's got to give.' (CPN PHC 
nurse 1, Facility 2)  
 
TB reform implementation requires good monitoring and evaluation systems and 
standardization of operational and technical processes which can only be established with 
good information and administration systems (Albert et al., 2016; McNerney et al., 2012).  
However, administrative demands were a prominent issue in all the nurses’ narratives in this 
study as noted in the narratives above. These demands include filling out patient files 
accurately, filling out lab request forms, following up on these requests, capturing data into 
information system databases, filing patient results, booking consultations, following up with 
specific patients that need to present to the facility on specific days, recording instructions 
from doctors, recording clinic observation data (National Tuberculosis Management 
Guidelines, 2014; Escott & Walley, 2005; Engel, 2012; Rendell et al., 2017). Administration 
is also linked to the processes that help with tracking patients and assessing targets, outputs 
and outcomes of implementation (Lomas, 2012).  
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This links to findings from previous studies that showed how paper-based 
administrative and communication systems, as well as gaps in coordinated information and 
computer training (ICT) and online communication systems in low resource settings, 
represent the major barriers for effective implementation of GeneXpert diagnostic technology 
(Albert et al., 2016; Menzies, Cohen, Lin, Murray & Salomon, 2012; Rendell et al., 2017; 
Colvin et al., 2015; Cowan et al., 2015; Pai et al., 2012; Palamountain et al., 2012). Nurses in 
this study acknowledged the importance of paperwork in their practice to promote service 
delivery, health systems reporting, and coordinated communication. Yet, the current 
administrative load as well as the bureaucratic procedures nurses have to navigate limits their 
care for patients (Cunningham, Kennedy, Nwolisa, Callard & Wike, 2012; Michel, Waelli, 
Allen & Minvielle, 2017). In this study, nurses talked about these processes became 
increasingly overwhelming with high TB caseloads and increasing suspect cases.  
 
Moreover, the reinforcement of existing institutionalised administrative procedures 
and beauracratic control systems hinder innovation (Bergen & While, 2005; McSherry & 
Douglas, 2011), resulting in conflict for nurses in making sense of how they can contribute to 
alleviating administrative demands to ensure that patient care is not compromised 
(Cunningham, Kennedy, Nwolisa, Callard & Wike, 2012; Lomas, 2012). Many nurses in this 
study report that audits and highly structured top-down bureaucratic control procedures from 
sub-district TB coordinators and management, compromised dignified patient care and 
limited them responding to patient needs. Anxieties triggered by bureaucratic and 
administrative control and processes devalue the humanity of nurses and the complex 
realities of patients, thus limiting people centeredness in the health system (Engel, 2012; 
Street, 1992). In this study nurses use their discretion as a means to offer personal input 
(Fletcher, 1984) to cope with the administrative demands in their practice to alleviate the 
pressure of heavy administrative and bureaucratic procedures in their implementation 
practices of TB diagnostics and care (Bergen & While, 2005).   
The nurses working in the TB room at Facility B noted that there was an old computer 
in the store room that was not currently being used by the administrators working in the 
record room and reception.  The nurses persistently requested that the computer be set up in 
the TB room to assist them with the administrative demands in their practice. Once this had 
been achieved, the nurses reported that the computer contributed to ‘getting a better system 
going in the TB room to help with the paperwork’ (CPN PHC nurse 2, Facility 2). These 
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nurses felt more motivated to catch up with administrative tasks and found it easier to engage 
more with patients while having access to databases for obtaining laboratory data and 
capturing patient information directly into the system. This reflects how nurses engage in 
innovative practices within their organizational contexts to promote people centeredness in 
their TB policy implementation practices (McSherry & Douglas, 2011). Compared to the 
other facilities, these nurses reported that they had contributed meaningfully to policy 
implementation and this promoted job satisfaction.  
Nevertheless, this innovation caused some problems because these nurses failed to 
complete paperwork and hardcopy patient files appropriately, and preferred to add 
information directly into the online database. This observation supports arguments from the 
existing GeneXpert literature that propose that electronic and online systems need to be 
sufficiently co-ordinated to help alleviate administrative pressure instead of adding to their 
workload (Albert et al., 2016; Menzies, Cohen, Lin, Murray & Salomon, 2012; Rendell et al., 
2017; Colvin et al., 2015; Cowan et al., 2015; Pai et al., 2012; Palamountain et al., 2012). 
This study shows that nurses readily utilized electronic databases, but they neglected the 
process of “paperwork first”. This begs the question of why paperwork is a core part of 
administrative systems when functioning electronic systems exists. Nevertheless, we cannot 
take for granted the need for mmore efficient and coordinated electronic and online systems 
in the implementation of GeneXpert. Current electronic systems thus need to be strengthened 
to alleviate the burden of admiration demands.  
Despite the limitations of this innovation, this example demonstrates that nurses’ 
value being more responsive to patients’ needs over heavy administrative procedures in their 
implementation practice.  It reflects that nurses exercise their agency to cope with heavy 
administrative demands and, although their contributions may hinder implementation 
processes, they perceive their contributions to be important for their practice of patient care. 
They interpreted their decision as an attempt to reduce the paperwork load so that they could 
better respond to the needs of their patients.  
The above findings also show that although the structured and routinized practices 
enforced by management may help nurses to cope with heavy patient loads and effectiveness 
through prescriptive and familiar practices, they may also pose challenges for nurses when 
they are overly rigid and structured (Engels, 2012; Lipsky, 2010). This may limit the extent 
to which nurses innovate and may stifle their priorities to deliver care effectively. A balance 
is needed between the extremes of controlling the diagnostic and administrative load through 
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standardization and bureaucracy, but still allowing for sufficient innovation that are relevant 
to local contexts and experiences (Cunningham, Kennedy, Nwolisa, Callard & Wike, 2012; 
Engels, 2012; Lipsky, 2010; Lomas, 2012).  
The contention between nurses using their discretion to cope with the demands of 
heavy administration procedures and the sub-district TB coordinator problematizing their 
innovation on the basis of them not following procedures correctly, speaks to the extent to 
which top-down control approaches to standardization of operational and technical processes 
are entrenched in sub-district governance. It also raises issues about the nature of engagement 
between sub-district management and nurses.   
3) ‘Communication is a big challenge for us… It is difficult to say when it is difficult for you 
or when something is not working’. Gaps in the engagement between sub district 
management and nurses.  
Most TB nurses in this study interpreted their engagement with sub-district 
management to be top down and autocratic. Nurses talked about how this fuels gaps in 
communication and policy transfer which ultimately limit effective implementation in their 
practice. This is reflected in the following quote:  
 
‘...many times we just sit in the meetings and we are told that this and this and 
this must be implemented in the clinic. We will sit there and we will not know what 
these things will be about and how it will improve our practice but when we go back 
to the clinic, we must start making changes and they will come and see if we are 
making the changes without us even knowing what we should actually be doing. 
Sometimes we will not even know how to do the changes and the bosses up there will 
not understand why we are struggling to implement these changes’. (Staff Nurse, 
Facility 2)   
	  
Valuing low level health workers’ contributions and input – especially that of nurses – 
is important for implementation of health care policy and the advancement of people-
centredness in health systems (Lipsky, 2010; Sheikh, George, & Gilson, 2014; Walker & 
Gilson, 2004). TB and Primary Health Care (PHC) policy frameworks encourage 
managements to create environments that acknowledge local contexts and frontline workers' 
input to help shape practice in new and improved ways (Beaglehole et al, 2008; National 
Tuberculosis Management Guidelines, 2014; Walley et al, 2008). Yet, many studies report 
	   	   	   	   23	  |	  P a g e 	  
	   	  
that frontline workers are still not meaningfully included in policy formulation processes. 
Furthermore, they are not effectively communicated with when there are shifts in policy and 
implementation practice guidelines and procedures, and they have minimal platforms or 
pathways to provide feedback to management and decision makers (Chandler et al., 2011; 
Colvin et al., 2015; Engel, 2012; Engel et al., 2015; Angotti, 2010). This is despite evidence 
showing the importance of communication in policy implementation processes (Chandler et 
al., 2011; Colvin et al., 2015; Engel, 2012; Engel et al., 2015; Angotti, 2010).  
In this study, nurses, facility managers and the TB coordinators accounted for how 
policy travels from sub-district management to the facility manager, from the sub-district 
management directly to the staff working in the TB room and from the facility manager and 
the staff in the TB room. Similar to findings reported by Albert et al. (2016), Colvin et al. 
(2015) and Rendell et al. (2017), all nurses in this study agreed that communication and 
coordination is central to policy implementation practice. All nurses specifically talked about 
how gaps in communication between them, the facility manager and the TB coordinator 
disrupt their practice. In the context of TB and HIV care where there are constant policy and 
procedural changes with the aim of strengthening implementation, when and how these 
changes are communicated to frontline workers will implicate their practice (Colvin et al., 
2015; Engel, 2012; Engel et al., 2015; Angotti, 2010; Rendell et al., 2017).  
Nurses spoke about times when they were expected to change their practices to 
accommodate shifts in policy and practice guidelines. Generally, nurses reported that there 
was a lack of clear directives to guide how these changes should take shape in their practice. 
For them, policy directives that are communicated vaguely and inconsistently are particularly 
difficult to follow. For example, during the time of the study, nurses in two of the three case 
facilities experienced some confusion about the results they requested from laboratory. When 
these nurses requested a GeneXpert test on the lab request form, smear microscopy test 
results would be returned instead. When nurses told the sub-district TB coordinators about 
this, they followed up and it became apparent that the laboratory request procedures and 
instructions had not been clearly communicated to these nurses. The laboratory requirements 
was that when nurses requested a GeneXpert sputum sample, the two plastic sleeves that 
contained the two sputum samples  must be attached. If the two sleeves were not attached, the 
laboratory would send smear results instead of GeneXpert results. The failure to clearly relay 
these instructions to the nurses had major consequences for the outcome of the diagnosis for 
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those patients who needed a GeneXpert result. This is an example of how clear 
communication is important for nursing implementation practice.  
Health policies with heavy information loads and with many different instructions can 
be overwhelming and sometimes contradictory for management to communicate to nurses 
(Graber, 2002). Low level management needs to devise strategies and instructions to 
incorporate policy and implementation changes in already overburdened health systems and 
ensure that nurses can follow through with these changes (Albert et al., 2016; Cowan et al., 
2015; Lipsky, 2010; Rendell et al., 2017). This process is challenging if appropriate channels 
have not been established to communicate policy effectively with nurses.  
Nurses in this study said that when they made mistakes due to being unaware of 
changes or directives not being sufficiently clear, they felt that management engages with 
them as if they are responsible for many of the consequences. Many nurses were very clear in 
their narratives that they cannot be held responsible for not following policy guidelines if 
they are not sufficiently trained or if instructions were not effectively communicated. 
Insufficient training capacity is a major barrier for TB diagnostic policy implementation, 
especially in LMIC settings (Albert et al., 2016; Cowan et al., 2015; Rendell et al., 2017), 
Added to the issue of feeling like they are not adequately trained before changes are 
implemented in their organizations, a key challenge for nurses in this study was how policies 
guidelines are communicated and the nature of engagement with management.  
Nevertheless, nurses talked about how the sub-district TB coordinators have become 
increasingly proactive in ensuring that they are informed. TB coordinators bridge some of the 
gaps in communication between nurses in the TB room and sub-district management and 
facilitate their engagement to address the inherent asymmetrical power relations and 
autocracies. As a means for continuous quality improvement, TB coordinators are tasked 
with providing ongoing support via telephone and email, as well as via periodic visits that 
offer face-to-face support and the opportunity to discuss policy and practice (National 
Tuberculosis Management Guidelines 2014; Natoli et al., 2015). Nurses talked about how the 
TB coordinators offer a number of different strategies and pathways that facilitates proactive 
engagement. This is especially important for when changes in policy and practice guidelines 
need to be communicated to nurses. The TB coordinator for the three facilities in this study 
said that they support the TB nurses by translating the policies and instructions into actions 
which facilitates policy uptake. Many nurses' narratives were congruent with this. Nurses 
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explained that there is a continuous point of communication from coordinators and 
management where errors and changes for improvement are always communicated to them. 
 
 ‘So we do have regular meetings and it is not just a piece of paper…. the coordinator 
is very good, I must give him an A for that- he will also come and check – especially when 
there is something new, he will come around, he will come and audit our folders and admin 
and he will try and be supportive. When he sees that maybe we are struggling or when we 
gets new information then he will ask you, did you receive this or that? He will go over 
documents and paperwork with us, he will emphasize things if it is not clear to us. Sometimes, 
he will come across as so (action to show assertiveness)- but it just to like print these things 
into you.” (CPN 2, Facility 2) 
 
Although TB coordinators address some of the communication issues in policy 
implementation practice for nurses and facilitate the transfer of information from 
management to nurses, some nurses stated that management does not consider their input.  
This finding supports the argument by Escott and Walley (2005) that the voices of frontline 
staff are taken for granted in policy implementation.  The following quote from a nurse in this 
study alludes to this notion:  
 
‘It is difficult to say when it is difficult for you or when something is not working... 
even if I make suggestions, it is never taken up. Because now, when you bringing 
things onto the table, you say, this is how my TB room is suffering or this making the 
TB implementation difficult, you are talking to the person who has no clue about what 
is happening here...[management] don't walk in my shoes. [Management] don't see 
what you need to do in the TB room for it to survive'. (PCN 1, Facility 3)  
 
The majority of the nurses in this study felt that management and the TB coordinator 
have not considered sufficient methods or strategies for nurses to provide input or feedback 
about their successes, challenges or grievances. Suggestions for improvements come from 
management i.e. top-down communication pathways. Similarly to Escott and Walley’s 
(2005) findings, nurses felt that they are not able to provide input into key decisions during 
different phases of implementation. It was observed that even if nurses had suggestions and 
innovations to strengthen policy, these were limited by engagements that focused mainly on 
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targets, routine and bureaucracy. This is reflected in the example of nurses’ innovation 
discussed earlier. Facility managers and the majority of the nurses across the three facilities 
felt that they had limited voice and opportunity to make recommendations for various factors 
that may stifle their implementation practice. These issues illuminate how issues of power 
and asymmetrical relationships between global, national and local policy may hinder or 
facilitate TB diagnostic policy implementation (Albert et al., 2016; Colvin et al., 2015; van 
Kampen, 2015). These issues pose major barriers for advancing people centeredness in health 
systems and the implementation of policy reform.  
Study Limitations 
Although this study offers rich insights into nurses’ experiences of policy 
implementation in their practice, the authors acknowledge that their interpretations are based 
on subjective accounts and individualized explanations. Narrative and observational data is 
limited to the city of Cape Town, an urbanized setting with reasonably sufficient resources 
and adequate laboratory and PHC facility infrastructure that is relatively well-managed 
compared to PHC service delivery facilities elsewhere in South Africa and in other LMIC 
countries (Colvin et al, 2015). Nevertheless, this study did not set out to make generalizable 
claims but, rather, to offer critical and credible insights from analytical interpretations of the 
empirical data.  
Another limitation of this study is that some nurses were not part of the restructuring 
process when GeneXpert was initially introduced and could not account for how changes in 
policy affected change in their practice. However, this was not necessarily the main aim of 
this investigation. Rather, our purpose was to assess the relational and human elements of the 
health system that may impact the process of policy reform implementation. These nurses 
could meaningfully reflect on their current experiences of working in the ‘reformed’ system 
of TB diagnostic policy and provide insight into the factors that facilitate and constrain their 
practice.  
Another gap in the research is that patients’ subjectivities and voices were absent in 
our data. Deepening patient-centered practice in research and policy implementation must 
consider tensions, contradictions and congruencies between different “people’s” narratives in 
the health system to truly understand how human elements of the health system may impact 
policy implementation in practice.  
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Conclusion and Recommendations 
This paper sought to investigate PHC nurses’ experiences of diagnosing TB since the 
implementation of GeneXpert policy in their practice. This was done to understand the 
barriers that limit implementation of TB diagnostic policy in nurses’ practice. An 
investigation into nurses’ experiences through an analysis of discourse and practice offer 
important lessons for people-centered health systems in TB diagnostic policy 
implementation. 
Findings from this study reflect a series of contradictions and tensions that nurses 
have to navigate in the process of diagnosis and care for patients presenting in the TB room. 
Paradoxes between nurses' talk and their practices are consequences of these contradictions. 
Nurses’ experiences of policy implementation are situated within the nexus between policy 
frameworks (including instructions, targeted outcomes and outputs, directives) and the 
organizational aspects of the health system at service delivery level (including contexts, 
management, communication, administration). This study found that, for nurses, broader 
systemic factors within health systems organizational contexts can both support and 
undermine people-centred care.   
The primary health care (PHC) approach, the patient rights charter and the ideologies 
underpinning TB policies support people-centeredness in health care delivery (Kironde & 
Kahirimbanyib, 2002; Van Lerberghe, 2008; WHO, 2003). This is also reflected in nurses' 
discourse as their narratives about their interactions with patients in their practice showed a 
deepened concern for patient care in their implementation practices. However, observing 
nurses' practices and their narratives revealed that TB targets, highly bureaucratized, 
routinized and heavy administration, and autocratic approaches to communication and 
engagement with nurses undermine their capacities to be responsive to the needs and 
complex realities of individual patients. Although the institutionalization of performance-
driven culture yields concrete benefits for patients, health workers and the organization 
system (Dye et al., 2006; Dye & Williams, 2008; Lönnroth, et al., 2010), nurses in this study 
were critical of the extent to which management prioritizes targets, bureaucracy and 
administration over dignity, responsiveness and humanity in the process of diagnostics care 
in TB policy implementation.  
Drawing on people-centred scientific approaches and foregrounding the humanity of 
nurses in their organizational and social systemic policy contexts can strengthen health 
systems implementation. Findings from this study reflect the significance of research, policy 
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and management to think beyond the solutions to policy implementation that only focuses on 
the hardware aspects of health systems. A focus on the human and relational elements of 
policy implementation within the health system is essential for advancing responsiveness and 
people-centeredness (Sheikh & Porter, 2010; Gilson et al., 2011). There is a need for 
increased awareness of the capacity to be intentional and deliberative in policy 
implementation processes for acknowledging the human qualities of the health system. This 
requires focussing attention on nurses’ perspectives of the process of care instead of merely 
focusing on targets, paperwork and bureaucracy (Lomas, 2012; Michel, Waelli, Allen, & 
Minvielle, 2017; Street, 1992). Furthermore, strengthening communication and engagement 
with nurses may be critical in implementing policy in health systems (Arabi, Rafii, Cheraghi, 
& Ghiyasvandian, 2014; Escott, & Walley, 2005; Haines, Kuruvilla, & Borchert, 2004; 
Parvin et al., 2017). Moreover, successful implementation further demands augmenting 
nurses’ contributions in the policy implementation process. There is a need for public health 
officials and different levels of management to provide opportunities for nurses to share their 
voices, input and prowess in the policy process. Future research and policy efforts must seek 
to actualize the contributions of low level health workers in relation to perspectives from and 
frameworks of policy makers and higher levels of management. At the same time, the 
humanity of actors and bureaucrats of the health system and their responses to the complex 
lived experiences of patients, must be acknowledged to deepen people-centric practices for 
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Part	  D:	  Appendices	  
Appendix	  1:	  Questionnaire/data	  capture	  instrument(s)	  
Semi structured interview schedule  
Main interview question: 
Tell me about how it is to diagnose a patient in practice? 
Tell me about how you are finding the process of patient diagnosis with GeneXpert. Start by 
when you first heard about GeneXpert and how it is up until now? 
Probing questions: 
Tell me about your facility from when you started working in the TB room? How did you 
find the process of diagnosing patients at first? Has it changed? If so, how?  
What is difficult/challenging for you? What do you find easy and meaningful?  
What does GeneXpert mean to you? How does mean in your practice?  
How do you see your role in relation to the GeneXpert Policy? 
How would you describe your relationships in the facility? The relationship with the lab, the 
relationships with your colleagues, the relationships with the facility managers? Who else do 
you have relationships with? Why are these people important/not important to you?  
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Appendix	  2:	  Consent	  forms	  and	  participant	  information	  forms	  –	  Nurses	  
University of Cape Town 












Health workers’ experiences of the implementation of molecular diagnostics for TB in South 
Africa: Xpert MTB/RIF 
 
Dear Health Worker,  
 
1. Invitation and Purpose 
You are invited to take part in this study which explores health workers’ experiences of the 
implementation of molecular diagnostics for TB in South Africa: Xpert MTB/RIF. I am a 
student researcher from the School of Public Health and Family Medicine at the University of 
Cape Town. This project is undertaken to fulfil the conditions of being awarded a master’s 
degree.   
 
2. Background  
This study focuses on health workers’ experiences with the implementation and operation 
GeneXpert, TB diagnostic technology. GeneXpert is a fairly new technology that has been 
implemented in SA health system approximately 5 years ago (in some facilities longer than 
others) and it is important to assess to understand the success, challenges and the factors that 
bring about these. It is thus the purpose of  this study to evaluate the implementation of 
GeneXpert and it aims to do this through obtaining narratives from health workers’ about 
their experiences of the implementation of GeneXpert. This area of research is important 
because it will contribute meaningfully to the growing literature of TB and the 
implementation of new TB diagnostics such as GeneXpert. It is further important because it 
will assist in uncovering successes and challenges of implementation generally and seek to 
develop strategies for such challenges and learn from successes to strengthen implementation 
in this area. More essentially, it will contribute to knowledge about health systems 
strengthening from the perspective of health workers and facility managers.  
 
3. Procedures 
• If you decide to take part in this study I will interview you and some of the staff of your 
facility about your and their experiences of the implementation of Xpert MTB/RIF molecular 
diagnostics for TB in your facility. I will ask you to share your experiences of when you first 
heard that Xpert MTB/RIF molecular diagnostics for TB will be implemented in your facility 
and how it is up until now. I will also ask you about your experiences of different areas within 
your facility. By interviewing you I hope to find out what it is like to work with GeneXpert 
and what you think about the technology and how it is working in your facility.  
• The interviews should take about an hour; however, you are free to speak to me for shorter or 
longer periods. 
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• Participating in this study is voluntary. You are free to end the interview at any time with no 
penalty or any other consequences. 
• In addition to the interviews, I would also like to engage as an active observer in your facility. 
This will be on request of your permission and the duration of the observation will occur 
simultaneously with interviews. This will mean that I will engage with and partake in 
informal discussion with staff, observe to understand processes and take notes of 
observations. 
 
4. Benefits  
• This study seeks to contribute effectively to the improvement of the implementation of TB 
diagnostics in South Africa primary health care facilities and to strengthen TB diagnostics 
with the broader objective of reducing the incidence and prevalence of TB in SA. 
• This study aims to contribute meaningfully to the evidence base in the area of the 
implementation of GeneXpert thus expanding our knowledge and understanding of 
GeneXpert and its implementation in SA.  
• Health workers and facility managers will be focus of this study, thus giving voice to your 
interpretations and experiences of GeneXpert and its implementation. There is very little 
research done on health workers’ and facility managers’ experiences at primary health care 
level in this field. Thus by taking part in this study, you will be able to share insights on your 
experiences and how these experiences influence the ‘actual’ implementation and operation 
of GeneXpert in your facility. You will therefore have an opportunity to express concerns, 
challenges and strategies for success that may inform policy, implementation guidelines and 
future research.  
• To find feasible solutions to assist health workers and facility managers working in PHC and 
gage success strategies to strengthen implementation and TB care in their facilities.   
 
5. Risks, Discomforts & Inconveniences 
• This study poses a low risk of harm to you. 
• Speaking about your experiences may potentially bring up sensitive issues and could 
potentially be emotionally distressing. However, you will decide what you would like to 
discuss in the interview and you will not be obligated to speak about anything you do not feel 
comfortable speaking about. Under no circumstances will your identity or that of the facility 
be revealed in any presentation of findings (see section on Privacy and Confidentiality 
below).  
• You might be inconvenienced by having to give an hour of your time (this may be during 
lunch time or during any other free time that you may have). You can decide on any time that 
is most suitable to you.  
• Taking part in this study or refusing to take part in this study/withdrawing from the study will 
not influence your current or future employment at this facility.  
 
6. Privacy and Confidentiality 
• Interviews will take place in a private space. In the event that we have no other option but to 
conduct the interview in a public space, it will be ensured that the interviewee (yourself or 
other staff members) and the interviewer (myself) are alone and that the space is secure.  
• Any information you share is strictly confidential. You will remain anonymous throughout 
the research process and to ensure anonymity, your identity and the identity of your facility 
will be masked with pseudo names in all writings and reports on the research. Explicit 
characteristics of the facility will not be mentioned (for examples, the exact location of the 
facility or specific attributes of the facility that will make it identifiable).You have the right to 
request that any information you have shared be omitted from the study and future reports. 
• In addition, all observations and participation in the facility will be recorded through note 
taking. Notes will be hand written in a personal journal that will be locked up after the 
research process and will only be accessed during the analysis phases of the research project.   
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• This conversation will be recorded and a digital recording device will be used to record the 
interview. This is only for the purposes of the research. You have the option to choose at any 
time during the interview when the recording device should be switched off. Recorded 
material will be transcribed.  
• All soft copy transcriptions will be stored on specific password protected hard drive and sky 
drive folders. Hard copies of transcriptions will be stored in hard cover folders and stored in a 
locked drawer in an office at UCT. These documents that will strictly only be accessed by the 
researchers, supervisors and transcribers of this project. 
• The findings of this research paper may be published in an academic journal, newspaper 
article or other modes of mass communication.  
• All audio-recordings and transcriptions will be destroyed approximately 5 years after the 
research has been accepted to be published in an academic journal.  
 
 
7. Contact details 
If you have questions, concerns, or complaints about the study please contact Lance 
Louskieter on 0837390528 or lsklan001@myuct.ac.za, Dr. Chris Colvin at the School of 
Public Health and Family Medicine, University of Cape Town (UCT) at 
coldvine@gmail.com.  
 
Alternatively, you may contact the ethics committee that approved the study if you have any 
ethical concerns or questions about your rights or welfare as a research participant at the 
following information:  
University of Cape Town, Faculty of Health Sciences 
Human Research Ethics Committee 
Telephone: (021) 406 6338  
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INFORMED CONSENT FORM FOR PARTICIPANTS 
University of Cape Town 
School of Public Health and Family Medicine 
 
 
Health workers’ experiences of the implementation of molecular diagnostics for TB in South 





{Participant’s name}________________________ has been informed of the nature and purpose of 
the procedures described above including any risks involved in its performance. He or she has been 
given time to ask any questions and these questions have been answered to the best of the 
investigator's ability. A signed copy of this consent form has been made available to the participant.  
 
_______________________       _______________ 
Investigator's Signature         Date 
 
 
I have been informed about this research study and understand its purpose, possible benefits, risks, 
and discomforts. I agree to take part in this research as a subject. I know that I am free to withdraw 
this consent and quit this project at any time, and that doing so will not cause me any penalty or loss 
of benefits that I would otherwise be entitled to enjoy. I am aware that the interview will be audio 
recorded and that I can ask for the audio recording device to be switched off at any given time of the 
duration of the interview. I am further aware that the research will be written up in the form of a 
master’s research project and may be published in an academic journal.   
 
_______________________       _______________ 
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Appendix	  3:	  Consent	  Forms	  And	  Participant	  Information	  Forms	  -­‐	  Facility	  
Managers	  
University of Cape Town 












Health workers’ experiences of the implementation of molecular diagnostics for TB in South 
Africa: Xpert MTB/RIF 
 
Dear Facility Manager,  
 
1. Invitation and Purpose 
You are invited to take part in this study which explores health workers’ experiences of the 
implementation of molecular diagnostics for TB in South Africa: Xpert MTB/RIF. I am a 
student researcher from the School of Public Health and Family Medicine at the University of 
Cape Town. This project is undertaken to fulfil the conditions of being awarded a master’s 
degree.   
 
2. Background  
This study focuses on health workers’ experiences with the implementation and operation 
GeneXpert, TB diagnostic technology. GeneXpert is a fairly new technology that has been 
implemented in SA health system approximately 5 years ago (in some facilities longer than 
others) and it is important to assess to understand the success, challenges and the factors that 
bring about these. It is thus the purpose of  this study to evaluate the implementation of 
GeneXpert and it aims to do this through obtaining narratives from health workers’ about 
their experiences of the implementation of GeneXpert. This area of research is important 
because it will contribute meaningfully to the growing literature of TB and the 
implementation of new TB diagnostics such as GeneXpert. It is further important because it 
will assist in uncovering successes and challenges of implementation generally and seek to 
develop strategies for such challenges and learn from successes to strengthen implementation 
in this area. More essentially, it will contribute to knowledge about health systems 
strengthening from the perspective of health workers and facility managers.  
 
3. Procedures 
• If you decide to take part in this study I will interview you and some of the staff of your 
facility about your and their experiences of the implementation of Xpert MTB/RIF molecular 
diagnostics for TB in your facility. I will ask you to share your experiences of when you first 
heard that Xpert MTB/RIF molecular diagnostics for TB will be implemented in your facility 
and how it is up until now. I will also ask you about your experiences of different areas within 
your facility. By interviewing you I hope to find out what it is like to work with GeneXpert 
and what you think about the technology and how it is working in your facility.  
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• The interviews should take about an hour; however, you are free to speak to me for shorter or 
longer periods. 
• Participating in this study is voluntary. You are free to end the interview at any time with no 
penalty or any other consequences. 
• In addition to the interviews, I would also like to engage as an active observer in your facility. 
This will be on request of your permission and the duration of the observation will occur 
simultaneously with interviews. This will mean that I will engage with and partake in 
informal discussion with staff, observe to understand processes and take notes of 
observations. 
 
4. Benefits  
• This study seeks to contribute effectively to the improvement of the implementation of TB 
diagnostics in South Africa primary health care facilities and to strengthen TB diagnostics 
with the broader objective of reducing the incidence and prevalence of TB in SA. 
• This study aims to contribute meaningfully to the evidence base in the area of the 
implementation of GeneXpert thus expanding our knowledge and understanding of 
GeneXpert and its implementation in SA.  
• Health workers and facility managers will be focus of this study, thus giving voice to your 
interpretations and experiences of GeneXpert and its implementation. There is very little 
research done on health workers’ and facility managers’ experiences at primary health care 
level in this field. Thus by taking part in this study, you will be able to share insights on your 
experiences and how these experiences influence the ‘actual’ implementation and operation 
of GeneXpert in your facility. You will therefore have an opportunity to express concerns, 
challenges and strategies for success that may inform policy, implementation guidelines and 
future research.  
• To find feasible solutions to assist health workers and facility managers working in PHC and 
gage success strategies to strengthen implementation and TB care in their facilities.   
 
5. Risks, Discomforts & Inconveniences 
• This study poses a low risk of harm to you. 
• Speaking about your experiences may potentially bring up sensitive issues and could 
potentially be emotionally distressing. However, you will decide what you would like to 
discuss in the interview and you will not be obligated to speak about anything you do not feel 
comfortable speaking about. Under no circumstances will your identity or that of the facility 
be revealed in any presentation of findings (see section on Privacy and Confidentiality 
below).  
• You might be inconvenienced by having to give an hour of your time (this may be during 
lunch time or during any other free time that you may have). You can decide on any time that 
is most suitable to you.  
• Taking part in this study or refusing to take part in this study/withdrawing from the study will 
not influence your current or future employment at this facility.  
 
6. Privacy and Confidentiality 
• Interviews will take place in a private space. In the event that we have no other option but to 
conduct the interview in a public space, it will be ensured that the interviewee (yourself or 
other staff members) and the interviewer (myself) are alone and that the space is secure.  
• The participants will be known to the researcher and thus anonymity cannot be fully 
guaranteed throughout the research process. However, the researcher will ensure that 
participants remain anonymous in the writings and reports of the research process to protect 
the identity of participants as far as possible. The researcher will do this by masking your 
identity and the identity of your facility with pseudo names (for example, Participant A or 
Facility X) in all writings and reports on the research. Explicit characteristics of the facility 
will not be mentioned (for examples, the exact location of the facility or specific attributes of 
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the facility that will make it identifiable).You have the right to request that any information 
you have shared be omitted from the study and future reports. 
• Information you share and all data generated in this study will be treated with confidentiality. 
• All observations and participation in the facility will be recorded through note taking. Notes 
will be hand written in a personal journal that will be locked up after the research process and 
will only be accessed during the analysis phases of the research project.   
• This conversation will be recorded and a digital recording device will be used to record the 
interview. This is only for the purposes of the research. You have the option to choose at any 
time during the interview when the recording device should be switched off. Recorded 
material will be transcribed.  
• All soft copy transcriptions will be stored on specific password protected hard drive and sky 
drive folders. Hard copies of transcriptions will be stored in hard cover folders and stored in a 
locked drawer in an office at UCT. These documents that will strictly only be accessed by the 
researchers, supervisors and transcribers of this project. 
• The findings of this research paper may be published in an academic journal, newspaper 
article or other modes of mass communication.  
• All audio-recordings and transcriptions will be destroyed approximately 5 years after the 
research has been accepted to be published in an academic journal.  
 
7. Contact details 
If you have questions, concerns, or complaints about the study please contact Lance 
Louskieter on 0837390528 or lsklan001@myuct.ac.za, Dr. Chris Colvin at the School of 
Public Health and Family Medicine, University of Cape Town (UCT) at 
coldvine@gmail.com.  
 
Alternatively, you may contact the ethics committee that approved the study if you have any 
ethical concerns or questions about your rights or welfare as a research participant at the 
following information:  
University of Cape Town, Faculty of Health Sciences 
Human Research Ethics Committee 
Telephone: (021) 406 6338  
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{Facility Manager’s name}________________________ has been informed of the nature and 
purpose of the procedures described above including any risks involved in its performance. He or she 
has been given time to ask any questions and these questions have been answered to the best of the 
investigator's ability. A signed copy of this consent form has been made available to the participant.  
 
_______________________       _______________ 
Investigator's Signature         Date 
 
 
I have been informed about this research study and understand its purpose, possible benefits, risks, 
and discomforts. I agree to take part in this research as a subject. I know that I am free to withdraw 
this consent and quit this project at any time, and that doing so will not cause me any penalty or loss 
of benefits that I would otherwise be entitled to enjoy. I am aware that the interview will be audio 
recorded and that I can ask for the audio recording device to be switched off at any given time of the 
duration of the interview. I am further aware that the research will be written up in the form of a 
master’s research project and may be published in an academic journal.   
 
_______________________       _______________ 
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Appendix	  4:	  Research	  Study	  Poster	  for	  Facility	  
University of Cape Town 





Health workers’ experiences of the implementation of molecular diagnostics for TB in South 
Africa: Xpert MTB/RIF 
Dear Patients attending facility X,  
 
  A study which explores health workers’ experiences of the implementation of molecular 
diagnostics for TB in South Africa: Xpert MTB/RIF, is taking place in this facility. As part of the 
study, an observation component will take place where the researcher may observe health workers’ 
interactions with patients. The nature of the observation is to assess the interactions and relationships 
of health workers with patients to better understand their actions and behaviours. I am a student 
researcher from the School of Public Health and Family Medicine at the University of Cape Town. 
This project is undertaken to fulfil the conditions of being awarded a master’s degree. Thank you for 
your time in reading this notice.  
 
This poster serves to notify and inform you of the nature and purpose of the study and how 
your privacy and confidentiality and that of the facility will be protected. It will also provide the 
contact details of the researcher and the contact details of the UCT Faculty of Health Sciences 
Research Ethics Committee who have approved this study.  
 
Background  
This study focuses on health workers’ experiences with the implementation GeneXpert, TB 
diagnostic technology. GeneXpert is a fairly new technology that has been implemented in SA health 
system approximately 5 years ago (in some facilities longer than others) and it is important to assess 
to understand the success, challenges and the factors that bring about these. It is thus the purpose of  
this study to understand the implementation of GeneXpert and it aims to do this through obtaining 
narratives from health workers’ about their experiences of the implementation of GeneXpert. This 
area of research is important because it will contribute meaningfully to the growing literature of TB 
and the implementation of new TB diagnostics such as GeneXpert. It is further important because it 
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will assist in uncovering successes and challenges of implementation in nursing practice and seek to 
develop strategies for such challenges and learn from successes to strengthen implementation in this 
area. More essentially, it will contribute to knowledge about health systems strengthening from the 
perspective of health workers and facility managers.  
	  
Benefits  
• This study seeks to contribute effectively to the improvement of the implementation of TB 
diagnostics in South Africa primary health care facilities and to strengthen TB diagnostics 
with the broader objective of reducing the incidence and prevalence of TB in SA. 
• This study aims to contribute meaningfully to the evidence base in the area of the 
implementation of GeneXpert thus expanding knowledge and understanding of GeneXpert 
and its implementation in SA.  
• Health workers and facility managers will be focus of this study, thus giving voice to their 
interpretations and experiences of GeneXpert and its implementation. There is very little 
research done on health workers’ and facility managers’ experiences at primary health care 
level in this field. Thus through observing their interactions with you, I hope to gain insights 
on their experiences and how their experiences influence the ‘actual’ implementation and 
operation of GeneXpert in this facility.  
• This study also seeks to find feasible solutions to assist health workers and facility managers 
working in PHC and gage success strategies to strengthen implementation and TB care in 




As the researcher, I will be present in the patient waiting areas and other areas that the facility 
manager gave me permission to be present in.  In these areas I will observe and engage with health 
workers in their day to day operations and activities associated with the TB diagnostic technologies 
with a primary focus on GeneXpert. I will take notes with a note book and pen.  
I will only be engaging and having conversations with the health workers directly and observing their 
actions, interactions and relationships. I will only be observing patients and not interact with them. 
You are free to request from the researcher not to be observed at all.   
Privacy and Confidentiality  
Any information gathered from this study is strictly confidential. You will remain anonymous in the 
writings and reports of the research and to ensure anonymity, your identity and the identity of the 
facility will be masked with pseudo names in all writings and reports on the research. Explicit 
characteristics of the facility and its patients will not be mentioned (for examples, the exact location 
of the facility or specific attributes of the facility that will make patients and it identifiable). 
 
Contact details 
For more information or if you have queries about the information presented in the poster, you may 
contact the researcher/s at the following details:  
 




Name (Supervisor): Associate Professor Chris Colvin  
Email: coldvine@gmail.com. 
 
Alternatively, you may contact the ethics committee that approved the study if you have any ethical 
concerns or questions about your rights or welfare as a research participant at the following 
information: 
University of Cape Town, Faculty of Health Sciences 
Human Research Ethics Committee 
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Appendix	  5:	  Information	  Sheet	  and	  Informed	  Consent	  Form	  for	  Facility	  
Meeting	  Attendees	  
University of Cape Town 












Health workers’ experiences of the implementation of molecular diagnostics for TB in South 
Africa: Xpert MTB/RIF 
 
Dear Facility Meeting Attendee,  
 
A study which explores health workers’ experiences of the implementation of molecular diagnostics 
for TB in South Africa: Xpert MTB/RIF, is taking place in this facility. As part of the study, an 
observation component will take place where the researcher will be attending meetings held at facility 
X and taking minutes.  
1. Invitation and Purpose 
You are invited to take part in this study which explores health workers’ experiences of the 
implementation of molecular diagnostics for TB in South Africa: Xpert MTB/RIF. I am a 
student researcher from the School of Public Health and Family Medicine at the University of 
Cape Town. This project is undertaken to fulfil the conditions of being awarded a master’s 
degree.   
 
2. Background  
This study focuses on health workers’ experiences with the implementation of GeneXpert, TB 
diagnostic technology. GeneXpert is a fairly new technology that has been implemented in 
SA health system approximately 5 years ago (in some facilities longer than others) and it is 
important to assess to understand the success, challenges and the factors that bring about 
these. It is thus the purpose of  this study to understand the implementation of GeneXpert and 
it aims to do this through obtaining narratives from health workers’ about their experiences of 
the implementation of GeneXpert. This area of research is important because it will contribute 
meaningfully to the growing literature of TB and the implementation of new TB diagnostics 
such as GeneXpert. It is further important because it will assist in uncovering successes and 
challenges of implementation in your practice and seek to develop strategies for such 
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challenges and learn from successes to strengthen implementation in this area. More 
essentially, it will contribute to knowledge about health systems strengthening from the 
perspective of health workers and facility managers.  
 
3. Procedures 
• As the researcher, I will be present in the facility meetings that the facility manager gave me 
permission to be present in.  In these a\meetings I will observe and take minutes of 
information and discussions associated with the implementation of the TB diagnostic 
technologies with a primary focus on GeneXpert. I will take meetings with a note book and 
pen or my computer or Ipad.  
• I will not be interrupting any part of the meeting and will not be actively engaging in the 
meetings.  
 
4. Benefits  
• This study seeks to contribute effectively to the improvement of the implementation of TB 
diagnostics in South Africa primary health care facilities and to strengthen TB diagnostics 
with the broader objective of reducing the incidence and prevalence of TB in SA. 
• This study aims to contribute meaningfully to the evidence base in the area of the 
implementation of GeneXpert thus expanding our knowledge and understanding of 
GeneXpert and its implementation in SA.  
• Health workers and facility managers will be focus of this study, thus giving voice to your 
interpretations and experiences of GeneXpert and its implementation. There is very little 
research done on health workers’ and facility managers’ experiences at primary health care 
level in this field. Thus by taking part in this study, you will be able to share insights on your 
experiences and how these experiences influence the ‘actual’ implementation and operation 
of GeneXpert in your facility. You will therefore have an opportunity to express concerns, 
challenges and strategies for success that may inform policy, implementation guidelines and 
future research.  
• To find feasible solutions to assist health workers and facility managers working in PHC and 
gage success strategies to strengthen implementation and TB care in their facilities.   
 
5. Risks, Discomforts & Inconveniences 
• This study poses a low risk of harm to you. 
• Under no circumstances will your identity or that of the facility be revealed in any 
presentation of findings (see section on Privacy and Confidentiality below).  
• Taking part in this study or refusing to take part in this study/withdrawing from the study will 
not influence your current or future employment at this facility.  
 
6. Privacy and Confidentiality 
• The participants will be known to the researcher and thus anonymity cannot be fully 
guaranteed throughout the research process. However, the researcher will ensure that 
participants remain anonymous in the writings and reports of the research process to protect 
the identity of participants as far as possible. The researcher will do this by masking your 
identity and the identity of your facility with pseudo names (for example, Participant A or 
Facility X) in all writings and reports on the research. Explicit characteristics of the facility 
will not be mentioned (for examples, the exact location of the facility or specific attributes of 
the facility that will make it identifiable).You have the right to request that any information 
you have shared be omitted from the study and future reports. 
• Information you share will be treated with confidentiality. 
• All observations and participation in the facility will be recorded through note taking. Notes 
will be hand written in a personal journal that will be locked up after the research process and 
will only be accessed during the analysis phases of the research project.   
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• Hard copies of transcriptions and had written notes will be stored in hard cover folders and 
stored in a locked drawer in an office at UCT. These documents that will strictly only be 
accessed by the researchers, supervisors and transcribers of this project. 
• The findings of this research paper may be published in an academic journal, newspaper 
article or other modes of mass communication.  
• All audio-recordings, transcriptions and notes will be destroyed approximately 5 years after 
the research has been accepted to be published in an academic journal.  
 
7. Contact details 
If you have questions, concerns, or complaints about the study please contact Lance 
Louskieter on 0837390528 or lsklan001@myuct.ac.za, Dr. Chris Colvin at the School of 
Public Health and Family Medicine, University of Cape Town (UCT) at 
coldvine@gmail.com.  
 
Alternatively, you may contact the ethics committee that approved the study if you have any 
ethical concerns or questions about your rights or welfare as a research participant at the 
following information:  
University of Cape Town, Faculty of Health Sciences 
Human Research Ethics Committee 
Telephone: (021) 406 6338  






{Participant’s name}________________________ has been informed of the nature and purpose of 
the procedures described above including any risks involved in its performance. He or she has been 
given time to ask any questions and these questions have been answered to the best of the 
investigator's ability. A signed copy of this consent form has been made available to the participant.  
  
_______________________       _______________ 
Investigator's Signature         Date 
 
 
I have been informed about this research study and understand its purpose, possible benefits, risks, 
and discomforts. I agree to take part in this research as a subject. I know that I am free to withdraw 
this consent and quit this project at any time, and that doing so will not cause me any penalty or loss 
of benefits that I would otherwise be entitled to enjoy. This means that I can decide to ask the 
researcher to stop the observation at any given time. I am aware that I will be observed as a meeting 
attendee in a meeting held at facility X and that I can request for information that I may share in the 
meeting to be withheld. I am further aware that the research will be written up in the form of a 
master’s research project and may be published in an academic journal.   
 
_______________________       _______________ 
Meeting Attendee Signature         Date 
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APPENDIX	  7:	  INSTRUCTIONS	  FOR	  AUTHOR	  OF	  JOURNAL	  WHOSE	  FORMAT	  HAS	  BEEN	  USED	  
JOURNAL:	  SOCIAL	  SCIENCE	  &	  MEDICINE	  
	  
DESCRIPTION	  
Social	   Science	   &	   Medicine	   provides	   an	   international	   and	   interdisciplinary	   forum	   for	   the	  
dissemination	   of	   social	   science	   research	   on	   health.	   We	   publish	   original	   research	   articles	   (both	  
empirical	  and	   theoretical),	   reviews,	  position	  papers	  and	  commentaries	  on	  health	   issues,	   to	   inform	  
current	   research,	   policy	   and	   practice	   in	   all	   areas	   of	   common	   interest	   to	   social	   scientists,	   health	  
practitioners,	   and	   policy	   makers.	   The	   journal	   publishes	  material	   relevant	   to	   any	   aspect	   of	   health	  
from	  a	  wide	  range	  of	  social	  science	  disciplines	  (anthropology,	  economics,	  epidemiology,	  geography,	  
policy,	   psychology,	   and	   sociology),	   and	   material	   relevant	   to	   the	   social	   sciences	   from	   any	   of	   the	  
professions	   concerned	   with	   physical	   and	   mental	   health,	   health	   care,	   clinical	   practice,	   and	   health	  
policy	   and	   organization.	   We	   encourage	   material	   which	   is	   of	   general	   interest	   to	   an	   international	  
readership.	  
	  
The	  journal	  publishes	  the	  following	  types	  of	  contribution:	  
1)	  Peer-­‐reviewed	  original	  research	  articles	  and	  critical	  or	  analytical	  reviews	  in	  any	  area	  of	  social	  
science	   research	   relevant	   to	   health.	   These	   papers	   may	   be	   up	   to	   8,000	   words	   including	   abstract,	  
tables,	  and	  references	  as	  well	  as	  the	  main	  text.	  Papers	  below	  this	  limit	  are	  preferred.	  
2)	  Peer-­‐reviewed	  short	  reports	  of	  research	  findings	  on	  topical	  issues	  or	  published	  articles	  of	  between	  
2000	  and	  4000	  words.	  
3)	  Submitted	  or	  invited	  commentaries	  and	  responses	  debating,	  and	  published	  alongside,	  selected	  
articles.	  
4)	   Special	   Issues	   bringing	   together	   collections	   of	   papers	   on	   a	   particular	   theme,	   and	   usually	   guest	  
edited.	  
	  
Please	  see	  our	  Guide	  for	  Authors	  for	  information	  on	  article	  submission.	  
	  
AUDIENCE	  
Social	  scientists	  (e.g.	  medical	  anthropologists,	  health	  economists,	  social	  epidemiologists,	  medical	  
geographers,	  health	  policy	  analysts,	  health	  psychologists,	  medical	  sociologists)	  interested	  in	  health,	  
illness,	   and	   health	   care;	   and	   health-­‐related	   policy	   makers	   and	   health	   care	   professionals	   (e.g.	  
dentists,	   epidemiologists,	   health	   educators,	   lawyers,	   managers,	   nurses,	   midwives,	   pharmacists,	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Social	  Sciences	  Citation	  Index	  
Sociological	  Abstracts	  




Co-­‐Editors	  in	  Chief:	  
Ichiro	   Kawachi,	   Harvard	   T.H.	   Chan	   School	   of	   Public	   Health,	   677	   Huntington	   Ave,	   SPH	   3,	   Floor	   7,	  
Boston,	  Massachusetts,	  02115,	  USA	  
S.V.	  Subramanian,	  Harvard	  T.H.	  Chan	  School	  of	  Public	  Health,	  677	  Huntington	  Ave,	  SPH	  3,	  Floor	  7,	  
Boston,	  Massachusetts,	  02115,	  USA	  Senior	  Editor,	  Medical	  Anthropology:	  
Catherine	   Panter-­‐Brick,	   Yale	   University,	   New	   Haven,	   Connecticut,	   USA	   Assistant	   Editor,	   Medical	  
Anthropology:	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Mark	  Eggerman,	  Yale	  University,	  New	  Haven,	  Connecticut,	  USA	  Senior	  Editor,	  Health	  Economics:	  
Joanna	  Coast,	  University	  of	  Bristol,	  Bristol,	  UK	  Senior	  Co-­‐Editors,	  Social	  Epidemiology:	  
Ichiro	  Kawachi,	  Harvard	  T.H.	  Chan	  School	  of	  Public	  Health,	  Boston,	  Massachusetts,	  USA	  
S.V.	  Subramanian,	  Harvard	  T.H.	  Chan	  School	  of	  Public	  Health,	  Boston,	  Massachusetts,	  USA	  Editorial	  
Associate,	  Social	  Epidemiology	  
Alexander	  Tsai,	  Massachusetts	  General	  Hospital,	  Boston,	  Massachusetts,	  USA	  Senior	  Editor,	  Medical	  
Geography:	  
Susan	   Elliott,	   University	   of	   Waterloo,	   Waterloo,	   Ontario,	   Canada	   Editorial	   Assistant:	   Medical	  
Geography:	  
Jenna	  Dixon,	  University	  of	  Waterloo,	  Waterloo,	  Ontario,	  Canada	  Senior	  Editor,	  Health	  Policy:	  
Winnie	  Yip,	  Harvard	  T.H.	  Chan	  School	  of	  Public	  Health,	  Boston,	  Massachusetts,	  USA	  Associate	  Editor,	  
Health	  Policy	  
Ashley	  M.	  Fox,	  University	  of	  Albany,	  Albany,	  New	  York,	  USA	  
Joseph	  Harris,	  Boston	  University,	  Boston,	  Massachusetts,	  USA	  Editorial	  Assistant,	  Health	  Policy:	  
Linda	   Anderson,	   La	   Trobe	   University,	   Melbourne,	   Victoria,	   Australia	   Senior	   Editor,	   Health	  
Psychology:	  
Blair	  T.	  Johnson,	  Institute	  for	  Collaboration	  on	  Health,	  Intervention,	  and	  Policy	  (InCHIP)	  &	  University	  
of	  Connecticut,	  Storrs,	  Connecticut,	  USA	  
Assistant	  Editors,	  Health	  Psychology:	  
Flora	  Cornish,	  London	  School	  of	  Economics,	  London,	  UK	  
Mark	  L.	  Hatzenbuehler,	  Mailman	  School	  of	  Public	  Health,	  Columbia	  University,	  New	  York,	  USA	  
Editorial	  Associate,	  Health	  Psychology:	  
Emily	   Alden	   Hennessy,	   Institute	   for	   Collaboration	   on	   Health,	   Intervention,	   and	   Policy	   (InCHIP)	   &	  
University	  of	  Connecticut,	  Storrs,	  Connecticut,	  USA	  
Rebecca	   L.	   Acabchuk,	   Institute	   for	   Collaboration	   on	   Health,	   Intervention,	   and	   Policy	   (InCHIP)	   &	  
University	  of	  Connecticut,	  Storrs,	  Connecticut,	  USA	  Senior	  Editor,	  Medical	  Sociology:	  
Stefan	   Timmermans,	   University	   of	   California	   at	   Los	   Angeles	   (UCLA),	   Los	   Angeles,	   California,	   USA	  
Editorial	  Assistant,	  Medical	  Sociology:	  
Caroline	  Tietbohl,	  University	  of	  California	  at	  Los	  Angeles	  (UCLA),	  Los	  Angeles,	  California,	  USA	  
Advisory	  Editors:	  
F.	  Aboud,	  McGill	  University,	  Montreal,	  Quebec,	  Canada	  
M.	  Avendano,	  London	  School	  of	  Economics,	  London,	  UK	  
K.	  Barker,	  University	  of	  New	  Mexico,	  Albuquerque,	  New	  Mexico,	  USA	  
J.R.	  Barnett,	  University	  of	  Canterbury,	  Christchurch,	  New	  Zealand	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S.	  Birch,	  McMaster	  University,	  Hamilton,	  Ontario,	  Canada	  
G.	  Bloom,	  University	  of	  Sussex,	  Brighton,	  UK	  
H.	  Bosma,	  University	  of	  Maastricht,	  Maastricht,	  Netherlands	  
B.	  Chaix,	  INSERM,	  Paris,	  France	  
D.	  Conradson,	  University	  of	  Canterbury,	  Christchurch,	  New	  Zealand	  
S.	  Curtis,	  Durham	  University,	  Durham,	  UK	  
J.	  De	  Berry,	  World	  Bank,	  Washington,	  District	  of	  Columbia,	  USA	  
A.	  De	  Silva,	  University	  of	  Peradeniya,	  Sri	  Lanka	  
M.	  DelVecchio	  Good,	  Harvard	  Medical	  School,	  Boston,	  Massachusetts,	  USA	  
C.	  Dunkel	  Schetter,	  University	  of	  California	  at	  Los	  Angeles	  (UCLA),	  Los	  Angeles,	  California,	  USA	  
S.	  Eggly,	  Wayne	  State	  University	  School	  of	  Medicine,	  Detroit,	  Michigan,	  USA	  
M.	  Emch,	  University	  of	  North	  Carolina	  at	  Chapel	  Hill,	  Chapel	  Hill,	  North	  Carolina,	  USA	  
D.	  Evans,	  Heartfile,	  Geneva,	  Switzerland	  
E.	  Fleegler,	  Childrens	  Hospital	  Boston,	  Boston,	  Massachusetts,	  USA	  
H.	  Fouts,	  University	  of	  Tennessee,	  Knoxville,	  Tennessee,	  USA	  
K.	  Frohlich,	  University	  of	  Montreal,	  Montreal,	  Quebec,	  Canada	  
J.	  Gabe,	  Royal	  Holloway,	  University	  of	  London,	  London,	  England,	  UK	  
B.	  Giles-­‐Corti,	  University	  of	  Melbourne,	  Melbourne,	  Victoria,	  Australia	  
S.	  Glantz,	  University	  of	  California	  at	  San	  Francisco	  (UCSF),	  San	  Francisco,	  California,	  USA	  
D.	  Hunter,	  Durham	  University,	  Durham,	  England,	  UK	  
R.	  S.	  Jorgensen,	  Syracuse	  University,	  Syracuse,	  New	  York,	  USA	  
A.	  Jutel,	  Victoria	  University	  of	  Wellington,	  Wellington,	  New	  Zealand	  
T.	  Kistemann,	  Rheinische	  Friedrich-­‐Wilhelms-­‐Universität	  Bonn,	  Bonn,	  Germany	  
B.	  Knäuper,	  McGill	  University,	  Montréal,	  Canada	  
K.	  Kondo,	  Chiba	  University,	  Chiba-­‐city,	  Chiba,	  Japan	  
M.	  Leach,	  University	  of	  Sussex,	  Brighton,	  UK	  
J.	  Lewis,	  University	  of	  Melbourne,	  Victoria,	  New	  South	  Wales,	  Australia	  
K.	  Y.	  Liu,	  University	  of	  California	  at	  Los	  Angeles	  (UCLA),	  Los	  Angeles,	  California,	  USA	  
W.	  W.	  S	  Mak,	  The	  Chinese	  University	  of	  Hong	  Kong,	  Shatin,	  N.T.,	  Hong	  Kong	  
D.	  McIntyre,	  University	  of	  Cape	  Town,	  Cape	  Town,	  South	  Africa	  
J.	  Merlo,	  Lund	  University,	  Malmö,	  Sweden	  
S.	  Nettleton,	  University	  of	  York,	  York,	  UK	  
M.	  Nichter,	  University	  of	  Arizona,	  Tucson,	  Arizona,	  USA	  
J.	  Niederdeppe,	  Cornell	  University,	  Ithaca,	  New	  York,	  USA	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A.	  Pilnick,	  Nottingham,	  Nottingham,	  England,	  UK	  
AUTHOR	  INFORMATION	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R.	  Pool,	  London	  School	  of	  Hygiene	  and	  Tropical	  Medicine,	  London,	  UK	  
U.	  Scholz,	  Universität	  Zürich,	  Zurich,	  Switzerland	  
M.	  Schooling,	  City	  University	  of	  New	  York	  (CUNY),	  USA	  
K.	  E.	  E.	  Schroder,	  University	  of	  Alabama	  at	  Birmingham,	  Birmingham,	  Alabama,	  USA	  
S.	  Shostak,	  Brandeis	  University,	  Waltham,	  Massachusetts,	  USA	  
S.	  Skevington,	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GUIDE	  FOR	  AUTHORS	  
Your	  Paper	  Your	  Way	  
We	  now	  differentiate	  between	  the	  requirements	  for	  new	  and	  revised	  submissions.	  You	  may	  choose	  
to	  submit	  your	  manuscript	  as	  a	  single	  Word	  or	  PDF	   file	   to	  be	  used	   in	   the	  refereeing	  process.	  Only	  
when	  your	  paper	   is	  at	   the	   revision	   stage,	  will	   you	  be	   requested	   to	  put	  your	  paper	   in	   to	  a	   'correct	  
format'	  for	  acceptance	  and	  provide	  the	  items	  required	  for	  the	  publication	  of	  your	  article.	  
To	  find	  out	  more,	  please	  visit	  the	  Preparation	  section	  below.	  
	  
INTRODUCTION	  
Click	  here	  for	  guidelines	  on	  Special	  Issues.	  
Click	  here	  for	  guidelines	  on	  Qualitative	  methods.	  
Social	   Science	   &	   Medicine	   provides	   an	   international	   and	   interdisciplinary	   forum	   for	   the	  
dissemination	   of	   social	   science	   research	   on	   health.	   We	   publish	   original	   research	   articles	   (both	  
empirical	  and	   theoretical),	   reviews,	  position	  papers	  and	  commentaries	  on	  health	   issues,	   to	   inform	  
current	   research,	   policy	   and	   practice	   in	   all	   areas	   of	   common	   interest	   to	   social	   scientists,	   health	  
practitioners,	  and	  policy	  makers.	  The	  journal	  publishes	  material	  relevant	  to	  any	  aspect	  of	  health	  and	  
healthcare	  from	  a	  wide	  range	  of	  social	  science	  disciplines	  (anthropology,	  economics,	  epidemiology,	  
geography,	  policy,	  psychology,	  and	  sociology),	  and	  material	  relevant	  to	  the	  social	  sciences	  from	  any	  
of	   the	   professions	   concerned	   with	   physical	   and	   mental	   health,	   health	   care,	   clinical	   practice,	   and	  
health	  policy	  and	  the	  organization	  of	  healthcare.	  We	  encourage	  material	  which	  is	  of	  general	  interest	  
to	  an	  international	  readership.	  
	  
Journal	  Policies	  
The	  journal	  publishes	  the	  following	  types	  of	  contribution:	  
1)	  Peer-­‐reviewed	  original	  research	  articles	  and	  critical	  analytical	  reviews	  in	  any	  area	  of	  social	  science	  
research	   relevant	   to	   health	   and	   healthcare.	   These	   papers	   may	   be	   up	   to	   8000	   words	   including	  
abstract,	  tables,	  figures,	  references	  and	  (printed)	  appendices	  as	  well	  as	  the	  main	  text.	  Papers	  below	  
this	  limit	  are	  preferred.	  
2)	  Systematic	  reviews	  and	  literature	  reviews	  of	  up	  to	  15000	  words	  including	  abstract,	  tables,	  figures,	  
references	  and	  (printed)	  appendices	  as	  well	  as	  the	  main	  text.	  
3)	   Peer-­‐reviewed	   short	   communications	   of	   findings	   on	   topical	   issues	   or	   published	   articles	   of	  
between	  2000	  and	  4000	  words.	  
4)	   Submitted	   or	   invited	   commentaries	   and	   responses	   debating,	   and	   published	   alongside,	   selected	  
articles	  (please	  select	  the	  article	  type	  'Discussion'	  when	  submitting	  a	  Commentary).	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5)	   Special	   Issues	   bringing	   together	   collections	   of	   papers	   on	   a	   particular	   theme,	   and	   usually	   guest	  
edited.	  Due	  to	  the	  high	  number	  of	  submissions	  received	  by	  Social	  Science	  &	  Medicine,	  Editorial	  
Offices	  are	  not	  able	   to	   respond	   to	  questions	   regarding	   the	  appropriateness	  of	  new	  papers	   for	   the	  
journal.	   If	   you	   are	   unsure	   whether	   or	   not	   your	   paper	   is	   within	   scope,	   please	   take	   some	   time	   to	  




You	  can	  use	  this	  list	  to	  carry	  out	  a	  final	  check	  of	  your	  submission	  before	  you	  send	  it	  to	  the	  journal	  for	  
review.	  Please	  check	  the	  relevant	  section	  in	  this	  Guide	  for	  Authors	  for	  more	  details.	  
Ensure	  that	  the	  following	  items	  are	  present:	  
One	  author	  has	  been	  designated	  as	  the	  corresponding	  author	  with	  contact	  details:	  
•	  E-­‐mail	  address	  
•	  Full	  postal	  address	  
All	  necessary	  files	  have	  been	  uploaded:	  
	  
Manuscript:	  
•	  Include	  keywords	  
•	  All	  figures	  (include	  relevant	  captions)	  
•	  All	  tables	  (including	  titles,	  description,	  footnotes)	  
•	  Ensure	  all	  figure	  and	  table	  citations	  in	  the	  text	  match	  the	  files	  provided	  
•	  Indicate	  clearly	  if	  color	  should	  be	  used	  for	  any	  figures	  in	  print	  
Graphical	  Abstracts	  /	  Highlights	  files	  (where	  applicable)	  
Supplemental	  files	  (where	  applicable)	  
	  
Further	  considerations	  
•	  Manuscript	  has	  been	  'spell	  checked'	  and	  'grammar	  checked'	  
•	  All	  references	  mentioned	  in	  the	  Reference	  List	  are	  cited	  in	  the	  text,	  and	  vice	  versa	  
•	  Manuscript	  does	  not	  exceed	  the	  word	  limit	  
•	  All	  identifying	  information	  has	  been	  removed	  from	  the	  manuscript,	  including	  the	  file	  name	  itself	  
•	  Permission	  has	  been	  obtained	  for	  use	  of	  copyrighted	  material	  from	  other	  sources	  (including	  the	  
Internet)	  
•	  Relevant	  declarations	  of	  interest	  have	  been	  made	  
•	  Journal	  policies	  detailed	  in	  this	  guide	  have	  been	  reviewed	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•	  Referee	  suggestions	  and	  contact	  details	  provided,	  based	  on	  journal	  requirements	  
For	  further	  information,	  visit	  our	  Support	  Center.	  
	  
BEFORE	  YOU	  BEGIN	  
Ethics	  in	  Publishing	  
For	  information	  on	  Ethics	  in	  publishing	  and	  Ethical	  guidelines	  for	  journal	  publication	  see	  
http://www.elsevier.com/publishingethics	  and	  http://www.elsevier.com/ethicalguidelines.	  
Please	   note	   that	   any	   submission	   that	   has	   data	   collected	   from	   human	   subjects	   requires	   ethics	  
approval.	  
If	  your	  manuscript	  does	  not	  include	  ethics	  approval,	  your	  paper	  will	  not	  be	  sent	  out	  for	  review.	  
Declaration	  of	  interest	  
All	  authors	  must	  disclose	  any	  financial	  and	  personal	  relationships	  with	  other	  people	  or	  organizations	  
that	   could	   inappropriately	   influence	   (bias)	   their	   work.	   Examples	   of	   potential	   conflicts	   of	   interest	  
include	   employment,	   consultancies,	   stock	   ownership,	   honoraria,	   paid	   expert	   testimony,	   patent	  
applications/	   registrations,	   and	   grants	   or	   other	   funding.	   If	   there	   are	   no	   conflicts	   of	   interest	   then	  
please	  state	  this:	  
	  
'Conflicts	  of	  interest:	  none'.	  More	  information.	  
Submission	  declaration	  and	  verification	  
Submission	   of	   an	   article	   implies	   that	   the	   work	   described	   has	   not	   been	   published	   previously	  
(excepting	   the	   form	   of	   a	   conference	   abstract	   or	   as	   part	   of	   a	   published	   lecture	   or	   thesis	   for	   an	  
academic	   qualification),	   that	   it	   is	   not	   under	   consideration	   for	   publication	   elsewhere,	   that	   its	  
publication	   is	  approved	  by	  all	  authors	  and	  tacitly	  or	  explicitly	  by	  the	  responsible	  authorities	  where	  
the	  work	  was	  carried	  out,	  and	  that,	  if	  accepted,	  it	  will	  not	  be	  published	  elsewhere	  in	  the	  same	  form,	  
in	   English	   or	   in	   any	   other	   language,	   including	   electronically	   without	   the	   written	   consent	   of	   the	  
copyright-­‐holder.	   To	   verify	   originality,	   your	   article	   may	   be	   checked	   by	   the	   originality	   detection	  
software	  iThenticate.	  See	  also	  http://www.elsevier.com/editors/plagdetect.	  
	  
Changes	  to	  authorship	  
Authors	   are	   expected	   to	   consider	   carefully	   the	   list	   and	   order	   of	   authors	   before	   submitting	   their	  
manuscript	   and	   provide	   the	   definitive	   list	   of	   authors	   at	   the	   time	   of	   the	   original	   submission.	   Any	  
addition,	   deletion	   or	   rearrangement	   of	   author	   names	   in	   the	   authorship	   list	   should	   be	  made	   only	  
before	   the	  manuscript	   has	   been	   accepted	   and	   only	   if	   approved	   by	   the	   journal	   Editor.	   To	   request	  
such	  a	  change,	  the	  Editor	  must	  receive	  the	  following	  from	  the	  corresponding	  author:	  (a)	  the	  reason	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for	  the	  change	  in	  author	  list	  and	  (b)	  written	  confirmation	  (e-­‐mail,	   letter)	  from	  all	  authors	  that	  they	  
agree	  with	  the	  addition,	   removal	  or	  rearrangement.	   In	  the	  case	  of	  addition	  or	  removal	  of	  authors,	  
this	  includes	  confirmation	  from	  the	  author	  being	  added	  or	  removed.	  
	  
Only	  in	  exceptional	  circumstances	  will	  the	  Editor	  consider	  the	  addition,	  deletion	  or	  rearrangement	  of	  
authors	  after	  the	  manuscript	  has	  been	  accepted.	  While	  the	  Editor	  considers	  the	  request,	  publication	  
of	  the	  manuscript	  will	  be	  suspended.	  If	  the	  manuscript	  has	  already	  been	  published	  in	  an	  online	  issue,	  
any	  requests	  approved	  by	  the	  Editor	  will	  result	  in	  a	  corrigendum.	  
	  
Article	  transfer	  service	  
This	   journal	   is	  part	  of	  our	  Article	  Transfer	  Service.	  This	  means	  that	   if	  the	  Editor	  feels	  your	  article	   is	  
more	   suitable	   in	   one	   of	   our	   other	   participating	   journals,	   then	   you	   may	   be	   asked	   to	   consider	  
transferring	  the	  article	  to	  one	  of	  those.	  If	  you	  agree,	  your	  article	  will	  be	  transferred	  automatically	  on	  





Upon	  acceptance	  of	  an	  article,	  authors	  will	  be	  asked	  to	  complete	  a	   'Journal	  Publishing	  Agreement'	  
(see	   more	   information	   on	   this).	   An	   e-­‐mail	   will	   be	   sent	   to	   the	   corresponding	   author	   confirming	  
receipt	  of	  the	  manuscript	  together	  with	  a	  'Journal	  Publishing	  Agreement'	  form	  or	  a	  link	  to	  the	  online	  
version	  of	  this	  agreement.	  
Subscribers	   may	   reproduce	   tables	   of	   contents	   or	   prepare	   lists	   of	   articles	   including	   abstracts	   for	  
internal	   circulation	   within	   their	   institutions.	   Permission	   of	   the	   Publisher	   is	   required	   for	   resale	   or	  
distribution	   outside	   the	   institution	   and	   for	   all	   other	   derivative	   works,	   including	   compilations	   and	  
translations.	   If	   excerpts	   from	   other	   copyrighted	   works	   are	   included,	   the	   author(s)	   must	   obtain	  
written	   permission	   from	   the	   copyright	   owners	   and	   credit	   the	   source(s)	   in	   the	   article.	   Elsevier	   has	  
preprinted	  forms	  for	  use	  by	  authors	  in	  these	  cases.	  For	  open	  access	  articles:	  Upon	  acceptance	  of	  an	  
article,	   authors	   will	   be	   asked	   to	   complete	   an	   'Exclusive	   License	   Agreement'	   (more	   information).	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As	   an	   author	   you	   (or	   your	   employer	   or	   institution)	   have	   certain	   rights	   to	   reuse	   your	  work.	  More	  
information.	  
	  
Elsevier	  supports	  responsible	  sharing	  
Find	  out	  how	  you	  can	  share	  your	  research	  published	  in	  Elsevier	  journals.	  
	  
Role	  of	  the	  funding	  source	  
You	  are	  requested	  to	  identify	  who	  provided	  financial	  support	  for	  the	  conduct	  of	  the	  research	  and/or	  
preparation	  of	  the	  article	  and	  to	  briefly	  describe	  the	  role	  of	  the	  sponsor(s),	  if	  any,	  in	  study	  design;	  in	  
the	  collection,	  analysis	  and	  interpretation	  of	  data;	  in	  the	  writing	  of	  the	  articles;	  and	  in	  the	  decision	  to	  
submit	   it	   for	   publication.	   If	   the	   funding	   source(s)	   had	   no	   such	   involvement	   then	   this	   should	   be	  
stated.	  Please	  see	  http://www.elsevier.com/funding.	  
	  
Funding	  body	  agreements	  and	  policies	  
Elsevier	  has	  established	  a	  number	  of	  agreements	  with	  funding	  bodies	  which	  allow	  authors	  to	  comply	  
with	  their	  funder's	  open	  access	  policies.	  Some	  funding	  bodies	  will	  reimburse	  the	  author	  for	  the	  Open	  
Access	  Publication	  Fee.	  Details	  of	  existing	  agreements	  are	  available	  online.	  
	  
Open	  access	  
This	  journal	  offers	  authors	  a	  choice	  in	  publishing	  their	  research:	  
Open	  access	  
•	  Articles	  are	  freely	  available	  to	  both	  subscribers	  and	  the	  wider	  public	  with	  permitted	  reuse.	  
•	   An	   open	   access	   publication	   fee	   is	   payable	   by	   authors	   or	   on	   their	   behalf,	   e.g.	   by	   their	   research	  
funder	  or	  institution.	  
Subscription	  
•	   Articles	   are	   made	   available	   to	   subscribers	   as	   well	   as	   developing	   countries	   and	   patient	   groups	  
through	  our	  universal	  access	  programs.	  
•	  No	  open	  access	  publication	  fee	  payable	  by	  authors.	  
Regardless	  of	  how	  you	  choose	   to	  publish	  your	  article,	   the	   journal	  will	  apply	   the	  same	  peer	   review	  
criteria	  and	  acceptance	  standards.	  or	  open	  access	  articles,	  permitted	  third	  party	  (re)use	  is	  defined	  by	  
the	  following	  Creative	  Commons	  user	  licenses:	  
	  
Creative	  Commons	  Attribution	  (CC	  BY)	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Lets	   others	   distribute	   and	   copy	   the	   article,	   create	   extracts,	   abstracts,	   and	   other	   revised	   versions,	  
adaptations	  or	  derivative	  works	  of	  or	   from	  an	  article	   (such	  as	  a	  translation),	   include	   in	  a	  collective	  
work	  (such	  as	  an	  anthology),	  text	  or	  data	  mine	  the	  article,	  even	  for	  commercial	  purposes,	  as	  long	  as	  
they	  credit	   the	  author(s),	  do	  not	  represent	  the	  author	  as	  endorsing	  their	  adaptation	  of	  the	  article,	  
and	  do	  not	  modify	  the	  article	  in	  such	  a	  way	  as	  to	  damage	  the	  author's	  honor	  or	  reputation.	  
	  
Creative	  Commons	  Attribution-­‐NonCommercial-­‐NoDerivs	  (CC	  BY-­‐NC-­‐ND)	  
For	   non-­‐commercial	   purposes,	   lets	   others	   distribute	   and	   copy	   the	   article,	   and	   to	   include	   in	   a	  
collective	  work	  (such	  as	  an	  anthology),	  as	  long	  as	  they	  credit	  the	  author(s)	  and	  provided	  they	  do	  not	  
alter	  or	  modify	  the	  article.	  
The	  open	  access	  publication	  fee	  for	  this	  journal	  is	  USD	  3200,	  excluding	  taxes.	  Learn	  more	  about	  
Elsevier's	  pricing	  policy:	  https://www.elsevier.com/openaccesspricing.	  
Green	  open	  access	  Authors	  can	  share	  their	  research	  in	  a	  variety	  of	  different	  ways	  and	  Elsevier	  has	  a	  
number	  of	  green	  open	  access	  options	  available.	  We	  recommend	  authors	  see	  our	  green	  open	  access	  
page	   for	   further	   information.	   Authors	   can	   also	   self-­‐archive	   their	   manuscripts	   immediately	   and	  
enable	  public	  access	  from	  their	   institution's	  repository	  after	  an	  embargo	  period.	  This	  is	  the	  version	  
that	   has	   been	   accepted	   for	   publication	   and	  which	   typically	   includes	   author-­‐incorporated	   changes	  
suggested	   during	   submission,	   peer	   review	   and	   in	   editor-­‐author	   communications.	   Embargo	   period:	  
For	   subscription	  articles,	  an	  appropriate	  amount	  of	   time	   is	  needed	   for	   journals	   to	  deliver	  value	   to	  
subscribing	  customers	  before	  an	  article	  becomes	  freely	  available	  to	  the	  public.	  This	  is	  the	  embargo	  
period	  and	  it	  begins	  from	  the	  date	  the	  article	  is	  formally	  published	  online	  in	  its	  final	  and	  fully	  citable	  
form.	  Find	  out	  more.	  
This	  journal	  has	  an	  embargo	  period	  of	  36	  months.	  
	  
Elsevier	  Publishing	  Campus	  
The	   Elsevier	   Publishing	   Campus	   (www.publishingcampus.com)	   is	   an	   online	   platform	   offering	   free	  
lectures,	  interactive	  training	  and	  professional	  advice	  to	  support	  you	  in	  publishing	  your	  research.	  The	  
College	   of	   Skills	   training	   offers	  modules	   on	   how	   to	   prepare,	   write	   and	   structure	   your	   article	   and	  
explains	   how	   editors	   will	   look	   at	   your	   paper	   when	   it	   is	   submitted	   for	   publication.	   Use	   these	  
resources,	  and	  more,	  to	  ensure	  that	  your	  submission	  will	  be	  the	  best	  that	  you	  can	  make	  it.	  
	  
Language	  (usage	  and	  editing	  services)	  
Please	  write	  your	  text	   in	  good	  English	  (American	  or	  British	  usage	   is	  accepted,	  but	  not	  a	  mixture	  of	  
these).	  Authors	  who	  feel	  their	  English	  language	  manuscript	  may	  require	  editing	  to	  eliminate	  possible	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grammatical	   or	   spelling	   errors	   and	   to	   conform	   to	   correct	   scientific	   English	   may	   wish	   to	   use	   the	  
English	  Language	  Editing	  service	  available	  from	  Elsevier's	  WebShop.	  
	  
Submission	  
Submission	   to	   this	   journal	  occurs	  online	  and	  you	  will	  be	  guided	  step	  by	   step	   through	   the	  creation	  
and	  uploading	  of	  your	  files.	  Please	  submit	  your	  article	  via	  http://ees.elsevier.com/ssm.	  The	  system	  
automatically	  converts	  source	  files	  to	  a	  single	  PDF	  file	  of	  the	  article,	  which	  is	  used	  in	  the	  peer-­‐review	  
process.	   Please	   note	   that	   even	   though	   manuscript	   source	   files	   are	   converted	   to	   PDF	   files	   at	  
submission	   for	   the	   review	   process,	   these	   source	   files	   are	   needed	   for	   further	   processing	   after	  
acceptance.	   All	   correspondence,	   including	   notification	   of	   the	   Editor's	   decision	   and	   requests	   for	  
revision,	  takes	  place	  by	  e-­‐mail.	  
	  
Reviewers	  
Please	  provide	  the	  names	  and	  email	  addresses	  of	  3	  potential	  reviewers	  and	  state	  the	  reason	  for	  each	  
suggestion.	  Colleagues	  within	  the	  same	  institution	  and	  co-­‐authors	  within	  the	  last	  5	  years	  should	  not	  
be	  included	  in	  the	  suggestions.	  Note	  that	  the	  editor	  retains	  the	  sole	  right	  to	  decide	  whether	  or	  not	  
the	  suggested	  reviewers	  are	  used.	  
	  
Additional	  information	  
Please	  note	  author	   information	   is	  entered	   into	  the	  online	  editorial	  system	  (EES)	  during	  submission	  
and	  must	  not	  be	  included	  in	  the	  manuscript	  itself.	  
Social	   Science	   &	   Medicine	   does	   not	   normally	   list	   more	   than	   six	   authors	   to	   a	   paper,	   and	   special	  
justification	  must	   be	   provided	   for	   doing	   so.	   Further	   information	   on	   criteria	   for	   authorship	   can	   be	  
found	  in	  Social	  Science	  &	  Medicine,	  2007,	  64(1),	  1-­‐4.	  
Authors	  should	  approach	  the	  Editors	  in	  Chief	  if	  they	  wish	  to	  submit	  companion	  articles.	  
Information	  about	  our	  peer-­‐review	  policy	  can	  be	  found	  here.	  




Submission	   to	   this	   journal	   proceeds	   totally	   online	   and	   you	   will	   be	   guided	   stepwise	   through	   the	  
creation	  and	  uploading	  of	  your	  files.	  The	  system	  automatically	  converts	  your	  files	  to	  a	  single	  PDF	  file,	  
which	  is	  used	  in	  the	  peer-­‐review	  process.	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As	  part	  of	  the	  Your	  Paper	  Your	  Way	  service,	  you	  may	  choose	  to	  submit	  your	  manuscript	  as	  a	  single	  
file	  to	  be	  used	  in	  the	  refereeing	  process.	  This	  can	  be	  a	  PDF	  file	  or	  a	  Word	  document,	  in	  any	  format	  or	  
layout	   that	   can	   be	   used	   by	   referees	   to	   evaluate	   your	  manuscript.	   It	   should	   contain	   high	   enough	  
quality	  figures	  for	  refereeing.	  If	  you	  prefer	  to	  do	  so,	  you	  may	  still	  provide	  all	  or	  some	  of	  the	  source	  




There	  are	  no	  strict	   requirements	  on	  reference	   formatting	  at	   submission.	  References	  can	  be	   in	  any	  
style	   or	   format	   as	   long	   as	   the	   style	   is	   consistent.	   Where	   applicable,	   author(s)	   name(s),	   journal	  
title/book	  title,	  chapter	  title/article	  title,	  year	  of	  publication,	  volume	  number/book	  chapter	  and	  the	  
pagination	  must	  be	  present.	  Use	  of	  DOI	  is	  highly	  encouraged.	  The	  reference	  style	  used	  by	  the	  journal	  
will	  be	  applied	  to	  the	  accepted	  article	  by	  Elsevier	  at	  the	  proof	  stage.	  Note	  that	  missing	  data	  will	  be	  
highlighted	  at	  proof	  stage	  for	  the	  author	  to	  correct.	  
	  
Formatting	  Requirements	  
The	  journal	  operates	  a	  double	  blind	  peer	  review	  policy.	  For	  guidelines	  on	  how	  to	  prepare	  your	  paper	  
to	  meet	  these	  criteria	  please	  see	  the	  attached	  guidelines.	  The	  journal	  requires	  that	  your	  manuscript	  
is	  submitted	  with	  double	  spacing	  applied.	  There	  are	  no	  other	  strict	  formatting	  requirements	  but	  all	  
manuscripts	  must	  contain	  the	  essential	  elements	  needed	  to	  convey	  your	  manuscript,	  for	  example	  
Abstract,	  Keywords,	  Introduction,	  Materials	  and	  Methods,	  Results,	  Conclusions,	  Artwork	  and	  Tables	  
with	  Captions.	  
If	  your	  article	  includes	  any	  Videos	  and/or	  other	  Supplementary	  material,	  this	  should	  be	  included	  in	  
your	  initial	  submission	  for	  peer	  review	  purposes.	  
Divide	  the	  article	  into	  clearly	  defined	  sections.	  
	  
Peer	  review	  
This	  journal	  operates	  a	  double	  blind	  review	  process.	  All	  contributions	  will	  be	  initially	  assessed	  by	  the	  
editor	  for	  suitability	  for	  the	  journal.	  Papers	  deemed	  suitable	  are	  then	  typically	  sent	  to	  a	  minimum	  of	  
two	   independent	   expert	   reviewers	   to	   assess	   the	   scientific	   quality	   of	   the	   paper.	   The	   Editor	   is	  
responsible	  for	  the	  final	  decision	  regarding	  acceptance	  or	  rejection	  of	  articles.	  The	  Editor's	  decision	  
is	  final.	  More	  information	  on	  types	  of	  peer	  review.	  
	  
REVISED	  SUBMISSIONS	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Use	  of	  word	  processing	  software	  	  
Regardless	   of	   the	   file	   format	   of	   the	   original	   submission,	   at	   revision	   you	  must	   provide	   us	  with	   an	  
editable	  file	  of	  the	  entire	  article.	  Keep	  the	  layout	  of	  the	  text	  as	  simple	  as	  possible.	  Most	  formatting	  
codes	   will	   be	   removed	   and	   replaced	   on	   processing	   the	   article.	   The	   electronic	   text	   should	   be	  
prepared	  in	  a	  way	  very	  similar	  to	  that	  of	  conventional	  manuscripts	  (see	  also	  the	  Guide	  to	  Publishing	  
with	  Elsevier).	  See	  also	  the	  section	  on	  Electronic	  artwork.	  
	  
To	  avoid	  unnecessary	  errors	  you	  are	  strongly	  advised	  to	  use	  the	   'spell-­‐check'	  and	   'grammar-­‐check'	  
functions	  of	  your	  word	  processor.	  
	  
Essential	  cover	  page	  information	  
The	  Cover	  Page	  should	  only	  include	  the	  following	  information:	  
• Title. Concise and informative. Titles are often used in information-retrieval systems. 
Avoid abbreviations and formulae where possible and make clear the article's aim and 
health relevance. 
• Author names and affiliations in the correct order. Where the family name may 
be ambiguous (e.g., a double name), please indicate this clearly. Present the authors' 
affiliation addresses (where the actual work was done) below the names. Indicate all 
affiliations with a lower-case superscript letter immediately after the author's name and 
in front of the appropriate address. Provide the full postal address of each affiliation, 
including the country name and, if available, the e-mail address of each author. 
• Corresponding author. Clearly indicate who will handle correspondence at all stages 
of refereeing and publication, also post-publication. Ensure that telephone and fax 
numbers (with country and area code) are provided in addition to the e-mail 
address and the complete postal address. Contact details must be kept up to 
date by the corresponding author. 
• Present/permanent address. If an author has moved since the work described in 
the article was done, or was visiting at the time, a 'Present address' (or 'Permanent 
address') may be indicated as a footnote to that author's name. The address at which 
the author actually did the work must be retained as the main, affiliation address. 
Superscript Arabic numerals are used for such footnotes. 
 
Text 
In the main body of the submitted manuscript this order should be followed: abstract, 
main text, references, appendix, figure captions, tables and figures. Author details, 
keywords and acknowledgements are entered separately during the online submission 
process, as is the abstract, though this is to be included in the manuscript as well. 
During submission authors are asked to provide a word count; this is to include ALL text, 
including that in tables, figures, references etc. 
 
Title 
Please consider the title very carefully, as these are often used in information-retrieval 
systems. 
Please use a concise and informative title (avoiding abbreviations where possible). Make 
sure that the health or healthcare focus is clear. 
 
Abstract 
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An abstract of up to 300 words must be included in the submitted manuscript. An 
abstract is often presented separately from the article, so it must be able to stand alone. 
It should state briefly and clearly the purpose and setting of the research, the principal 
findings and major conclusions, and the paper's contribution to knowledge. For empirical 
papers the country/countries/locations of the study should be clearly stated, as should 
the methods and nature of the sample, the dates, and a summary of the 
findings/conclusion. Please note that excessive statistical details should be avoided, 
abbreviations/acronyms used only if essential or firmly established, and that the abstract 
should not be structured into subsections. Any references cited in the abstract must be 
given in full at the end of the abstract. 
 
Research highlights 
Research highlights are a short collection of 3 to 5 bullet points that convey an article's 
unique contribution to knowledge and are placed online with the final article. We 
allow 85 characters per bullet point including spaces. They should be supplied as a 
separate file in the online submission system (further instructions will be provided 
there). You should pay very close attention to the formulation of the Research Highlights 
for your article.  
 
Make sure that they are clear, concise and capture the reader's attention. If your 
research highlights do not meet these criteria we may need to return your article to you 
leading to a delay in the review process. 
 
Keywords 
Up to 8 keywords are entered separately into the online editorial system during 
submission, and should accurately reflect the content of the article. Again 
abbreviations/acronyms should be used only if essential or firmly established. For 
empirical papers the country/countries/locations of the research should be included. The 
keywords will be used for indexing purposes. 
 
Methods 
Authors of empirical papers are expected to provide full details of the research methods 
used, including study location(s), sampling procedures, the date(s) when data were 
collected, research instruments, and techniques of data analysis. Specific guidance on 
the reporting of qualitative studies are provided here. 
 








• Make sure you use uniform lettering and sizing of your original artwork. 
• Preferred fonts: Arial (or Helvetica), Times New Roman (or Times), Symbol, Courier. 
• Number the illustrations according to their sequence in the text. 
• Use a logical naming convention for your artwork files. 
• Indicate per figure if it is a single, 1.5 or 2-column fitting image. 
• For Word submissions only, you may still provide figures and their captions, and tables 
within a single file at the revision stage. 
• Please note that individual figure files larger than 10 MB must be provided in separate 
source files. 
 
A detailed guide on electronic artwork is available. 
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You are urged to visit this site; some excerpts from the detailed information are 
given here. 
Formats 
Regardless of the application used, when your electronic artwork is finalized, please 
'save as' or convert the images to one of the following formats (note the resolution 
requirements for line drawings, halftones, and line/halftone combinations given below): 
EPS (or PDF): Vector drawings. Embed the font or save the text as 'graphics'. 
TIFF (or JPG): Color or grayscale photographs (halftones): always use a minimum of 300 
dpi. 
TIFF (or JPG): Bitmapped line drawings: use a minimum of 1000 dpi. 
TIFF (or JPG): Combinations bitmapped line/half-tone (color or grayscale): a minimum 
of 500 dpi is required. 
 
Please do not: 
• Supply files that are optimized for screen use (e.g., GIF, BMP, PICT, WPG); the 
resolution is too low. 
• Supply files that are too low in resolution. 
• Submit graphics that are disproportionately large for the content. Color artwork 
Please make sure that artwork files are in an acceptable format (TIFF (or JPEG), EPS (or 
PDF), or MS Office files) and with the correct resolution. If, together with your accepted 
article, you submit usable color figures then Elsevier will ensure, at no additional charge, 
that these figures will appear in color online (e.g., ScienceDirect and other sites) 
regardless of whether or not these illustrations are reproduced in color in the printed 
version. For color reproduction in print, you will receive information regarding 
the costs from Elsevier after receipt of your accepted article. Please indicate your 




Ensure that each illustration has a caption. A caption should comprise a brief title (not 
on the figure itself) and a description of the illustration. Keep text in the illustrations 
themselves to a minimum but explain all symbols and abbreviations used. 
 
Tables 
Please submit tables as editable text and not as images. Tables can be placed either 
next to the relevant text in the article, or on separate page(s) at the end. Number tables 
consecutively in accordance with their appearance in the text and place any table notes 
below the table body. Be sparing in the use of tables and ensure that the data presented 
in them do not duplicate results described elsewhere in the article. Please avoid using 
vertical rules and shading in table cells. 
 
References 
Citation in text 
Please ensure that every reference cited in the text is also present in the reference list 
(and vice versa). 
Any references cited in the abstract must be given in full at the end of the abstract. 
Unpublished results and personal communications are not recommended in the reference 
list, but may be mentioned in the text. If these references are included in the reference 
list they should follow the standard reference style of the journal (see below) and should 
include a substitution of the publication date with either "Unpublished results" or 
"Personal communication" Citation of a reference as "in press" implies that the item has 
been accepted for publication. 
 
As a minimum, the full URL should be given and the date when the reference was last 
accessed. Any further information, if known (DOI, author names, dates, reference to a 
source publication, etc.), should also be given. Web references can be listed separately 
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(e.g., after the reference list) under a different heading if desired, or can be included in 
the reference list. 
 
Data references 
This journal encourages you to cite underlying or relevant datasets in your manuscript 
by citing them in your text and including a data reference in your Reference List. Data 
references should include the following elements: author name(s), dataset title, data 
repository, version (where available), year, and global persistent identifier. Add 
[dataset] immediately before the reference so we can properly identify it as a data 
reference. The [dataset] identifier will not appear in your published article. 
 
References in special issue articles, commentaries and responses to commentaries 
 
Please ensure that the words 'this issue' are added to any references in the reference list 
(and any citations in the text) to other articles which are referred to in the same issue. 
Reference management software 
 
Most Elsevier journals have their reference template available in many of the most 
popular reference management software products. These include all products that 
support Citation Style Language styles, such as Mendeley and Zotero, as well as 
EndNote. Using the word processor plug-ins from these products, authors only need to 
select the appropriate journal template when preparing their article, after which citations 
and bibliographies will be automatically formatted in the journal's style. 
 
If no template is yet available for this journal, please follow the format of the sample 
references and citations as shown in this Guide. 
The current Social Science & Medicine EndNote file can be directly accessed by clicking 
here. 
 
Users of Mendeley Desktop can easily install the reference style for this journal by 
clicking the following 
link: 
http://open.mendeley.com/use-citation-style/social-science-and-medicine 
When preparing your manuscript, you will then be able to select this style using the 
Mendeley plugins for Microsoft Word or LibreOffice. 
 
Reference formatting 
There are no strict requirements on reference formatting at submission. References can 
be in any style or format as long as the style is consistent. Where applicable, author(s) 
name(s), journal title/book title, chapter title/article title, year of publication, volume 
number/book chapter and the pagination must be present. Use of DOI is highly 
encouraged. The reference style used by the journal will be applied to the accepted 
article by Elsevier at the proof stage. Note that missing data will be highlighted at proof 
stage for the author to correct. If you do wish to format the references yourself they 
should be arranged according to the following examples: 
 
Reference style 
Text: All citations in the text should refer to: 
1. Single author: the author's name (without initials, unless there is ambiguity) and the 
year of publication; 
2. Two authors: both authors' names and the year of publication; 
3. Three or more authors: first author's name followed by 'et al.' and the year of 
publication. 
Citations may be made directly (or parenthetically). Groups of references should be 
listed first alphabetically, then chronologically. 
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Examples: 'as demonstrated (Allan, 2000a, 2000b, 1999; Allan and Jones, 1999). 
Kramer et al. (2010) have recently shown ....' 
List: References should be arranged first alphabetically and then further sorted 
chronologically if necessary. More than one reference from the same author(s) in the 




Reference to a journal publication: 
Van der Geer, J., Hanraads, J.A.J., Lupton, R.A., 2010. The art of writing a scientific 
article. J. Sci. Commun. 163, 51–59. 
Reference to a book: 
Strunk Jr., W., White, E.B., 2000. The Elements of Style, fourth ed. Longman, New York. 
Reference to a chapter in an edited book: 
Mettam, G.R., Adams, L.B., 2009. How to prepare an electronic version of your article, 
in: Jones, B.S., Smith , R.Z. (Eds.), Introduction to the Electronic Age. E-Publishing Inc., 
New York, pp. 281–304. 
 
Reference to a website: 
Cancer Research UK, 1975. Cancer statistics reports for the UK. 
http://www.cancerresearchuk.org/aboutcancer/statistics/cancerstatsreport/ (accessed 
13.03.03). 
Reference to a dataset: [dataset] Oguro, M., Imahiro, S., Saito, S., Nakashizuka, T., 
2015. Mortality data for Japanese oak wilt disease and surrounding forest compositions. 
Mendeley Data, v1. https://doi.org/10.17632/ xwj98nb39r.1. 
 
Video data 
Elsevier accepts video material and animation sequences to support and enhance your 
scientific research. Authors who have video or animation files that they wish to submit 
with their article may do so during online submission. Where relevant, authors are 
strongly encouraged to include a video still within the body of the article. This can be 
done in the same way as a figure or table by referring to the video or animation content 
and noting in the body text where it should be placed. These will be used instead of 
standard icons and will personalize the link to your video data. All submitted files should 
be properly labeled so that they directly relate to the video file's content. In order to 
ensure that your video or animation material is directly usable, please provide the files in 
one of our recommended file formats with a maximum size of 10 MB. Video and 
animation files supplied will be published online in the electronic version of your article in 
Elsevier Web products, including 
ScienceDirect: http://www.sciencedirect.com. For more detailed instructions please visit 
our video instruction pages at http://www.elsevier.com/artworkinstructions. Note: since 
video and animation cannot be embedded in the print version of the journal, please 
provide text for both the electronic 
and the print version for the portions of the article that refer to this content. 
 
Supplementary data 
Elsevier accepts electronic supplementary material to support and enhance your 
research. 
Supplementary files offer the author additional possibilities to publish supporting 
applications, accompanying videos describing the research, more detailed tables, 
background datasets, sound clips and more. Supplementary files supplied will be 
published online alongside the electronic version of your article in Elsevier Web products, 
including ScienceDirect: http://www.sciencedirect.com. In order to ensure that your 
submitted material is directly usable, please provide the data in one of our 
recommended file formats. Authors should submit the material in electronic format 
together with the article and supply a concise and descriptive caption for each file. For 
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This journal encourages and enables you to share data that supports your research 
publication where appropriate, and enables you to interlink the data with your published 
articles. Research data refers to the results of observations or experimentation that 
validate research findings. To facilitate 
reproducibility and data reuse, this journal also encourages you to share your software, 
code, models, algorithms, protocols, methods and other useful materials related to the 
project. 
Below are a number of ways in which you can associate data with your article or make a 
statement about the availability of your data when submitting your manuscript. If you 
are sharing data in one of these ways, you are encouraged to cite the data in your 
manuscript and reference list. Please refer to the "References" section for more 
information about data citation. For more information on depositing, sharing and using 
research data and other relevant research materials, visit the research data page. 
 
Data linking 
If you have made your research data available in a data repository, you can link your 
article directly to the dataset. Elsevier collaborates with a number of repositories to link 
articles on ScienceDirect with relevant repositories, giving readers access to underlying 
data that gives them a better understanding of the research described. 
There are different ways to link your datasets to your article. When available, you can 
directly link your dataset to your article by providing the relevant information in the 
submission system. For more information, visit the database linking page. 
For supported data repositories a repository banner will automatically appear next to 
your published article on ScienceDirect. 
 
In addition, you can link to relevant data or entities through identifiers within the text of 
your manuscript, using the following format: Database: xxxx (e.g., TAIR: AT1G01020; 
CCDC: 734053; PDB: 1XFN). 
Mendeley Data 
This journal supports Mendeley Data, enabling you to deposit any research data 
(including raw and processed data, video, code, software, algorithms, protocols, and 
methods) associated with your manuscript in a free-to-use, open access repository. 
Before submitting your article, you can deposit the relevant datasets to Mendeley Data. 
Please include the DOI of the deposited dataset(s) in your main manuscript file. The 
datasets will be listed and directly accessible to readers next to your published article 
online. 
For more information, visit the Mendeley Data for journals page. 
Data statement 
To foster transparency, we encourage you to state the availability of your data in your 
submission. 
This may be a requirement of your funding body or institution. If your data is unavailable 
to access or unsuitable to post, you will have the opportunity to indicate why during the 
submission process, for example by stating that the research data is confidential. The 
statement will appear with your published article on ScienceDirect. For more 
information, visit the Data Statement page. 
 
AudioSlides 
The journal encourages authors to create an AudioSlides presentation with their 
published article. AudioSlides are brief, webinar-style presentations that are shown next 
to the online article on ScienceDirect. This gives authors the opportunity to summarize 
their research in their own words and to help readers understand what the paper is 
about. More information and examples are available. Authors of this journal will 
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automatically receive an invitation e-mail to create an AudioSlides presentation after 
acceptance of their paper. 
 
Interactive plots 
This journal enables you to show an Interactive Plot with your article by simply 
submitting a data file. Full instructions. 
 
AFTER ACCEPTANCE 
Online proof correction 
Corresponding authors will receive an e-mail with a link to our online proofing system, 
allowing annotation and correction of proofs online. The environment is similar to MS 
Word: in addition to editing text, you can also comment on figures/tables and answer 
questions from the Copy Editor. 
Web-based proofing provides a faster and less error-prone process by allowing you to 
directly type your corrections, eliminating the potential introduction of errors. 
 
If preferred, you can still choose to annotate and upload your edits on the PDF version. 
All instructions for proofing will be given in the e-mail we send to authors, including 
alternative methods to the online version and PDF. 
We will do everything possible to get your article published quickly and accurately. 
Please use this proof only for checking the typesetting, editing, completeness and 
correctness of the text, tables and figures. Significant changes to the article as accepted 
for publication will only be considered at this stage with permission from the Editor. It is 
important to ensure that all corrections are sent back to us in one communication. 
Please check carefully before replying, as inclusion of any subsequent corrections cannot 
be guaranteed. Proofreading is solely your responsibility. 
 
Offprints 
The corresponding author will, at no cost, receive a customized Share Link providing 50 
days free access to the final published version of the article on ScienceDirect. The Share 
Link can be used for sharing the article via any communication channel, including email 
and social media. For an extra charge, paper offprints can be ordered via the offprint 
order form which is sent once the article is accepted for publication. Both corresponding 
and co-authors may order offprints at any time via Elsevier's Webshop. Corresponding 
authors who have published their article open access do 
not receive a Share Link as their final published version of the article is available open 
access on ScienceDirect and can be shared through the article DOI link. 
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